Health consequences of adverse fetal growth : studies in twins by Öberg, Sara
	  	  
	  Department	  of	  Medical	  Epidemiology	  and	  Biostatistics	  	  Karolinska	  Institutet,	  Stockholm,	  Sweden	  	  	  	  	  	  
HEALTH	  CONSEQUENCES	  OF	  ADVERSE	  FETAL	  GROWTH	  –	  STUDIES	  IN	  TWINS	  

















The	  picture	  “Två	  bröder	  ser	  på	  stjärnor”	  on	  the	  front	  page	  is	  reproduced	  with	  kind	  permission	  from	  the	  artist	  Helena	  Bergenrud	  (www.bergenrud.com)	  	  All	  previously	  published	  papers	  were	  reproduced	  with	  permission	  from	  the	  publishers	  indicated	  in	  the	  list	  of	  publications	  	  Published	  by	  Karolinska	  Institutet	  Printed	  by	  Larserics	  Digital	  Print	  AB	  	  ©	  Sara	  Öberg,	  2011	  ISBN	  978-­‐91-­‐7457-­‐371-­‐8	  	   	  
	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   The	  real	  voyage	  of	  discovery	  consists	  not	  in	  seeking	  new	  lands	  	  but	  in	  having	  new	  eyes	  	  	   	   	   	   	   -­‐Marcel	  Proust	  

	  	   	   	  1	  
ABSTRACT	  Findings	  of	  associations	  between	  birth	  weight	  and	  adult	  health	  outcomes	  have	  been	  taken	  to	  indicate	  that	  fetal	  growth	  –	  and	  fetal	  nutrition	  in	  particular	  –	  may	  program	  future	  health	  and	  disease	  in	  the	  developing	  individual.	  However,	  the	  study	  of	  prenatal	  exposures	  in	  humans	  is	  challenging,	  and	  most	  of	  the	  evidence	  to	  support	  fetal	  programming	  thus	  rests	  on	  proxy	  measures,	  such	  as	  birth	  weight	  and	  birth	  weight	  for	  gestational	  age.	  These	  measures	  are	  not	  only	  crude	  indicators	  for	  fetal	  growth	  and	  fetal	  nutrition,	  but	  also	  influenced	  by	  many	  other	  factors,	  some	  of	  which	  may	  be	  involved	  in	  disease	  development	  (common	  causes).	  	  	  	  	  The	  aim	  of	  this	  thesis	  has	  been	  to	  make	  use	  of	  the	  unique	  features	  of	  twins	  to	  increase	  the	  understanding	  of	  potential	  health	  consequences	  of	  adverse	  fetal	  growth.	  Birth	  weight	  differences	  within	  twin	  pairs	  target	  a	  specific	  measure	  of	  fetal	  growth,	  and	  within-­‐twinpair	  comparison	  further	  allows	  for	  evaluation	  of	  the	  influence	  of	  fetal	  growth	  independent	  of	  factors	  shared	  by	  the	  twins	  in	  a	  twin	  pair.	  Some	  of	  these	  factors	  (e.g.	  early	  socioeconomic	  environment	  and	  genetic	  factors)	  have	  been	  proposed	  to	  potentially	  confound	  associations	  between	  birth	  weight	  and	  adult	  disease.	  Twins	  as	  a	  group	  are	  further	  exposed	  to	  a	  more	  adverse	  fetal	  environment	  than	  singletons.	  By	  comparing	  adult	  morbidity	  and	  mortality	  in	  twins	  to	  singletons	  from	  twin	  families,	  the	  potential	  influence	  of	  twinning	  on	  later	  health	  could	  be	  evaluated,	  independent	  of	  twin	  family	  factors.	  	  	  	  In	  a	  cohort	  of	  bi-­‐ethnic	  adolescent	  twins	  in	  Georgia	  (US)	  we	  could	  confirm	  that	  the	  previously	  reported	  inverse	  linear	  association	  between	  birth	  weight	  and	  blood	  pressure	  was	  present	  also	  in	  African	  Americans,	  and	  independent	  of	  familial	  factors.	  The	  findings	  support	  a	  role	  for	  fetal	  programming	  in	  African	  Americans	  that	  warrants	  further	  tracking	  of	  the	  association	  into	  adulthood.	  	  	  	  	  Associations	  between	  birth	  weight	  and	  adult	  outcomes	  were	  further	  studied	  in	  a	  cohort	  of	  like-­‐sexed	  twins	  of	  the	  Swedish	  Twin	  Register,	  born	  1926	  to	  1958.	  First	  the	  previously	  reported	  positive	  association	  between	  birth	  weight	  and	  breast	  cancer	  was	  investigated	  in	  over	  11	  000	  female	  twins.	  A	  linear	  association	  (from	  2,500	  grams	  and	  upward)	  was	  noted	  for	  the	  log-­‐rate	  of	  breast	  cancer	  diagnosed	  before	  the	  age	  of	  50	  among	  unrelated	  twins	  as	  well	  as	  within	  twin	  pairs,	  indicating	  that	  the	  intrauterine	  experience	  may	  play	  a	  role	  in	  the	  development	  of	  early	  onset	  breast	  cancer.	  Next	  we	  performed	  conditional	  logistic	  regression	  on	  all	  twin	  pairs	  discordant	  for	  cardiovascular	  disease	  (N=1942),	  finding	  birth	  weight	  inversely	  associated	  with	  coronary	  heart	  disease	  and	  stroke	  within	  dizygotic	  (DZ)	  but	  not	  within	  monozygotic	  (MZ)	  twin	  pairs.	  Understanding	  which	  factors	  are	  shared	  within	  MZ	  but	  not	  DZ	  twin	  pairs	  could	  help	  shed	  some	  light	  on	  the	  underlying	  mechanisms	  to	  the	  association	  between	  birth	  weight	  and	  cardiovascular	  disease.	  	  	  	  Lastly,	  we	  compared	  cumulative	  risks	  of	  cardiovascular	  disease,	  overall	  cancer	  and	  death	  in	  twins,	  singletons	  from	  twin	  families	  as	  well	  as	  from	  the	  population	  (identified	  in	  the	  Multi-­‐Generation	  Register	  and	  born	  between	  1932-­‐1958).	  For	  all	  three	  outcomes	  twins	  appeared	  similar	  to	  singletons	  of	  twin	  families,	  and	  these	  in	  turn	  were	  not	  found	  any	  different	  from	  singletons	  of	  non-­‐twin	  families	  overall.	  The	  findings	  indicate	  that	  the	  unique	  experience	  of	  twinning	  does	  not	  influence	  risk	  of	  adult	  morbidity	  or	  mortality	  compared	  to	  the	  general	  population.	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1 INTRODUCTION	  	  The	  time	  we	  spend	  in	  utero	  is	  undoubtedly	  the	  most	  important	  developmental	  time	  period	  of	  our	  lives;	  we	  go	  from	  one	  cell	  to	  a	  viable	  individual	  in	  roughly	  38	  weeks!	  Potential	  disturbances	  of	  growth	  and	  maturation	  in	  the	  perinatal	  period	  may	  seriously	  affect	  the	  future	  functioning	  of	  the	  developing	  individual.	  If	  responsible	  triggers	  and	  insults	  could	  be	  correctly	  identified,	  carefully	  weighted	  interventions	  could	  have	  great	  impact	  on	  the	  life	  and	  health	  of	  the	  individual.	  However,	  if	  a	  targeted	  agent	  is	  not	  causal,	  the	  intervention	  may	  be	  ineffective,	  costly	  and	  potentially	  even	  harmful.	  In	  the	  special	  case	  of	  pregnancy	  the	  importance	  of	  establishing	  causality	  is	  further	  emphasized,	  as	  interventions	  may	  affect	  both	  mother	  and	  fetus.	  	  	  The	  last	  two	  decades	  have	  seen	  the	  emergence	  of	  a	  research	  field	  dedicated	  to	  the	  Developmental	  Origins	  of	  Health	  and	  Disease	  (DOHaD).	  Following	  the	  first	  findings	  of	  an	  inverse	  association	  between	  birth	  weight	  and	  mortality	  from	  coronary	  heart	  disease,	  birth	  weight	  has	  been	  found	  inversely	  associated	  with	  both	  cardiovascular	  disease	  and	  its	  risk	  factors,	  including	  hypertension	  and	  non-­‐insulin	  dependent	  diabetes	  (NIDDM)	  [1-­‐4].	  Considering	  birth	  weight	  a	  proxy	  for	  fetal	  growth	  and	  fetal	  nutrition,	  it	  has	  been	  suggested	  that	  critical	  insults	  to	  fetal	  nutrition	  may	  program	  later	  disease	  [5].	  With	  most	  focus	  on	  the	  role	  of	  fetal	  and	  maternal	  nutrition,	  this	  has	  paved	  way	  for	  sophisticated	  evolutionary	  theories	  of	  developmental	  plasticity,	  whereby	  the	  fetus	  adapts	  in	  preparation	  for	  the	  outside	  world	  in	  response	  to	  signals	  via	  the	  nutritional	  supply	  line	  from	  the	  mother	  [6].	  While	  this	  field	  of	  research	  has	  moved	  on	  to	  consider	  such	  signals	  (prenatal	  exposures)	  that	  may	  not	  even	  influence	  birth	  weight	  or	  fetal	  growth,	  the	  underlying	  mechanisms	  of	  the	  original	  findings	  remain	  to	  be	  explained.	  Birth	  weight	  is	  a	  product	  of	  gestational	  age	  and	  fetal	  growth,	  and	  is	  thus	  a	  crude	  proxy	  for	  fetal	  growth,	  which	  in	  turn	  is	  an	  even	  more	  crude	  proxy	  for	  fetal	  nutrition.	  The	  factors	  that	  influence	  birth	  weight	  and	  fetal	  growth	  may	  also	  be	  involved	  in	  cardiovascular	  disease	  development,	  e.g.	  socioeconomic	  and	  genetic	  factors.	  It	  is	  thus	  possible	  that	  the	  reported	  associations	  could	  be	  partly	  or	  entirely	  explained	  by	  the	  presence	  of	  shared	  common	  causes	  (confounding).	  It	  is	  also	  possible	  that	  suboptimal	  fetal	  growth	  results	  in	  morphological	  and	  structural	  changes	  in	  the	  developing	  fetus	  that	  will	  ultimately	  influence	  later	  disease	  risk.	  	  The	  perhaps	  most	  studied	  association	  within	  this	  field	  is	  that	  between	  birth	  weight	  and	  blood	  pressure	  [7-­‐9].	  Drawing	  on	  this	  well-­‐established	  inverse	  association,	  it	  has	  been	  proposed	  that	  the	  higher	  blood	  pressure	  levels	  seen	  in	  African	  Americans	  (AAs)	  compared	  to	  European	  Americans	  (EAs)	  could	  be	  explained	  by	  fetal	  programming,	  as	  AAs	  also	  experience	  higher	  incidence	  of	  both	  low	  birth	  weight	  and	  small	  for	  gestational	  age,	  compared	  to	  EAs	  [10,	  11].	  	  	  At	  the	  other	  end	  of	  the	  spectrum,	  excessive	  fetal	  growth	  and	  high	  birth	  weight	  may	  not	  necessarily	  benefit	  future	  health.	  In	  1990	  Trichopoulos	  proposed	  that	  breast	  cancer	  may	  originate	  in	  utero	  [12],	  speculating	  that	  intrauterine	  exposure	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to	  pregnancy	  estrogens	  could	  increase	  breast	  cancer	  risk	  in	  female	  offspring,	  both	  by	  increasing	  the	  amount	  of	  cells	  at	  risk	  and	  the	  likelihood	  for	  malignant	  transformation	  [13].	  Considering	  birth	  weight	  a	  proxy	  for	  hormone	  exposure	  in	  utero	  [14,	  15],	  the	  positive	  association	  between	  birth	  weight	  and	  risk	  of	  breast	  cancer	  [16-­‐19]	  has	  been	  put	  forward	  as	  supporting	  evidence	  of	  the	  hypothesis.	  It	  is	  also	  possible	  that	  birth	  weight	  and	  breast	  cancer	  share	  common	  causes,	  which	  confound	  the	  association.	  	  	  Twin	  siblings	  share	  early	  environment,	  and	  a	  varying	  degree	  of	  genetic	  factors.	  	  As	  a	  result,	  birth	  weight	  differences	  within	  twin	  pairs	  will	  reflect	  fetal	  growth	  that	  is	  independent	  of	  gestational	  age,	  maternal	  and	  other	  factors	  shared	  by	  the	  twins.	  Within	  monozygotic	  (MZ)	  twin	  pairs	  birth	  weight	  reflects	  fetal	  growth	  that	  is	  independent	  also	  of	  genetic	  factors.	  Thus,	  evaluating	  the	  effects	  of	  birth	  weight	  within	  twin	  pairs	  may	  help	  gain	  more	  insights	  about	  the	  early	  life	  influence	  on	  adult	  disease.	  Previous	  investigations	  of	  disease-­‐discordant	  twin	  pairs	  from	  the	  Swedish	  Twin	  Registry	  have	  shown	  attenuation	  of	  birth	  weight	  associations	  within	  MZ	  twin	  siblings	  for	  NIDDM	  [20]	  but	  not	  for	  hypertension	  [21].	  	  	  Findings	  in	  twins	  are	  commonly	  questioned	  concerning	  their	  representativeness	  of	  the	  general	  population.	  This	  is	  of	  particular	  concern	  with	  respect	  to	  perinatal	  conditions	  where	  differences	  in	  prenatal	  environment	  between	  twins	  and	  singletons	  need	  to	  be	  considered.	  Due	  to	  spatial	  and	  nutritional	  constraints,	  twins	  generally	  have	  shorter	  gestation	  as	  well	  as	  lower	  birth	  weights	  for	  gestational	  age,	  compared	  to	  singletons.	  Yet,	  twins	  do	  not	  appear	  to	  be	  different	  from	  the	  general	  population	  with	  respect	  to	  cardiovascular	  mortality	  in	  adulthood	  [22,	  23].	  At	  the	  same	  time,	  there	  are	  many	  reports	  of	  associations	  between	  birth	  weight	  and	  adult	  diseases	  in	  twin	  samples	  similar	  to	  those	  widely	  reported	  in	  singleton	  populations	  [20,	  21,	  24].	  It	  has	  been	  suggested	  that	  the	  general	  growth	  constraint	  of	  twinning	  (due	  to	  sharing	  of	  space	  and	  supply	  line)	  may	  not	  influence	  adult	  disease	  risk,	  whereas	  the	  factors	  that	  make	  twins	  experience	  different	  growth	  (compared	  to	  unrelated	  twins	  and/or	  the	  co-­‐twin)	  could	  [25].	  For	  cancer	  overall,	  twins	  do	  not	  appear	  to	  differ	  from	  the	  general	  population.	  Reports	  from	  studies	  of	  specific	  types	  of	  cancer	  indicate	  that	  twins	  may	  experience	  lower	  risk	  of	  some	  types	  of	  cancers	  [26-­‐28]	  and	  higher	  risk	  of	  others	  [26,	  28].	  Previous	  twin-­‐singleton	  comparisons	  could	  also	  be	  confounded	  if	  twins	  as	  a	  group	  were	  to	  have	  a	  slightly	  different	  genetic	  or	  socioeconomic	  background	  than	  the	  general	  population	  [29].	  	  The	  main	  aim	  of	  this	  thesis	  has	  been	  to	  take	  advantage	  of	  the	  unique	  features	  of	  twins	  to	  increase	  the	  understanding	  of	  how	  early	  life	  exposure	  may	  influence	  later	  health.	  In	  the	  first	  three	  studies	  previously	  well-­‐described	  associations	  between	  birth	  weight	  and	  later	  health	  outcomes	  are	  re-­‐assessed	  within	  twin	  pairs	  in	  order	  to	  evaluate	  the	  influence	  of	  fetal	  growth	  that	  is	  independent	  of	  factors	  shared	  by	  twins	  in	  a	  twin	  pair.	  In	  the	  final	  study,	  the	  health	  consequences	  (in	  terms	  of	  adult	  morbidity	  and	  mortality)	  of	  the	  twin	  experience,	  whether	  being	  a	  twin	  or	  a	  member	  of	  a	  twin	  family,	  are	  investigated.	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2 BACKGROUND	  	  2.1 FETAL	  GROWTH	  By	  tradition,	  a	  pregnancy	  dates	  from	  the	  first	  day	  of	  the	  last	  menstrual	  period	  [30].	  Because	  of	  the	  variability	  of	  the	  menstrual	  cycle,	  both	  within	  and	  between	  women,	  this	  will	  be	  between	  1	  to	  3	  weeks	  before	  the	  ovulation	  that	  enables	  fertilization	  takes	  place	  [31].	  It	  follows	  that	  the	  gestational	  age	  will	  overestimate	  that	  of	  the	  fetus	  by	  approximately	  2	  weeks.	  A	  normal	  pregnancy	  lasts	  281-­‐282	  gestational	  days	  [32].	  Stages	  of	  growth	  and	  development	  are	  commonly	  described	  in	  relation	  to	  the	  three	  trimesters	  of	  pregnancy,	  referring	  to	  the	  first	  14	  weeks	  (1st	  trimester),	  weeks	  14-­‐28	  (2nd	  trimester)	  and	  weeks	  28-­‐40	  (3rd	  trimester).	  	  Essentially	  all	  vital	  structures	  and	  organs	  are	  formed	  already	  during	  the	  first	  8	  weeks	  of	  life,	  in	  what	  is	  called	  the	  embryonic	  period.	  For	  the	  remainder	  of	  the	  pregnancy,	  the	  fetal	  period,	  focus	  is	  on	  growth,	  development	  and	  maturation.	  	  	  Fetal	  growth	  is	  a	  carefully	  weighted	  process,	  in	  which	  the	  needs	  of	  the	  fetus	  must	  be	  balanced	  against	  the	  capacity	  of	  the	  mother.	  To	  secure	  survival	  of	  the	  offspring	  the	  fetus	  has	  to	  be	  allowed	  to	  grow	  and	  mature,	  but	  not	  more	  than	  it	  can	  also	  be	  delivered	  without	  complication.	  According	  to	  the	  parent-­‐offspring	  conflict,	  the	  mother	  may	  also	  have	  an	  invested	  interest	  to	  protect	  her	  future	  reproductive	  capacity	  by	  not	  putting	  all	  effort	  into	  one	  offspring	  [33].	  Along	  these	  lines,	  parental	  imprinting	  of	  genes	  has	  inspired	  the	  idea	  of	  an	  evolutionary	  genetic	  struggle	  between	  paternal	  and	  maternal	  genes,	  where	  paternal	  genes	  would	  seek	  to	  optimize	  growth	  whereas	  the	  maternal	  would	  balance	  or	  counter	  this	  [34].	  	  	  
2.1.1 FETAL	  GROWTH	  REGULATION	  The	  premises	  for	  fetal	  growth	  are	  thus	  a	  fetus	  with	  a	  certain	  growth	  potential,	  and	  a	  space	  and	  supply	  line	  to	  enable	  it.	  In	  other	  words,	  the	  full	  realization	  of	  the	  fetal	  genetic	  growth	  potential	  will	  depend	  on	  the	  physical	  constraints	  (maternal	  physiognomy)	  and	  availability	  of	  nutrients	  and	  oxygen	  (the	  supply	  line	  from	  the	  mother).	  Thus,	  the	  mother	  influences	  the	  potential	  for	  growth	  both	  by	  providing	  genes	  (to	  the	  fetus)	  and	  intrauterine	  environment	  (which	  in	  turn	  will	  be	  a	  result	  of	  both	  her	  genes	  and	  environment).	  Maternal	  genetic	  factors	  have	  been	  found	  to	  account	  for	  approximately	  20%,	  and	  fetal	  genetic	  factors	  for	  30	  %,	  of	  the	  normal	  variation	  in	  birth	  weight	  [35]	  and	  the	  liability	  for	  small	  for	  gestational	  age	  [36].	  	  Since	  the	  mother	  is	  the	  sole	  supply	  provider,	  her	  own	  consumption	  of	  nutrients	  as	  well	  as	  other	  substances	  (such	  as	  caffeine,	  alcohol	  and	  tobacco)	  may	  affect	  fetal	  growth.	  Other	  impairing	  maternal	  conditions,	  such	  as	  hypoxia	  and	  systemic	  disease,	  may	  also	  influence	  the	  availability	  of	  nutrients	  and	  oxygen	  to	  the	  fetus.	  	  Some	  of	  the	  maternal	  exposures	  may	  further	  exercise	  an	  influence	  by	  impairing	  the	  function	  of	  the	  placenta,	  which	  is	  the	  main	  regulator	  of	  the	  supply	  line.	  In	  addition	  to	  enabling	  and	  maintaining	  the	  critical	  exchange	  of	  nutrients	  and	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oxygen,	  the	  placenta	  serves	  as	  a	  barrier	  (e.g.	  for	  maternal	  glucocorticoids)	  as	  well	  as	  a	  communicator	  between	  the	  mother	  and	  fetus.	  The	  placenta	  is	  also	  an	  important	  producer	  of	  hormones	  (e.g.	  estrogens,	  progesterone,	  human	  placental	  lactogen	  and	  leptin)	  and	  local	  growth	  factors	  (e.g.	  insulin-­‐like,	  fibroblast,	  and	  vascular	  endothelial	  growth	  factors)	  which	  may	  regulate	  fetal	  growth	  by	  influencing	  the	  growth	  and	  function	  of	  the	  placenta	  [37].	  	  	  A	  number	  of	  factors	  influencing	  fetal	  growth	  can	  be	  expected	  to	  do	  so	  through	  one	  or	  several	  of	  these	  pathways	  [38].	  Height	  and	  weight	  of	  the	  mother	  could	  for	  example	  be	  linked	  to	  fetal	  growth	  through	  the	  (genetic)	  growth	  potential	  and	  also	  the	  maternal	  milieu.	  Among	  the	  most	  consistent	  predictors	  of	  fetal	  growth	  are	  socioeconomic	  status	  (SES),	  ethnicity	  and	  fetal	  sex.	  The	  influence	  of	  SES	  is	  likely	  mediated	  by	  maternal	  factors	  such	  as	  diet,	  smoking,	  alcohol,	  body	  constitution,	  etc.	  While	  the	  same	  applies	  to	  some	  of	  the	  observed	  ethnic	  influence	  as	  well,	  it	  may	  not	  account	  for	  all	  of	  the	  discrepancy	  between	  Americans	  of	  African	  and	  European	  descent	  [38].	  Lastly,	  while	  an	  influence	  of	  sex	  on	  fetal	  growth	  is	  well	  known,	  the	  mechanisms	  and	  patterns	  are	  not	  well	  understood.	  Male	  embryos	  appear	  to	  experience	  more	  rapid	  cell	  division	  and	  end	  up,	  on	  average,	  larger	  than	  girls	  of	  the	  same	  gestational	  age	  at	  birth.	  Still,	  they	  are	  at	  higher	  risk	  of	  adverse	  perinatal	  outcome,	  and	  accumulating	  evidence	  suggests	  that	  boys	  are	  more	  vulnerable	  to	  various	  influences	  throughout	  gestation	  [39].	  	  	  	  
2.1.2 MONITORING	  AND	  MEASUREMENT	  Growth	  is	  a	  dynamic	  property,	  and	  as	  such	  needs	  to	  be	  evaluated	  between	  at	  least	  two	  points	  in	  time.	  Rough	  estimates	  of	  fetal	  growth	  could	  be	  obtained	  from	  monitoring	  maternal	  weight	  gain	  and	  measurements	  of	  symphysis-­‐fundus	  height	  throughout	  pregnancy	  [40].	  In	  the	  last	  decades	  ultrasound	  examination	  has	  made	  biometry	  of	  the	  fetus	  possible,	  but	  in	  clinical	  practice	  repeated	  monitoring	  is	  generally	  only	  performed	  on	  indication	  (high-­‐risk	  pregnancies)	  [41]	  .	  	  	  Anthropometric	  measures	  (weight,	  length	  and	  head	  circumference)	  are	  routinely	  recorded	  at	  birth.	  As	  with	  any	  cross-­‐sectional	  anthropometric	  measure,	  these	  will	  be	  a	  result	  of	  the	  cumulative	  growth	  and	  age	  of	  the	  individual.	  It	  is	  thus	  common	  for	  fetal	  growth	  to	  be	  evaluated	  from	  curves	  based	  on	  birth	  weight	  for	  gestational	  age.	  Importantly,	  for	  any	  given	  gestational	  age,	  the	  weight	  prediction	  of	  such	  a	  curve	  will	  be	  based	  on	  those	  who	  were	  born	  at	  that	  age.	  Such	  revealed	  weight	  curves	  may	  not	  be	  representative	  of	  the	  intrauterine	  population,	  and	  may	  underestimate	  fetal	  growth	  in	  preterm	  born	  infants	  [42].	  	  	  Of	  the	  three	  most	  commonly	  recorded	  anthropometric	  measures	  at	  birth,	  weight	  is	  the	  most	  readily	  available	  as	  well	  as	  the	  most	  reliably	  measured	  [43].	  As	  an	  approximation	  of	  growth,	  some	  claim	  birth	  weight	  may	  be	  more	  indicative	  of	  environmental	  influences	  in	  later	  gestation	  compared	  to	  length	  and	  head	  circumference,	  possibly	  due	  to	  “sparing”	  of	  head	  and	  length	  [35,	  44].	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2.1.3 PATTERNS	  OF	  FETAL	  GROWTH	  Based	  on	  the	  sigmoid	  shape	  of	  standard	  intrauterine	  growth	  curves,	  fetal	  growth	  is	  often	  described	  to	  be	  approximately	  linear,	  with	  a	  noticeable	  decline	  in	  the	  rate	  of	  growth	  toward	  term	  [45].	  The	  decline	  has	  further	  been	  attributed	  to	  a	  gradual	  depletion	  of	  the	  nutritional	  influx	  (either	  from	  mother,	  placenta	  or	  both)	  [46].	  	  Others	  claim	  that	  the	  plateau	  seen	  in	  growth	  curves	  towards	  term	  may	  be	  a	  result	  of	  inaccurate	  pregnancy	  dating,	  placing	  birth	  weights	  of	  earlier	  gestation	  at	  term	  (due	  to	  overestimation	  by	  the	  last	  menstrual	  period	  method)	  [47].	  Curves	  based	  on	  ultrasonographically	  estimated	  fetal	  weights	  in	  uncomplicated	  term	  pregnancies	  indicate	  a	  fairly	  constant	  rate	  of	  growth	  until	  term	  [42].	  	  It	  is	  also	  commonly	  assumed	  that	  the	  overall	  linear	  growth	  should	  be	  the	  result	  of	  a	  sequential	  timing	  of	  the	  body	  dimensional	  growth	  such	  that	  length	  growth	  is	  favored	  in	  the	  2nd	  trimester	  and	  weight	  in	  the	  3rd	  [48].	  The	  data	  to	  support	  this	  rests	  on	  cross-­‐sectional	  measures	  of	  live-­‐born	  at	  various	  gestational	  ages	  [49,	  50]	  .	  More	  recent	  longitudinal	  measurements	  using	  ultrasound	  have	  failed	  to	  confirm	  the	  proposed	  timing	  of	  growth	  in	  length	  versus	  weight	  [51,	  52].	  	  	  Intrauterine	  growth	  restriction	  is	  defined	  as	  a	  reduction	  in	  the	  expected	  pattern	  of	  fetal	  growth	  (i.e.	  failure	  to	  reach	  the	  growth	  potential).	  Assessment	  thus	  requires	  repeated	  measures;	  nevertheless	  in	  most	  practice	  evaluation	  is	  made	  cross-­‐sectionally,	  by	  relating	  size	  to	  gestational	  age.	  Based	  on	  the	  distribution	  in	  the	  sample	  or	  a	  reference	  population,	  a	  cut-­‐off	  either	  at	  2	  standard	  deviations	  (SD)	  below	  the	  mean	  or	  below	  the	  10th	  percentile	  is	  used	  to	  define	  small	  for	  gestational	  age	  (SGA).	  Measures	  that	  describe	  the	  tail	  of	  the	  normal	  distribution	  may	  not	  successfully	  discriminate	  between	  those	  who	  are	  constitutionally	  small	  and	  those	  that	  are	  pathologically	  small.	  In	  an	  attempt	  to	  address	  this,	  some	  advocate	  the	  use	  of	  customized	  growth	  curves,	  in	  which	  various	  predictors	  of	  growth	  may	  be	  taken	  into	  account	  (e.g.	  sex,	  ethnicity,	  maternal	  stature,	  parity	  etc.)	  [47].	  Others	  caution	  against	  inappropriate	  adjustment	  for	  factors	  associated	  with	  pathological	  growth	  restriction,	  as	  in	  the	  case	  of	  ethnic	  (AA	  vs.	  EA)	  differences	  in	  fetal	  growth	  [53,	  54].	  	  Intrauterine	  growth	  restriction	  is	  commonly	  assumed	  to	  result	  in	  two	  different	  phenotypes	  with	  respect	  to	  body	  proportionality	  (at	  birth).	  These	  have	  further	  been	  attributed	  different	  etiologies	  on	  account	  of	  timing	  and	  type	  of	  insult.	  The	  “timing	  hypothesis”	  stipulates	  that	  early	  and/or	  chronic	  insults	  (e.g.	  congenital	  malformations,	  maternal	  smoking	  and	  low	  socioeconomic	  status)	  will	  result	  in	  symmetric	  growth	  restriction.	  Conversely,	  asymmetric	  growth	  restriction	  would	  be	  the	  consequence	  of	  a	  faltering	  supply	  line	  later	  in	  pregnancy,	  resulting	  in	  short	  	  (if	  in	  in	  2nd	  trimester)	  or	  long	  and	  thin	  neonates	  (if	  in	  3rd	  trimester)	  [48].	  Building	  on	  the	  notion	  of	  a	  sequential	  fetal	  growth	  pattern,	  the	  timing	  hypothesis	  has	  had	  great	  impact	  both	  in	  the	  theoretical	  and	  the	  practical	  world	  of	  perinatology	  and	  obstetrics.	  The	  theory	  has	  also	  been	  used	  in	  epidemiological	  practice	  as	  a	  means	  of	  identifying	  potential	  critical	  periods	  of	  prenatal	  insults,	  not	  least	  with	  respect	  to	  the	  potential	  influences	  on	  adult	  disease	  [55].	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Independent	  of	  the	  more	  recent	  longitudinal	  findings	  failing	  to	  support	  the	  sequential	  growth	  pattern	  on	  which	  the	  timing	  hypothesis	  rests,	  several	  others	  have	  questioned	  the	  use	  of	  proportionality	  as	  a	  means	  to	  infer	  etiology	  of	  the	  insult	  (whether	  in	  time	  or	  character)	  [56].	  With	  respect	  to	  growth	  restriction,	  proportionality	  has	  rather	  been	  proposed	  to	  reflect	  a	  continuum,	  with	  progressive	  disproportionality	  as	  severity	  of	  growth	  restriction	  increases	  [44].	  The	  weak	  support	  for	  the	  existence	  of	  proportionality	  phenotypes	  in	  the	  normal	  population	  should	  further	  discourage	  their	  use	  in	  attempts	  to	  identify	  stages	  of	  development	  at	  which	  undernutrition	  would	  lead	  to	  permanent,	  negative	  health	  outcomes	  [57].	  	  	  2.2 HEALTH	  CONSEQUENCES	  OF	  ADVERSE	  FETAL	  GROWTH	  Adverse	  fetal	  growth	  may	  put	  the	  fetus	  at	  risk	  of	  complications	  both	  inside	  and	  outside	  the	  womb.	  Severe	  growth	  restriction	  may	  lead	  to	  intrauterine	  death,	  and	  growth	  restricted	  newborns	  are	  at	  increased	  risk	  of	  perinatal	  morbidity	  and	  mortality.	  Babies	  that	  are	  large	  on	  the	  other	  hand	  are	  at	  increased	  risk	  of	  delivery	  complications,	  with	  negative	  consequences	  for	  both	  infant	  and	  mother.	  In	  this	  thesis	  however,	  the	  focus	  is	  on	  the	  potential	  long-­‐term	  consequences	  of	  adverse	  fetal	  growth,	  which	  have	  attracted	  much	  research	  attention	  in	  the	  last	  decades.	  	  	  
2.2.1 DEVELOPMENTAL	  ORIGINS	  OF	  ADULT	  HEALTH	  AND	  DISEASE	  In	  1986,	  drawing	  from	  their	  findings	  in	  an	  ecological	  study	  geographically	  linking	  previous	  infant	  mortality	  to	  later	  coronary	  heart	  disease	  mortality,	  David	  Barker	  and	  Clive	  Osmond	  proposed	  that	  early	  life	  deprivation	  could	  predispose	  coronary	  heart	  disease	  [58].	  This	  was	  by	  no	  means	  a	  novel	  idea,	  but	  rather	  built	  on	  findings	  by	  Kermack,	  Rose	  and	  Forsdahl	  who	  in	  the	  1930s,	  1960s	  and	  1970s	  respectively	  had	  noted	  that	  the	  early	  environment	  appeared	  to	  be	  of	  importance	  for	  later	  health	  [59-­‐61].	  What	  made	  Barker	  &	  Osmond’s	  paper	  seminal	  was	  the	  emphasis	  made	  on	  the	  influence	  of	  nutrition	  in	  prenatal	  and	  early	  postnatal	  life,	  from	  which	  the	  hypothesis	  of	  a	  fetal	  origin	  of	  adult	  disease	  was	  developed.	  This	  hypothesis	  was	  further	  elaborated	  in	  a	  number	  of	  papers	  (and	  books)	  and	  by	  1995	  refined	  to	  state	  “that	  coronary	  heart	  disease	  is	  associated	  with	  specific	  patterns	  of	  disproportionate	  fetal	  growth	  that	  result	  from	  fetal	  undernutrition	  in	  middle	  to	  late	  gestation”	  [5].	  	  By	  then	  the	  Southampton	  group	  had	  linked	  individual	  anthropometric	  measures	  at	  birth,	  and	  birth	  weight	  in	  particular,	  to	  coronary	  heart	  disease	  mortality,	  blood	  pressure	  and	  NIDDM	  [1,	  62,	  63].	  	  With	  the	  launch	  of	  the	  fetal	  origins	  hypothesis,	  the	  interest	  in	  early	  nutrition	  came	  to	  almost	  exclusively	  target	  the	  prenatal	  period,	  sparking	  an	  avalanche	  of	  observational	  studies	  linking	  size	  at	  birth	  to	  a	  number	  of	  outcomes	  later	  in	  life.	  Other	  than	  cardiovascular	  and	  metabolic	  outcomes,	  size	  at	  birth	  has	  for	  example	  been	  shown	  to	  predict	  psychiatric	  disorders	  and	  asthma	  [64,	  65].	  Parallel	  to	  this	  process,	  clinical	  researchers	  were	  becoming	  increasingly	  concerned	  with	  the	  long-­‐term	  effects	  of	  postnatal	  nutrition,	  leading	  them	  to	  invoke	  the	  concept	  of	  “programming”,	  whereby	  a	  stimulus	  or	  insult	  at	  a	  critical	  period	  will	  have	  lasting	  consequences	  [66].	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To	  explain	  their	  findings	  of	  an	  inverse	  association	  between	  birth	  weight	  and	  glucose	  intolerance	  and	  NIDDM,	  Hales	  and	  Barker	  further	  hypothesized	  about	  a	  “thrifty	  phenotype”.	  According	  to	  this,	  a	  fetus	  subjected	  to	  scarce	  resources	  may	  develop	  insulin	  resistance	  in	  order	  to	  limit	  growth	  and	  thereby	  increase	  the	  chance	  of	  survival	  [67].	  The	  mismatch	  that	  occurs	  if	  such	  a	  phenotype	  enters	  a	  world	  of	  plenty	  would	  then	  lead	  to	  the	  development	  of	  metabolic	  disorders.	  	  	  The	  idea	  of	  early	  programming	  as	  an	  adaptive	  response	  has	  recently	  been	  adopted	  and	  further	  refined	  by	  evolutionary	  theorists.	  Through	  a	  process	  known	  as	  plasticity,	  it	  has	  been	  suggested	  that	  the	  fetus	  adjusts	  its	  phenotype	  according	  to	  predictions	  about	  the	  future,	  made	  possible	  by	  nutritional	  or	  hormonal	  signaling	  from	  the	  mother	  [68].	  The	  fact	  that	  these	  mechanisms	  persist,	  and	  that	  the	  environments	  we	  live	  in	  today	  are	  so	  different	  from	  those	  within	  which	  they	  evolved,	  may	  further	  contribute	  to	  explain	  the	  increasing	  burden	  of	  metabolic	  and	  cardiovascular	  disease	  [69].	  	  	  In	  an	  effort	  to	  unify	  the	  past	  and	  ongoing	  research	  of	  the	  field	  and	  to	  signify	  the	  “paradigm	  shift”	  in	  the	  perception	  of	  early	  life	  influence,	  the	  term	  Developmental	  Origins	  of	  Adult	  Health	  and	  Disease	  (DOHaD)	  was	  proposed	  in	  2004	  [69].	  This	  field	  now	  covers	  a	  broad	  range	  of	  research	  including	  experimental,	  evolutionary,	  clinical,	  and	  laboratory	  research,	  and	  life-­‐course	  epidemiology.	  	  	  To	  note,	  the	  increasing	  focus	  and	  reliance	  on	  animal	  models	  (in	  which	  the	  maternal	  diet	  can	  be	  manipulated)	  within	  the	  DOHaD	  framework	  has	  led	  to	  the	  recognition	  that	  birth	  weight	  (and	  presumably	  also	  fetal	  growth)	  may	  not	  necessarily	  be	  on	  the	  causal	  pathway	  between	  such	  insults	  that	  trigger	  adaptive	  responses	  and	  their	  consequences	  [70].	  However,	  other	  than	  natural	  experiments	  of	  intrauterine	  malnutrition	  during	  the	  Dutch	  famine	  and	  Leningrad	  siege	  [71,	  72],	  studies	  in	  humans	  have	  been	  restricted	  to	  the	  use	  of	  proxies	  for	  fetal	  growth,	  predominantly	  size	  at	  birth.	  While	  these	  measures	  are	  poor	  proxies	  for	  fetal	  nutrition	  (or	  other	  triggers	  of	  an	  adaptive	  response),	  their	  association	  to	  later	  health	  outcomes	  appears	  to	  be	  robust	  (replicated	  in	  various	  populations)	  and	  also	  strikingly	  consistent	  across	  the	  entire	  range	  of	  normal	  variation	  (of	  birth	  weight).	  	  	  	  	  
2.2.2 CARDIOVASCULAR	  DISEASE	  In	  the	  past	  century	  there	  has	  been	  an	  epidemiological	  transition	  with	  cancer	  and	  cardiovascular	  disease	  (CVD)	  replacing	  infectious	  disease	  and	  malnutrition	  as	  the	  main	  causes	  of	  death	  in	  most	  high-­‐income	  countries	  [73].	  At	  the	  turn	  of	  the	  millennium	  CVD	  was	  the	  leading	  cause	  of	  death	  worldwide	  [74].	  Although	  mortality	  from	  CVD	  is	  declining	  in	  the	  developed	  world	  as	  a	  result	  of	  improved	  diagnosis,	  treatment	  and	  prevention,	  coronary	  heart	  disease	  and	  stroke	  are	  still	  the	  1st	  and	  3rd	  most	  common	  causes	  of	  death	  [75].	  	  Identification	  of	  risk	  profiles	  for	  CVD	  has	  been	  one	  of	  the	  most	  important	  public	  health	  contributions	  of	  epidemiology,	  improving	  not	  only	  prevention	  but	  also	  diagnosis	  and	  treatment.	  At	  the	  time	  Barker	  launched	  his	  hypothesis	  the	  main	  life-­‐
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style	  and	  other	  modifiable	  risk	  factors	  (e.g.	  raised	  blood	  pressure,	  blood	  glucose	  and	  lipids,	  obesity,	  tobacco	  smoking,	  and	  physical	  inactivity)	  had	  been	  established,	  and	  genetic	  association	  studies	  had	  not	  yet	  been	  well	  developed.	  It	  is	  perhaps	  then	  not	  so	  surprising	  that	  the	  promise	  of	  an	  entirely	  new	  framework	  with	  potentially	  modifiable	  precursors	  was	  met	  with	  much	  interest	  and	  enthusiasm. 	  Following	  Barker	  and	  colleagues’	  first	  findings	  of	  inverse	  associations	  between	  birth	  weight	  and	  mortality	  from	  coronary	  heart	  disease	  [1],	  a	  number	  of	  studies	  have	  linked	  weight	  at	  birth	  to	  cardiovascular	  disease	  overall,	  hypertension,	  coronary	  heart	  disease	  and	  stroke	  .	  Overall,	  it	  appears	  as	  though	  the	  association	  is	  (inverse)	  linear,	  with	  a	  decrease	  in	  birth	  weight	  associated	  with	  an	  increase	  in	  the	  risk	  of	  CVD	  across	  the	  entire	  range	  of	  normal	  birth	  weights.	  	  There	  have	  also	  been	  several	  attempts	  to	  use	  other	  anthropometric	  measures	  at	  birth,	  alone	  or	  in	  relation	  to	  birth	  weight	  (as	  with	  ponderal	  index,	  where	  birth	  weight	  is	  divided	  by	  the	  birth	  length	  cubed)	  in	  order	  to	  target	  distinct	  temporal	  patterns	  of	  undernutrition	  (building	  on	  the	  notion	  that	  timing	  of	  growth	  restriction	  results	  in	  a	  particular	  body	  shape)	  [55].	  Maternal	  pelvic	  size	  and	  placental	  weight	  have	  also	  been	  used	  to	  speculate	  about	  the	  roles	  of	  maternal	  nutrition	  and	  placental	  function	  in	  fetal	  programming	  [76].	  Only	  a	  minority	  of	  studies	  have	  had	  the	  ability	  to	  adjust	  for	  gestational	  age,	  or	  potential	  confounders	  such	  as	  maternal	  smoking	  or	  socioeconomic	  status.	  On	  the	  other	  hand,	  most	  studies	  have	  adjusted	  for	  measures	  of	  body	  size	  later	  in	  life	  (e.g.	  weight	  in	  infancy	  or	  BMI	  in	  adulthood).	  Interestingly	  this	  does	  not	  only	  appear	  to	  generally	  strengthen	  the	  association	  at	  hand,	  but	  in	  many	  studies	  in	  fact	  be	  necessary	  to	  achieve	  statistical	  significance.	  A	  potential	  explanation,	  as	  well	  as	  cause	  for	  caution	  concerning	  this	  practice,	  is	  presented	  in	  the	  causal	  inference	  section	  (page	  22).	  	  	  2.2.2.1 CORONARY	  HEART	  DISEASE	  In	  a	  systematic	  review	  and	  meta-­‐analysis	  from	  2007,	  Huxley	  et	  al.	  evaluated	  18	  published	  and	  2	  unpublished	  studies,	  and	  found	  that	  all	  had	  reported	  an	  inverse	  association	  between	  birth	  weight	  and	  risk	  of	  coronary	  heart	  disease	  [2].	  There	  further	  appeared	  to	  be	  little	  heterogeneity	  between	  the	  results	  of	  the	  studies.	  Another	  more	  recent	  meta-­‐analysis	  reviewed	  the	  association	  between	  birth	  weight	  and	  cardiovascular	  disease	  mortality	  [77].	  Out	  of	  14	  studies	  included,	  11	  had	  reported	  of	  an	  inverse	  association.	  Neither	  of	  these	  reviews	  found	  any	  indication	  of	  difference	  in	  effect	  between	  men	  and	  women.	  	  They	  also	  shared	  the	  conclusion	  that	  many	  of	  the	  included	  studies	  had	  had	  limited	  ability	  to	  adjust	  for	  gestational	  age	  and	  potential	  confounders.	  	  	  	  2.2.2.2 STROKE	  Low	  birth	  weight	  has	  been	  shown	  to	  predict	  stroke	  in	  both	  men	  and	  women	  [76,	  78-­‐81].	  Some	  indications	  of	  a	  more	  pronounced	  association	  for	  hemorrhagic	  stroke	  [78,	  79]	  have	  not	  been	  confirmed	  in	  larger	  studies	  [80,	  81].	  The	  number	  of	  hemorrhagic	  cases	  also	  tends	  to	  be	  small,	  leading	  to	  imprecise	  estimates.	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2.2.2.3 HYPERTENSION	  Upon	  their	  first	  finding	  of	  an	  association	  between	  weight	  at	  birth	  and	  blood	  pressure	  in	  middle-­‐aged	  men	  and	  women,	  the	  Southampton	  group	  concluded	  that	  prevention	  of	  hypertension	  may	  depend	  on	  improving	  maternal	  health	  and	  nutrition	  [82].	  While	  a	  few	  later	  studies	  have	  evaluated	  hypertension	  as	  main	  outcome	  [3,	  21,	  83],	  the	  overwhelming	  majority	  of	  studies	  that	  followed	  have	  assessed	  the	  association	  with	  blood	  pressure	  continuously.	  As	  a	  result	  it	  was	  concluded	  a	  decade	  later	  that	  the	  inverse	  association	  between	  birth	  weight	  and	  blood	  pressure	  appeared	  robust,	  albeit	  modest	  [7].	  To	  reconcile	  the	  small	  effects	  of	  birth	  weight	  on	  blood	  pressure	  with	  its	  proposed	  large	  effect	  on	  the	  risk	  of	  hypertension,	  it	  was	  later	  suggested	  that	  slow	  fetal	  growth	  initiates	  a	  self-­‐perpetuating	  process	  that	  in	  turn	  leads	  to	  hypertension	  in	  adulthood	  [84].	  	  	  
2.2.3 BLOOD	  PRESSURE	  As	  already	  indicated,	  the	  best-­‐studied	  outcome	  with	  respect	  to	  early	  life	  influence	  on	  later	  health	  is,	  by	  far,	  blood	  pressure.	  This	  may	  perhaps	  in	  part	  be	  a	  result	  of	  the	  discovery	  that	  the	  association	  could	  be	  studied	  in	  children,	  facilitating	  follow-­‐up	  and	  search	  for	  birth	  data.	  A	  joint	  effort	  of	  two	  reviews	  of	  the	  literature	  up	  until	  the	  year	  of	  2000	  found	  80	  studies	  that	  had	  explored	  the	  association	  between	  birth	  weight	  and	  blood	  pressure	  in	  children	  and	  adults	  [85].	  The	  majority	  had	  reported	  that	  blood	  pressure	  fell	  with	  increasing	  birth	  weight,	  with	  an	  effect	  size	  of	  -­‐2	  mmHg/kg	  (pooled).	  A	  closer	  look	  at	  the	  55	  studies	  that	  had	  reported	  regression	  coefficients	  indicated	  that	  this	  effect	  may	  have	  been	  overestimated	  due	  to	  publication	  bias	  (favoring	  of	  small	  studies	  with	  large	  effects),	  failure	  to	  account	  for	  random	  error,	  inappropriate	  (current	  body	  size)	  and	  inadequate	  adjustments	  for	  potential	  confounding	  [7].	  	  	  2.2.3.1 AGE	  Among	  the	  first	  to	  explore	  the	  association	  between	  birth	  weight	  and	  blood	  pressure	  in	  children,	  Whincup	  et	  al.	  noted	  that	  an	  inverse	  association	  was	  present	  already	  in	  5-­‐7-­‐year	  olds,	  however	  only	  statistically	  significant	  with	  adjustment	  for	  current	  size	  [86].	  With	  exception	  of	  the	  newly	  born,	  it	  appears	  as	  though	  the	  inverse	  association	  may	  be	  apparent	  across	  the	  lifespan,	  and	  potentially	  amplify	  with	  age	  [9,	  87].	  The	  association	  also	  appears	  to	  temporarily	  attenuate	  throughout	  adolescence	  [85,	  88],	  which	  has	  been	  suggested	  to	  be	  a	  result	  of	  perturbed	  tracking	  of	  blood	  pressure	  during	  the	  adolescent	  growth	  phase	  [89,	  90]	  possibly	  due	  to	  puberty-­‐related	  hormonal	  changes	  [88].	  The	  general	  indications	  are	  thus	  that	  the	  association	  appears	  already	  in	  early	  childhood,	  attenuates	  with	  puberty,	  and	  then	  manifests	  and	  potentially	  even	  amplifies	  throughout	  adulthood.	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2.2.3.2 ETHNICITY	  In	  the	  US	  it	  has	  been	  long	  recognized	  that	  African	  Americans	  have	  higher	  blood	  pressure	  levels	  than	  European	  Americans,	  and	  the	  difference	  appears	  to	  manifest	  already	  in	  childhood	  and	  adolescence	  [91].	  	  Since	  AAs	  are	  also	  at	  increased	  risk	  of	  being	  born	  small	  compared	  to	  EAs	  of	  the	  same	  gestational	  age	  [92],	  it	  has	  been	  proposed	  that	  the	  ethnic	  difference	  in	  blood	  pressure	  originates	  in	  utero	  [10,	  11].	  However,	  the	  association	  motivating	  such	  a	  claim	  has	  been	  established	  in	  predominantly	  white	  populations.	  Two	  previous	  smaller	  studies	  of	  AA	  adults	  have	  found	  no	  correlation	  between	  size	  at	  birth	  and	  blood	  pressure	  [93,	  94].	  In	  children,	  findings	  have	  been	  inconsistent,	  with	  some	  indications	  of	  a	  positive	  association	  in	  young	  children	  [95,	  96].	  Longitudinal	  tracking	  of	  a	  bi-­‐ethnic	  sample	  however	  has	  shown	  an	  inverse	  association	  in	  both	  AAs	  and	  EAs,	  amplifying	  with	  age	  (into	  adulthood)	  [97].	  	  	  	  
2.2.4 BREAST	  CANCER	  Parallel	  to	  the	  developing	  theory	  of	  a	  fetal	  origin	  for	  cardiovascular	  disease,	  it	  was	  hypothesized	  that	  breast	  cancer	  may	  originate	  in	  utero	  [12].	  	  In	  1990,	  Trichopoulos	  speculated	  that	  prenatal	  estrogen	  exposure	  would	  create	  a	  “fertile	  soil”	  for	  breast	  cancer	  disease	  development,	  and	  that	  diet	  during	  pregnancy	  could	  be	  a	  potential	  determinant	  of	  pregnancy	  estrogen	  levels	  [12].	  	  The	  hypothesis	  was	  inspired	  by	  observations	  that	  exposure	  to	  prenatal	  ionizing	  radiation	  increase	  risks	  of	  childhood	  leukemia	  [98],	  and	  that	  daughters	  of	  mothers	  using	  diethylstilbestrol	  (DES)	  during	  pregnancy	  were	  at	  increased	  risk	  of	  vaginal	  adenocarcinoma	  [99].	  It	  was	  thus	  speculated	  that	  risk	  factors	  of	  cancer	  could	  operate	  already	  in	  the	  fetal	  period.	  An	  increasing	  body	  of	  evidence	  had	  already	  supported	  a	  link	  between	  estrogen	  and	  breast	  cancer	  (via	  reproductive	  factors	  indicative	  of	  endogenous	  estrogen	  exposure,	  such	  as	  parity,	  age	  at	  menarche,	  first	  birth	  and	  menopause	  [100,	  101]	  and	  exogenous	  exposure	  in	  the	  form	  of	  hormone	  replacement	  therapies	  [102]).	  Trichopoulos	  further	  hypothesized	  that	  prenatal	  estrogen	  exposure	  would	  increase	  the	  number	  of	  susceptible	  stem	  cells	  in	  the	  mammary	  gland,	  in	  which	  cancer	  may	  later	  develop	  [103].	  	  	  A	  number	  of	  observational	  studies	  have	  reported	  positive	  associations	  between	  breast	  cancer	  and	  potential	  indicators	  of	  prenatal	  estrogen	  exposure,	  such	  as	  maternal	  age	  [104,	  105],	  preeclampsia	  [106]	  and	  twinning	  [106,	  107].	  Trichopoulos’	  initial	  proposal	  that	  twins	  may	  be	  at	  lower	  risk	  due	  to	  shorter	  gestation	  was	  modified	  with	  the	  suggestions	  of	  higher	  maternal	  estrogen	  levels	  in	  twin	  pregnancies,	  and	  dizygotic	  in	  particular	  [108,	  109].	  Evidence	  to	  support	  an	  increased	  risk	  in	  twins	  has	  however	  been	  inconclusive.	  Overall	  twins	  do	  not	  appear	  to	  be	  at	  different	  risk	  of	  breast	  cancer	  compared	  to	  singletons	  [17],	  and	  a	  modest	  risk	  increase	  in	  dizygotic	  twins	  remains	  speculative	  [17].	  	  Birth	  weight	  is	  the	  most	  studied	  indicator	  of	  prenatal	  estrogen	  exposure	  to	  date.	  While	  birth	  weight	  is	  positively	  correlated	  with	  maternal	  estrogen	  [110],	  available	  data	  to	  date	  do	  not	  support	  any	  correlation	  with	  fetal	  estrogen	  concentrations	  [111].	  The	  original	  hypothesis’	  focus	  on	  estrogens	  has	  nevertheless	  been	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generalized	  to	  include	  other	  hormones	  [112],	  with	  particular	  interest	  in	  the	  role	  of	  insulin-­‐like	  growth	  factor	  I	  and	  II	  (IGF-­‐I	  and	  IGF-­‐II).	  These	  peptides	  have	  been	  implicated	  in	  breast	  carcinogenesis	  [113,	  114],	  and	  are	  also	  believed	  to	  be	  major	  modulators	  of	  both	  fetal	  and	  placental	  growth	  [115,	  116].	  	  In	  recent	  years	  several	  reviews	  and	  a	  large	  re-­‐analysis	  of	  individual	  level	  data	  including	  over	  22,000	  cases	  have	  all	  confirmed	  a	  positive	  association	  between	  birth	  weight	  and	  risk	  of	  breast	  cancer,	  in	  particular	  when	  diagnosed	  before	  menopause	  [16-­‐19].	  While	  the	  majority	  of	  studies	  report	  of	  a	  linear	  association,	  some	  have	  noted	  an	  increased	  risk	  of	  breast	  cancer	  also	  in	  the	  lower	  end	  of	  the	  birth	  weight	  range	  [105,	  117].	  Birth	  length	  has	  also	  been	  reported	  a	  predictor	  of	  breast	  cancer,	  independent	  of	  birth	  weight	  [19].	  	  	  	  
2.2.5 POTENTIAL	  MECHANISMS	  Crude	  measures	  of	  fetal	  growth	  (predominantly	  birth	  weight)	  have	  been	  shown	  to	  predict	  a	  number	  of	  health	  outcomes	  later	  in	  life,	  with	  inverse	  associations	  to	  blood	  pressure,	  risks	  of	  CVD	  and	  NIDDM	  being	  the	  most	  consistently	  reported.	  While	  these	  findings	  have	  inspired	  to	  well-­‐developed	  and	  widely	  accepted	  theories	  about	  early	  life	  influence	  on	  health	  and	  disease,	  the	  underlying	  mechanisms	  to	  the	  associations	  are	  yet	  to	  be	  unraveled.	  	  	  	  2.2.5.1 SUBOPTIMAL	  GROWTH	  –	  SUBOPTIMAL	  FUNCTION	  Considering	  not	  only	  the	  degree	  of	  development	  and	  growth	  in	  the	  prenatal	  period,	  but	  also	  the	  vital	  features	  and	  structures	  of	  nearly	  every	  organ,	  it	  is	  quite	  astonishing	  that	  organ	  malformation	  or	  malfunctioning	  is	  so	  rare.	  In	  this	  light	  it	  also	  seems	  quite	  plausible	  that	  disruptions	  that	  interrupt	  or	  impair	  these	  processes	  may	  result	  in	  structural	  and	  functional	  long-­‐term	  effects.	  With	  respect	  to	  cardiovascular	  disease	  development,	  the	  vascular	  tree	  will	  be	  of	  importance	  and	  impaired	  endothelial	  function	  and	  arterial	  stiffness	  are	  risk	  factors	  for	  both	  hypertension	  and	  stroke	  [118].	  Another	  often	  mentioned	  plausible	  candidate	  to	  suffer	  structural	  changes	  if	  deprived	  during	  development	  is	  the	  kidney.	  A	  few	  studies	  in	  humans	  have	  found	  a	  linear	  association	  between	  birth	  weight	  and	  nephron	  number	  [119,	  120].	  Reduced	  nephron	  number	  has	  in	  turn,	  on	  account	  of	  animal	  models,	  been	  hypothesized	  to	  lead	  to	  increased	  filtration	  pressure	  (glomerular	  hyper	  filtration)	  and,	  ultimately,	  hypertension	  [121].	  Another	  strong	  candidate	  proposed	  to	  play	  a	  role	  both	  in	  the	  occurrence	  and/or	  perpetuation	  of	  growth	  restriction	  and	  the	  pathogenesis	  of	  disease	  is	  glucocorticoid	  exposure.	  It	  has	  been	  speculated	  that	  prenatal	  glucocorticoid	  exposure	  could	  reset	  the	  hypothalamic-­‐pituitary	  axis	  and	  the	  following	  endocrine	  changes	  could	  contribute	  to	  the	  progression	  of	  disease	  [15].	  Structural	  changes	  in	  vital	  organs,	  such	  as	  muscle,	  liver,	  and	  pancreatic	  tissue,	  may	  further	  lead	  to	  impaired	  metabolic	  control,	  that	  could	  contribute	  to	  disease	  development	  later	  in	  life	  [122-­‐124].	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While	  there	  are	  a	  number	  of	  studies	  to	  support	  structural	  changes	  in	  animals,	  evidence	  from	  humans	  is	  scarce.	  In	  humans,	  most	  studies	  into	  the	  potential	  mechanisms	  have	  involved	  linking	  birth	  weight	  to	  known	  or	  hypothesized	  antecedents	  of	  cardiovascular	  disease	  (to	  evaluate	  a	  potential	  causal	  pathway).	  Birth	  weight	  can	  for	  example	  predict	  endothelial	  function	  in	  adulthood	  [125]	  and	  low	  birth	  weight	  has	  been	  linked	  to	  sympathetic	  nerve	  activity	  [126],	  beta-­‐cell	  function	  [127],	  and	  low	  grade	  inflammation	  [128],	  all	  of	  which	  have	  been	  shown	  to	  play	  a	  part	  in	  cardiovascular	  disease	  development.	  	  2.2.5.2 DEVELOPMENTAL	  PLASTICITY	  AND	  EPIGENETICS	  While	  structural	  changes	  may	  be	  plausible	  in	  the	  case	  of	  fetal	  growth	  restriction,	  they	  may	  be	  more	  difficult	  to	  reconcile	  with	  the	  consistent	  observations	  of	  effects	  across	  the	  entire	  range	  of	  birth	  weight,	  and	  not	  just	  in	  the	  supposedly	  growth	  restricted	  [6].	  Building	  on	  the	  theory	  of	  a	  mismatch	  between	  the	  early	  and	  later	  nutritional	  environment,	  the	  adaptive	  predictive	  response	  was	  proposed	  as	  a	  unifying	  explanation	  to	  observed	  associations	  [68].	  Through	  this,	  nutritional	  stimuli	  would	  work	  as	  clues	  about	  the	  outside	  world	  according	  to	  which	  the	  fetus	  could	  tune	  its	  metabolism	  in	  expectation	  of	  the	  future	  (to	  increase	  the	  chance	  of	  survival	  in	  the	  long	  term,	  rather	  than	  the	  short).	  However,	  if	  the	  predictions	  fail	  (deprived	  intrauterine	  environment	  does	  not	  equal	  deprived	  outside	  world)	  the	  mismatch	  of	  the	  altered	  homeostatic	  capacity	  and	  the	  environment	  could	  lead	  to	  negative	  health	  outcomes.	  The	  interest	  for	  the	  theory	  of	  developmental	  plasticity	  to	  explain	  the	  impact	  of	  early	  life	  on	  later	  health	  and	  disease	  has	  surged	  with	  the	  advent	  of	  epigenetics,	  offering	  a	  promising	  mechanism	  through	  which	  it	  could	  act.	  	  Developmental	  plasticity	  is	  described	  as	  a	  regulated	  phenomenon	  by	  which	  one	  genotype	  can	  give	  rise	  to	  a	  range	  of	  different	  phenotypes.	  While	  environmental	  stimuli	  may	  directly	  affect	  gene	  expression,	  such	  effects	  are	  often	  transient	  and	  reversible,	  and	  may	  thus	  not	  readily	  explain	  the	  long-­‐term	  changes	  proposed	  to	  act	  in	  programming.	  Chemical	  modification	  of	  the	  DNA	  or	  chromatin	  –	  i.e.	  epigenetic	  modulation	  –	  on	  the	  other	  hand,	  can	  lead	  to	  a	  permanent	  switch	  into	  “on”	  or	  “off”	  mode.	  Environmentally	  induced	  epigenetic	  changes	  thus	  offer	  a	  sophisticated	  and	  plausible	  mechanism	  for	  how	  environmental	  influences	  could	  produce	  the	  proposed	  adaptive	  programming	  of	  various	  phenotypes	  [68].	  	  	  Epigenetic	  modulation	  of	  the	  genome	  plays	  an	  integral	  part	  in	  the	  regulation	  of	  gene	  expression	  throughout	  development.	  By	  silencing	  specific	  genes	  it	  initiates	  and	  perpetuates	  cell	  differentiation,	  and	  is	  also	  the	  mechanism	  behind	  imprinting	  (asymmetrical	  expression	  of	  alleles	  depending	  on	  their	  parent-­‐of-­‐origin)	  and	  X-­‐chromosome	  inactivation	  in	  females.	  Importantly,	  epigenetic	  change	  can	  occur	  in	  response	  to	  extracellular	  signals,	  e.g.	  endocrine	  and	  nutrient.	  Commonly,	  epigenetic	  modulation	  is	  defined	  as	  heritable	  changes	  in	  gene	  expression	  not	  caused	  by	  altered	  DNA	  sequence	  [129].	  This	  stems	  from	  the	  observation	  that	  all	  epigenetic	  mechanisms	  are	  mitotically	  heritable	  (maintaining	  e.g.	  cell-­‐specific	  differentiation).	  Although	  imprinted	  genes	  appear	  to	  have	  developed	  mechanisms	  to	  convey	  epigenetic	  information	  across	  generations,	  the	  extent	  to	  which	  such	  transmission	  is	  possible	  for	  other	  epigenetic	  changes	  is	  not	  known	  [129].	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With	  respect	  to	  DOHaD,	  an	  increasing	  number	  of	  animal	  models	  indicate	  that	  nutrition	  (and	  other	  environmental	  stimuli)	  during	  early	  development	  may	  influence	  the	  establishment	  and/or	  maturation	  of	  epigenetic	  mechanisms,	  ultimately	  leading	  to	  permanent	  changes	  in	  gene	  expression	  [130].	  The	  role	  of	  epigenetics	  in	  cardiovascular	  disease	  development	  remains	  to	  be	  elucidated.	  The	  strongest	  link	  between	  CVD	  and	  epigenetics	  to	  date	  appears	  to	  be	  through	  homocysteine,	  as	  hyper-­‐homocysteinemia	  is	  associated	  with	  increased	  risk	  of	  CVD	  and	  can	  also	  impair	  the	  one-­‐carbon	  metabolism,	  of	  importance	  for	  DNA-­‐methylation	  (the	  most	  widely	  known	  epigenetic	  mechanism)	  [131].	  There	  are	  also	  some	  indications	  of	  links	  between	  epigenetic	  changes	  and	  early	  vascular	  atherogenesis	  [132,	  133].	  However,	  as	  a	  recent	  review	  of	  epigenetics	  and	  CVD	  concluded	  	  “prenatal	  epigenetic	  contributions	  to	  adult	  CVD	  risk	  in	  humans	  are	  often	  inferred,	  but	  difficult	  to	  confirm	  in	  observational	  studies”	  [134].	  	  	  While	  most	  of	  the	  mechanisms	  (e.g.	  altered	  function	  of	  the	  kidney,	  vascular	  tree	  and	  pancreas)	  proposed	  to	  bridge	  fetal	  growth	  restriction	  with	  adult	  disease	  are	  also	  implicated	  in	  developmental	  plasticity,	  the	  key	  discriminating	  factor	  is	  that	  these	  are	  then	  not	  the	  result	  of	  structural	  damage	  due	  to	  impaired	  fetal	  growth,	  but	  rather	  secondary	  to	  epigenetic	  changes	  in	  gene	  expression	  [6].	  	  	  2.2.5.3 BREAST	  CANCER	  AND	  EPIGENETICS	  Epigenetics	  have	  also	  been	  proposed	  to	  affect	  virtually	  every	  step	  in	  cancer	  progression	  [135].	  10-­‐15%	  of	  women	  with	  non-­‐familial	  breast	  cancer	  have	  for	  example	  been	  found	  to	  have	  a	  hypermethylated	  BRCA1	  gene	  [135].	  Interestingly,	  loss	  or	  relaxation	  of	  imprinting	  of	  the	  IGF2	  gene	  resulting	  in	  bi-­‐allelic	  expression	  has	  been	  linked	  to	  cancer	  of	  the	  breast	  [113,	  114]	  as	  well	  as	  to	  fetal	  growth	  stimulation	  [116].	  However,	  due	  to	  the	  cross-­‐sectional	  nature	  of	  studies	  showing	  epigenetic	  changes	  in	  tumor	  cells,	  it	  is	  not	  possible	  to	  establish	  whether	  these	  are	  causes	  or	  effects	  of	  the	  carcinogenous	  process	  [130].	  	  	  2.2.5.4 CONFOUNDING	  Another	  mechanism	  by	  which	  size	  at	  birth	  would	  appear	  associated	  with	  later	  health	  outcomes	  is	  if	  they	  share	  common	  causes.	  In	  such	  a	  case,	  the	  association	  could	  be	  partly	  or	  entirely	  due	  to	  confounding.	  	  In	  the	  early	  ecological	  studies	  both	  Forsdahl	  and	  Barker	  discussed	  the	  possibilities	  that	  the	  associations	  seen	  may	  be	  the	  result	  of	  other	  factors	  independently	  related	  to	  infant	  mortality	  and	  cardiovascular	  disease	  mortality,	  notably	  maternal	  smoking	  and	  the	  socioeconomic	  environment	  [58,	  61].	  	  With	  respect	  to	  the	  findings	  of	  individual	  birth	  weight	  and	  coronary	  heart	  disease	  mortality,	  it	  was	  also	  speculated	  that	  the	  environment	  in	  which	  low	  birth	  weights	  are	  more	  common	  may	  also	  negatively	  influence	  health	  in	  adulthood	  [62].	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Socioeconomic	  environment	  is	  a	  predictor	  of	  birth	  weight	  and	  fetal	  growth	  [38]	  and	  it	  was	  recently	  shown	  that	  the	  risk	  of	  CVD	  was	  inversely	  related	  to	  (fathers)	  social	  class	  at	  the	  time	  of	  birth	  [136].	  Maternal	  smoking	  during	  pregnancy	  also	  influences	  birth	  weight	  (by	  a	  negative	  effect	  on	  both	  fetal	  growth	  and	  length	  of	  gestation)	  [137]	  and	  children	  of	  mothers	  who	  smoked	  during	  pregnancy	  have	  been	  found	  to	  have	  higher	  blood	  pressure	  than	  those	  of	  mothers	  who	  did	  not	  smoke	  [138].	  Although	  maternal	  smoking	  has	  been	  proposed	  to	  explain	  the	  connection	  between	  birth	  weight	  and	  blood	  pressure	  [139],	  this	  has	  not	  been	  supported	  by	  studies	  evaluating	  the	  influence	  of	  maternal	  smoking	  during	  pregnancy	  on	  the	  association	  [140,	  141].	  Several	  studies	  have	  also	  attempted	  to	  account	  for	  the	  potentially	  confounding	  influence	  of	  the	  socioeconomic	  environment	  at	  birth	  on	  the	  association	  between	  birth	  weight	  and	  adult	  outcomes.	  Overall,	  results	  from	  these	  studies	  indicate	  that	  adjusting	  for	  various	  measures	  of	  social	  class	  and/or	  level	  of	  education	  has	  quite	  modest	  effects	  on	  the	  association	  [2].	  Importantly,	  measured	  variables	  of	  SES	  such	  as	  education,	  occupation	  and	  income,	  cannot	  be	  expected	  to	  capture	  the	  full	  range	  of	  mechanisms	  by	  which	  social	  factor	  may	  influence	  health.	  	  	  Breast	  cancer	  has	  been	  reported	  to	  be	  associated	  with	  SES	  both	  at	  the	  individual	  and	  community-­‐level,	  and	  women	  of	  higher	  education	  in	  particular	  appear	  to	  be	  at	  increased	  risk	  of	  breast	  cancer	  [142].	  Family	  socioeconomic	  status	  is	  a	  strong	  predictor	  of	  educational	  attainment	  (also	  in	  adoptees)	  [143,	  144].	  Thus,	  an	  affluent	  environment	  in	  early	  life	  (and	  childhood)	  may	  not	  only	  be	  more	  likely	  to	  produce	  full	  grown	  (well-­‐nourished)	  newborns,	  but	  also	  women	  that	  become	  well-­‐educated	  and	  possibly	  more	  likely	  to	  develop	  breast	  cancer.	  	  Genetic	  factors	  are	  important	  determinants	  of	  birth	  weight	  and	  fetal	  growth	  restriction	  [35,	  36],	  and	  of	  the	  outcomes	  these	  have	  been	  found	  associated	  with,	  e.g.	  blood	  pressure,	  coronary	  heart	  disease,	  NIDDM,	  and	  breast	  cancer	  [145-­‐148].	  If	  some	  of	  these	  genetic	  factors	  were	  to	  be	  involved	  in	  both	  fetal	  growth	  regulation	  and	  disease	  development,	  the	  influence	  of	  such	  common	  causes	  could	  explain	  all	  or	  parts	  of	  the	  observed	  association	  between	  birth	  weight	  and	  disease.	  	  	  The	  genetic	  perspective	  has	  been	  put	  forward	  in	  the	  “fetal	  insulin	  hypothesis”,	  proposing	  a	  common	  genetic	  background	  for	  fetal	  growth	  and	  insulin	  resistance	  [149].	  	  Indeed,	  allelic	  variations	  in	  genes	  involved	  in	  insulin	  regulation	  and	  action	  (INS,	  IGF1,	  IRS-­‐I	  and	  ADCY5)	  have	  been	  found	  associated	  with	  low	  birth	  weight	  and	  glucose	  intolerance	  and	  NIDDM	  [150,	  151]	  and	  myocardial	  infarction	  [77,	  152,	  153].	  Most	  recently,	  common	  polymorphisms	  in	  the	  promotor	  region	  of	  PONI	  (encoding	  Paraoxonase-­‐I	  which	  protects	  low-­‐density	  lipoproteins	  from	  oxidative	  modification),	  previously	  linked	  to	  oxidative	  stress	  and	  risk	  of	  CVD	  [154],	  were	  found	  to	  be	  determinants	  of	  occurrence	  of	  small	  for	  gestational	  age	  [155].	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2.3 CAUSAL	  INFERENCE	  IN	  OBSERVATIONAL	  STUDIES	  Epidemiology	  involves	  the	  description	  and	  explanation	  of	  human	  variability	  (generally	  with	  respect	  to	  health).	  Although	  it	  may	  not	  always	  be	  apparent	  (even	  to	  the	  researchers	  themselves),	  most	  epidemiological	  studies	  are	  concerned	  with	  causality.	  Several	  definitions	  of	  epidemiology,	  such	  as	  that	  of	  the	  WHO,	  include	  “the	  application	  of	  this	  study	  to	  the	  control	  of	  diseases	  and	  other	  health	  problems”	  [156].	  With	  an	  ultimate	  goal	  of	  successful	  (and	  safe)	  prevention	  of	  disease,	  correct	  identification	  of	  causal	  relationships	  should	  be	  vital.	  	  In	  observational	  studies	  causation	  can	  never	  be	  proved.	  In	  epidemiology	  it	  has	  traditionally	  been	  inferred	  from	  observed	  associations,	  sometimes	  with	  the	  guidance	  of	  a	  set	  of	  criteria	  for	  causality	  [157].	  	  Coincidental	  with	  the	  growing	  interest	  for	  early	  life	  influence	  on	  health,	  there	  has	  however	  been	  a	  development	  toward	  a	  formal	  theory	  for	  causal	  inference.	  Counterfactual	  reasoning	  and	  the	  use	  of	  directed	  acyclic	  graphs	  in	  particular	  are	  now	  gradually	  making	  their	  way	  into	  epidemiological	  practice.	  	  	  For	  a	  given	  individual,	  the	  causal	  effect	  is	  defined	  as	  a	  comparison	  between	  the	  outcome	  under	  exposure	  and	  that	  under	  no	  exposure,	  ceteris	  paribus.	  At	  the	  population	  level	  this	  translates	  into	  comparing	  the	  average	  outcome	  had	  everyone	  been	  exposed	  to	  that	  had	  everyone	  not	  been	  exposed.	  In	  contrast	  to	  this	  counterfactual	  definition	  of	  a	  causal	  effect,	  epidemiological	  measures	  of	  association	  come	  from	  comparing	  the	  actually	  exposed	  individuals	  to	  the	  actually	  unexposed	  (since	  we	  can	  observe	  only	  one	  counterfactual	  scenario	  per	  individual).	  This	  explains	  the	  well-­‐known	  dictum	  that	  association	  is	  not	  causation.	  For	  association	  to	  be	  causation,	  the	  average	  outcome	  under	  no	  exposure	  in	  those	  that	  were	  actually	  exposed	  would	  have	  to	  be	  the	  same	  as	  the	  average	  outcome	  in	  the	  actually	  non-­‐exposed.	  Such	  exchangeability	  (with	  respect	  to	  counterfactual	  outcomes)	  between	  the	  exposed	  and	  unexposed	  can	  be	  assumed	  if	  the	  exposure	  is	  assigned	  completely	  at	  random.	  Due	  to	  ethical	  and/or	  practical	  reasons	  however,	  many	  research	  questions	  do	  not	  lend	  themselves	  to	  randomized	  experiments	  and	  what	  is	  left	  is	  the	  possibility	  to	  observe	  the	  consequences	  of	  “natural”	  exposure	  assignment.	  The	  great	  challenge	  then	  involves	  identification	  of	  and	  proper	  dealing	  with	  sources	  of	  non-­‐exchangeability	  between	  the	  naturally	  exposed	  and	  unexposed	  individuals.	  	  	  	  
2.3.1 COMMON	  THREATS	  TO	  CAUSAL	  INFERENCE	  Validity	  concerns	  how	  closely	  we	  measure	  what	  we	  intend	  to	  measure.	  The	  most	  common	  threats	  to	  validity	  are	  bias	  and	  random	  variability.	  Since	  an	  infinitely	  large	  population	  rarely	  can	  be	  studied,	  sampling	  will	  introduce	  random	  variability.	  This	  affects	  the	  precision	  of	  estimation;	  the	  more	  random	  variability,	  the	  less	  precision.	  The	  resulting	  random	  error	  can	  be	  reduced	  by	  increasing	  the	  sample	  size	  (thereby	  increasing	  the	  precision).	  The	  presence	  or	  consequence	  of	  bias,	  on	  the	  other	  hand,	  cannot	  be	  mitigated	  by	  increased	  sample	  size.	  The	  systematic	  
errors	  that	  result	  from	  bias	  need	  to	  be	  addressed	  by	  proper	  study	  design,	  data	  collection,	  analysis	  and	  interpretation.	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2.3.1.1 SYSTEMATIC	  ERRORS	  Sources	  of	  bias	  can	  be	  described,	  explained	  and	  classified	  using	  directed	  acyclic	  graphs	  (DAGs).	  Construction	  of	  causal	  diagrams	  using	  DAGs	  may	  also	  help	  clarify	  causal	  questions	  and	  identify	  how/if	  they	  can	  be	  tested	  (the	  initiated	  reader	  may	  choose	  to	  turn	  to	  the	  work	  by	  Judea	  Pearl	  for	  a	  formal	  introduction)	  [158,	  159].	  Variables	  in	  a	  DAG	  are	  linked	  by	  directed	  arrows,	  which	  represent	  a	  direct	  causal	  effect	  from	  one	  variable	  to	  another.	  The	  graph	  is	  acyclic:	  by	  following	  the	  direction	  of	  the	  arrows	  one	  can	  never	  end	  up	  where	  one	  started	  (in	  other	  words	  there	  can	  be	  no	  arrows	  from	  effects	  to	  causes).	  A	  causal	  DAG	  should	  include	  all	  variables,	  measured	  and	  unmeasured,	  which	  are	  common	  causes	  of	  any	  pair	  of	  variables	  in	  the	  DAG	  [159,	  160].	  Importantly,	  this	  implies	  that	  in	  a	  causal	  DAG	  there	  will	  be	  information	  in	  missing	  variables,	  as	  well	  as	  in	  missing	  arrows.	  This	  also	  explains	  why	  construction	  of	  causal	  diagrams	  will	  require	  subject-­‐matter	  knowledge	  [161].	  DAGs	  come	  attached	  with	  a	  set	  of	  rules	  on	  how	  to	  decide	  whether	  two	  variables	  are	  independent	  or	  associated	  (d-­‐separation).	  Generally,	  these	  are	  evaluated	  on	  the	  basis	  of	  marginal	  versus	  conditional	  independence,	  or	  association.	  The	  act	  of	  conditioning	  on	  a	  variable	  in	  a	  DAG	  is	  represented	  graphically	  by	  enclosing	  it	  in	  a	  box/square.	  	  	  2.3.1.1.1 Confounding	  We	  say	  there	  is	  confounding	  when	  the	  exposure	  and	  outcome	  share	  common	  causes.	  If	  two	  variables	  share	  a	  common	  cause,	  this	  will	  induce	  a	  marginal	  association	  between	  the	  two,	  even	  though	  neither	  of	  them	  causes	  the	  other;	  an	  association	  due	  to	  common	  causes	  is	  referred	  to	  as	  “spurious”.	  	  
	  Figure	  1.	  	   DAG	  representing	  confounding:	  An	  association	  between	  birth	  weight	  or	  fetal	  growth	  (A)	  and	  CVD	  (Y)	  is	  due	  to	  shared	  socioeconomic	  factors	  (L)	  and/or	  shared	  genetic	  factors	  (U)	  1	  	  	  A	  confounder	  is	  any	  variable	  that	  can	  be	  used	  to	  block	  the	  spurious	  association	  produced	  by	  the	  common	  cause.	  Such	  blocking	  can	  be	  achieved	  by	  methods	  such	  as	  standardization	  or	  stratification	  (most	  commonly	  conditioning	  on	  the	  confounder	  by	  including	  it	  in	  a	  regression	  model).	  It	  should	  be	  noted	  that	  there	  are	  situations	  in	  which	  the	  standard	  method	  (stratification)	  may	  not	  be	  appropriate,	  as	  in	  the	  case	  of	  e.g.	  time-­‐varying	  exposure	  and/or	  confounding.	  	  ______________________________________________________________________________________________	  1	  No	  arrow	  from	  A	  to	  Y	  in	  this	  DAG	  implies	  that	  there	  is	  no	  causal	  effect	  of	  A	  on	  Y,	  and	  any	  association	  between	  the	  two	  is	  the	  result	  of	  shared	  common	  causes.	  	  The	  DAG	  merely	  serves	  to	  illustrate	  the	  structure	  of	  the	  bias;	  in	  real	  life	  we	  would	  probably	  have	  preferred	  to	  include	  an	  arrow	  from	  A	  to	  Y	  as	  well,	  since	  we	  do	  not	  know	  if	  e.g.	  fetal	  growth	  impairment	  may	  cause	  CVD.	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2.3.1.1.2 Selection	  bias	  Selection	  bias	  arises	  from	  the	  act	  of	  conditioning	  on	  a	  common	  effect	  of	  both	  the	  exposure	  and	  the	  outcome,	  or	  a	  common	  effect	  of	  a	  cause	  of	  the	  exposure	  and	  a	  cause	  of	  the	  outcome,	  or	  a	  combination	  of	  the	  two.	  
	  	  Figure	  2.	   DAG	  illustrating	  selection	  bias:	  An	  association	  between	  birth	  weight	  (A)	  and	  blood	  pressure	  (Y)	  is	  introduced	  by	  conditioning	  on	  participation	  in	  the	  study	  (C)	  if	  this	  is	  an	  effect	  of	  a	  cause	  of	  A,	  e.g.,	  socioeconomic	  status	  (L),	  and	  of	  a	  cause	  of	  Y,	  e.g.	  health	  consciousness/healthy	  behavior	  (U)	  	  	  Selection	  bias	  can	  arise	  as	  subjects	  are	  selected	  into	  a	  study	  (e.g.	  volunteer	  bias	  or	  inappropriate	  control	  selection),	  into	  a	  particular	  analysis	  (missing	  data	  bias),	  or	  when	  certain	  subjects	  are	  censored	  before	  the	  outcome	  can	  be	  observed	  (differential	  loss	  to	  follow-­‐up).	  Ideally,	  this	  type	  of	  bias	  should	  be	  handled	  in	  the	  design	  phase	  of	  a	  study	  (e.g.	  by	  proper	  selection	  of	  controls,	  data	  collection	  etc.),	  whereas	  a	  potential	  analysis	  solution	  would	  be	  to	  block	  the	  path	  that	  was	  opened	  by	  conditioning	  on	  C,	  which	  in	  the	  example	  above	  could	  be	  made	  by	  conditioning	  on	  L.	  Similar	  to	  the	  case	  of	  handling	  confounding	  however,	  there	  are	  situations	  in	  which	  stratification	  may	  not	  serve	  to	  remove	  bias.	  The	  use	  of	  DAGs	  may	  help	  identify	  when	  other	  methods	  would	  be	  more	  appropriate	  (e.g.	  when	  the	  variable	  we	  wish	  to	  condition	  on	  to	  block	  the	  path	  is	  itself	  an	  effect	  of	  A).	  	  Variables	  that	  are	  effects	  of	  more	  than	  one	  cause	  (i.e.	  have	  more	  than	  one	  arrow	  pointing	  to	  them)	  are	  called	  colliders,	  and	  the	  bias	  is	  therefore	  sometimes	  also	  referred	  to	  as	  collider-­‐stratification	  bias.	  A	  special	  case	  of	  this	  type	  of	  bias	  arises	  with	  the	  act	  of	  conditioning	  on	  a	  variable	  in	  the	  causal	  pathway,	  when	  there	  are	  also	  unmeasured	  common	  causes	  of	  the	  intermediate	  and	  the	  outcome.	  	  	  
	  	  Figure	  3.	   DAG	  illustrating	  “collider-­‐stratification”	  bias:	  The	  association	  between	  fetal	  growth	  (A)	  and	  blood	  pressure	  (Y)	  is	  due	  to	  conditioning	  on	  the	  intermediate	  adult	  BMI	  (M)	  which	  is	  an	  effect	  of	  A	  and	  a	  cause	  of	  Y	  but	  also	  shares	  common	  cause	  physical	  activity	  (U)	  with	  Y	  1	  	  Conditioning	  on	  a	  variable	  in	  the	  causal	  pathway	  is	  often	  cautioned	  against	  but	  less	  so	  with	  a	  motivation.	  Other	  than	  the	  concern	  for	  spurious	  associations	  [162],	  the	  relevance	  or	  plausibility	  of	  such	  practice	  could	  perhaps	  be	  questioned	  in	  some	  situations	  (e.g.	  when	  holding	  the	  intermediate	  constant	  makes	  little	  sense).	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2.3.1.1.3 Information	  bias	  Information	  bias	  occurs	  when	  the	  exposure	  and/or	  outcome	  cannot	  be	  measured	  perfectly.	  The	  resulting	  misclassification	  can	  be	  expressed	  in	  terms	  of	  sensitivity	  and	  specificity.	  The	  sensitivity	  describes	  the	  proportion	  of	  correctly	  classified	  among	  those	  truly	  affected	  (by	  e.g.	  exposure	  or	  disease)	  and	  the	  specificity	  refers	  to	  the	  proportion	  correctly	  identified	  among	  the	  non-­‐affected	  (correspondingly	  the	  unexposed	  or	  unhealthy).	  The	  degree	  of	  information	  bias	  will	  depend	  on	  the	  sensitivity	  and	  specificity	  of	  the	  classification	  method,	  and	  the	  prevalence	  of	  the	  state	  of	  interest	  (exposure	  or	  outcome)	  [163].	  If	  the	  misclassification	  of	  exposure	  is	  random	  with	  respect	  to	  the	  outcome,	  or	  vice	  versa,	  the	  misclassification	  is	  traditionally	  referred	  to	  as	  non-­‐differential.	  	  
	  	  Figure	  4.	  	   DAG	  illustrating	  information	  bias	  (non-­‐differential	  misclassification):	  	  The	  association	  between	  fetal	  growth	  (A)	  and	  a	  diagnosis	  of	  CVD	  in	  the	  Inpatient	  Register	  (Y*)	  is	  expected	  to	  underestimate	  a	  potential	  causal	  effect	  of	  A	  on	  CVD	  (Y)	  if	  Y*	  is	  not	  perfectly	  correlated	  with	  Y	  (M	  can	  be	  a	  vector	  of	  reasons	  for	  receiving	  disease	  status	  in	  the	  register,	  e.g.	  whether	  the	  onset	  of	  disease	  warrants	  hospital	  care)	  	  	  Non-­‐differential	  misclassification	  of	  a	  dichotomous	  trait	  (as	  with	  CVD	  in	  the	  example	  above)	  tends	  to	  lead	  to	  an	  attenuation	  of	  the	  true	  effect.	  In	  the	  case	  of	  differential	  misclassification,	  i.e.	  misclassification	  that	  differs	  systematically	  between	  the	  groups	  contrasted	  (diseased/non-­‐diseased	  in	  the	  case	  of	  exposure	  misclassification	  or	  exposed/unexposed	  in	  the	  case	  of	  outcome	  misclassification),	  the	  bias	  can	  go	  in	  any	  direction	  (and	  sometimes	  it	  may	  be	  hard	  to	  predict	  which).	  	  	  	  2.3.1.2 EXTERNAL	  VALIDITY	  The	  closer	  a	  study	  measures	  what	  it	  intends	  to	  measure	  (whether	  a	  causal	  effect	  or	  association)	  the	  higher	  the	  internal	  validity.	  Thus	  the	  degree	  of	  random	  and	  systematic	  error	  in	  a	  study	  determines	  its	  internal	  validity.	  As	  the	  “internal”	  implies,	  this	  pertains	  only	  to	  the	  sample	  studied.	  If	  the	  study	  subjects	  are	  representative	  of	  the	  source	  population,	  and/or	  other	  populations,	  the	  findings	  may	  be	  generalized	  to	  these	  populations	  as	  well.	  Such	  generalizability,	  or	  representativeness,	  is	  referred	  to	  as	  external	  validity.	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In	  a	  sense,	  the	  studies	  of	  this	  thesis	  were	  motivated	  by	  the	  “association	  is	  not	  causation”	  axiom,	  and	  the	  reservation	  that	  associations	  that	  have	  not	  only	  inspired	  extensive	  research	  and	  advanced	  theories,	  but	  potentially	  also	  the	  promotion	  of	  preventive	  measures,	  may	  not	  represent	  the	  proposed	  causal	  effect.	  First,	  and	  most	  important,	  none	  of	  the	  studies	  directly	  measure	  the	  exposure	  believed	  to	  be	  causal	  (fetal	  and/or	  maternal	  nutrition).	  The	  proxies	  used	  are	  poor	  and	  at	  times	  only	  speculative	  (such	  as	  with	  the	  proportionality	  phenotypes	  used	  to	  target	  types	  and	  timing	  of	  insults).	  Also,	  it	  is	  unclear	  whether	  they	  are	  in	  the	  causal	  pathway	  between	  fetal	  nutrition	  and	  outcome	  (as	  could	  be	  the	  case	  with	  fetal	  growth),	  or	  associated	  with	  the	  outcome	  because	  they	  share	  the	  exposure	  as	  a	  common	  cause	  (likely	  the	  case	  with	  birth	  weight,	  as	  illustrated	  in	  the	  DAG	  below).	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2.4 TWINS	  The	  phenomenon	  of	  twinning	  has	  been	  an	  inspiration	  to	  many	  myths	  and	  stories,	  from	  Castor	  &	  Pollux	  of	  Greek	  mythology	  to	  Viola	  &	  Sebastian	  in	  Shakespeare’s	  Twelfth	  night.	  With	  sir	  Francis	  Galton	  noting	  	  (in	  1875)	  that	  the	  study	  of	  twins	  may	  allow	  “to	  weigh	  in	  just	  scales	  the	  effects	  of	  Nature	  and	  Nurture”	  [164],	  the	  unique	  features	  of	  twins	  have	  also	  intrigued	  and	  inspired	  scientists.	  	   	  	  
2.4.1 BIOLOGY	  Twinning	  occurs	  as	  a	  result	  of	  the	  implantation	  (and	  maintenance)	  of	  two	  embryos.	  This	  can	  essentially	  happen	  spontaneously	  in	  two	  different	  ways;	  either	  through	  the	  separate	  fertilization	  of	  two	  eggs,	  or	  through	  the	  early	  division	  of	  one	  fertilized	  egg	  (zygote)	  into	  two	  viable	  embryos.	  	  Roughly	  one-­‐third	  of	  all	  twins	  stem	  from	  the	  same	  zygote	  and	  are	  thus	  called	  monozygotic	  (MZ	  or	  identical	  twins)	  whereas	  the	  remaining	  two-­‐thirds	  are	  dizygotic	  (DZ	  or	  fraternal	  twins;	  stemming	  from	  two	  separate	  zygotes)[165].	  	  	  The	  rate	  of	  twinning	  varies	  greatly	  across	  different	  geographic	  regions	  and	  between	  ethnic	  groups	  (from	  8-­‐16/1000	  maternities	  in	  the	  Nordic	  countries	  to	  up	  to	  1/20	  in	  Nigeria)	  [166,	  167].	  The	  general	  perception	  appears	  to	  be	  that	  MZ	  twinning	  rates	  are	  relatively	  constant	  across	  both	  time	  and	  populations,	  so	  that	  differences	  in	  overall	  twinning	  rates	  roughly	  reflect	  the	  variability	  in	  DZ	  twinning	  [165].	  With	  no	  identified	  risk	  factors	  MZ	  twinning	  is	  generally	  considered	  a	  random	  event,	  whereas	  DZ	  twinning	  has	  been	  shown	  to	  increase	  with	  maternal	  age,	  parity,	  and	  height	  [168].	  It	  has	  also	  been	  proposed	  that	  diet	  could	  influence	  DZ	  twinning	  rates	  [169].	  	  	   	  Dizygotic	  twins	  stem	  from	  two	  separately	  fertilized	  eggs	  and	  will	  therefore	  be	  genetically	  related	  like	  any	  full	  siblings.	  Originating	  from	  the	  same	  zygote,	  monozygotic	  twins,	  on	  the	  other	  hand,	  are	  expected	  to	  share	  the	  same	  genetic	  setup.	  However,	  all	  MZ	  twin	  pairs	  may	  not	  be	  strictly	  genetically	  identical	  due	  to	  rare	  post-­‐zygotic	  genomic	  changes,	  such	  as	  chromosomal	  abnormalities	  and	  point	  mutations	  [170,	  171].	  There	  is	  also	  a	  recent	  report	  that	  copy	  variation	  profiles	  may	  differ	  between	  MZ	  co-­‐twins	  [172],	  but	  the	  extent	  and	  consequences	  of	  this	  for	  phenotypic	  variation	  requires	  further	  study.	  	  	  Although	  the	  genetic	  material	  is	  expected	  to	  be	  overall	  very	  similar	  within	  MZ	  twin	  pairs,	  epigenetic	  modulation	  of	  the	  DNA	  (potentially	  influencing	  gene	  expression)	  may	  differ.	  Permanent	  epigenetic	  silencing,	  such	  as	  the	  X-­‐chromosome	  inactivation	  in	  females,	  may	  differ	  in	  MZ	  twin	  pairs	  depending	  on	  the	  timing	  of	  division	  and	  the	  commitment	  to	  inactivation	  [173].	  Epigenetic	  modulation	  of	  the	  genome	  can	  also	  occur	  throughout	  the	  life	  course,	  possibly	  in	  response	  to	  environmental	  factors	  [174],	  and	  could	  be	  responsible	  for	  phenotypic	  differences	  within	  monozygotic	  twin	  pairs	  [175].	  	  According	  to	  a	  recent	  study,	  epigenetic	  markers	  appear	  to	  be	  overall	  very	  similar	  in	  young	  MZ	  twins	  but	  significantly	  different	  in	  elderly	  MZ	  twin	  pairs	  [176].	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In	  utero,	  twins	  will	  need	  to	  share	  both	  space	  and	  supply	  line	  from	  the	  mother,	  and	  the	  premises	  for	  this	  sharing	  will	  mainly	  depend	  on	  placentation.	  Normally,	  an	  embryo	  is	  enclosed	  in	  two	  membranes;	  the	  inner	  amnion	  forming	  the	  amniotic	  sac	  around	  the	  embryo,	  and	  the	  outer	  chorion,	  which	  forms	  the	  connection	  to	  the	  maternal	  circulation	  via	  the	  placenta.	  Embryos	  that	  are	  separate	  will	  develop	  their	  own	  membranes	  and	  are	  thus	  able	  to	  form	  individual	  placentas.	  This	  is	  the	  case	  for	  roughly	  all	  of	  DZ	  and	  ~30%	  of	  MZ	  twins.	  Approximately	  half	  of	  these	  dichorionic	  placentas	  will	  fuse	  together	  throughout	  the	  course	  of	  pregnancy	  [177].	  If	  in	  MZ	  twins	  the	  division	  occurs	  after	  the	  chorion	  has	  formed	  (>3	  days	  after	  fertilization)	  there	  will	  only	  be	  one	  chorion,	  and	  thus	  one	  placenta,	  to	  share.	  Monochorionic	  placentas	  are	  more	  prone	  to	  vascular	  anastomoses	  than	  fused	  dichorionic	  placentas	  [177]	  .	  Also,	  peripheral	  chord	  insertion	  (into	  the	  membranes)	  tends	  to	  be	  more	  common	  in	  monochorionic	  placentas	  [178].	  In	  rare	  cases	  the	  division	  can	  occur	  even	  after	  the	  amnion	  has	  formed,	  at	  which	  the	  twins	  share	  both	  amnion	  and	  chorion.	  1-­‐2%	  of	  all	  MZ	  pregnancies	  turn	  out	  to	  be	  monochorionic-­‐monoamniotic	  (MCMA),	  and	  the	  potential	  for	  their	  chords	  to	  twist	  around	  each	  other	  put	  these	  twins	  at	  greater	  risk	  of	  complications	  [165].	  	  	  
2.4.2 FETAL	  GROWTH	  IN	  TWINS	  The	  prenatal	  growth	  of	  twins	  is	  commonly	  described	  to	  be	  similar	  to	  that	  of	  singletons	  up	  until	  the	  3rd	  trimester	  when	  a	  downregulation	  of	  growth	  occurs	  [179].	  According	  to	  ultrasound	  measurements	  this	  decrease	  in	  the	  twin	  growth	  velocity	  begins	  around	  week	  32	  [180,	  181].	  The	  primary	  process	  for	  the	  slowed	  growth	  in	  multiple	  pregnancies	  is	  believed	  to	  be	  a	  response	  to	  the	  environment	  when	  the	  size	  of	  the	  fetuses	  combined	  exceeds	  a	  certain	  threshold	  [182].	  Others	  have	  claimed	  that	  twins	  may	  downregulate	  their	  growth	  already	  in	  the	  first	  half	  of	  gestation,	  and	  by	  setting	  a	  lower	  growth	  trajectory	  this	  early	  would	  be	  better	  protected	  against	  undernutrition	  later	  in	  gestation	  [183].	  	  	  Twins	  also	  experience	  shorter	  gestations	  than	  singletons	  (3	  weeks	  on	  average).	  The	  lower	  birth	  weights	  seen	  in	  twins	  compared	  to	  singletons	  may	  thus	  be	  a	  result	  of	  growth	  restriction	  or	  shorter	  gestation,	  or	  both.	  	  In	  comparison	  to	  singletons,	  the	  unique	  constraints	  on	  twins	  due	  to	  their	  sharing	  of	  space	  and	  supply	  line	  is	  likely	  to	  overshadow	  most	  other	  influences	  on	  growth.	  The	  variation	  in	  growth	  between	  (unrelated)	  twins	  however,	  is	  likely	  to	  be	  influenced	  by	  the	  same	  determinants	  described	  for	  singletons,	  i.e.	  the	  individual	  growth	  potential	  and	  the	  supply	  line	  supporting	  it.	  In	  a	  twin	  cohort	  we	  would	  therefore	  expect	  differences	  in	  fetal	  genes,	  maternal	  factors	  and	  placental	  function	  to	  influence	  the	  variation	  in	  fetal	  growth.	  In	  twins,	  zygosity	  and/or	  chorionicity	  can	  predict	  fetal	  growth,	  which	  probably	  mainly	  is	  a	  reflection	  of	  the	  importance	  of	  placentation,	  and	  in	  particular	  the	  location	  of	  the	  chord	  insertion	  (which	  if	  peripheral	  risks	  impairing	  the	  critical	  exchange	  between	  mother	  and	  fetus)	  [184].	  A	  peripheral	  chord	  insertion	  appears	  even	  further	  unfavorable	  in	  the	  case	  of	  shared	  or	  fused	  placentas	  [184].	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2.4.2.1 TWIN	  GROWTH	  DISCORDANCE	  Twins	  in	  a	  twin	  pair	  may	  also	  experience	  different	  growth.	  Discordance	  in	  the	  availability	  of	  nutrients	  and	  oxygen	  may	  cause	  restriction	  of	  the	  growth	  of	  one	  twin	  relative	  to	  the	  other.	  In	  DZ	  twin	  pairs	  a	  difference	  in	  growth	  could	  also	  stem	  from	  differences	  in	  the	  genetic	  growth	  potential.	  It	  has	  been	  speculated	  that	  lower	  levels	  of	  discordance	  (the	  difference	  in	  birth	  weight	  being	  <25%	  of	  the	  weight	  of	  the	  heavier	  twin)	  reflect	  natural	  differences	  between	  twin	  siblings,	  whereas	  more	  severe	  discordance	  would	  rather	  be	  the	  result	  of	  growth	  restriction	  in	  response	  to	  an	  exhausted	  intrauterine	  environment	  [185].	  It	  has	  further	  been	  proposed	  that	  twin	  growth	  discordance	  may	  be	  an	  adaptation	  to	  the	  limited	  space,	  aimed	  at	  promoting	  maturity	  by	  increasing	  the	  length	  of	  gestation	  (as	  discordant	  twins	  appear	  to	  be	  delivered	  later	  than	  concordant	  twins	  of	  the	  same	  combined	  weight)	  [186].	  	  	  Allocation	  of	  nutrients	  and	  oxygen	  is	  mainly	  a	  result	  of	  placentation.	  In	  dichorionic	  twins,	  whether	  placentas	  are	  separate	  or	  fused,	  allocation	  may	  vary	  according	  to	  differences	  in	  the	  location	  of	  the	  chord	  insertion	  as	  well	  as	  the	  function	  of	  the	  individual	  placenta.	  The	  location	  of	  the	  chord	  insertion	  appears	  even	  more	  important	  in	  monochorionic	  twins	  who	  share	  one	  placenta.	  The	  monochorionic	  placenta	  is	  also	  more	  richly	  vascularized	  with	  anastomoses	  than	  a	  fused	  placenta.	  Plenty	  of	  vascular	  anastomoses	  may	  protect	  against	  unilateral	  shunting	  of	  blood	  from	  one	  twin	  to	  the	  other	  (as	  occurs	  in	  the	  twin	  to	  twin	  transfusion	  syndrome,	  TTTS)	  and,	  similarly,	  compensate	  for	  an	  unfavorable	  placental	  function	  in	  one	  twin	  to	  mitigate	  growth	  discordance	  [187].	  Conversely,	  a	  paucity	  of	  vascular	  anastomoses	  could	  increase	  the	  risk	  of	  TTTS	  and	  severe	  growth	  discordancy	  in	  monochorionic	  twins	  [188].	  Irrespective	  of	  this,	  birth	  weight	  discordance	  in	  MC	  has	  been	  shown	  to	  be	  the	  result	  of	  unequal	  sharing	  of	  the	  placenta	  and/or	  chord	  insertion,	  and	  that	  these	  in	  turn	  are	  not	  associated	  with	  the	  vascular	  architecture	  (anastomoses)	  of	  the	  placenta	  [189,	  190].	  	  	  	  To	  conclude,	  other	  than	  the	  potential	  influence	  from	  the	  difference	  in	  genetic	  resemblance	  between	  DZ	  and	  MZ,	  the	  main	  determinants	  of	  growth	  discordance	  appear	  to	  be	  the	  same	  in	  both	  monochorionic	  and	  dichorionic	  twins,	  namely	  placental	  function	  and	  chord	  insertion	  [189,	  190].	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2.4.3 THE	  USE	  OF	  TWINS	  IN	  DOHAD	  In	  the	  classical	  twin	  study,	  the	  degree	  of	  twin	  pair	  similarity	  in	  MZ	  and	  DZ	  is	  used	  to	  estimate	  the	  relative	  contributions	  of	  genes	  and	  environment	  to	  phenotypic	  variation.	  The	  similarities	  of	  twins	  may	  also	  offer	  unique	  opportunities	  to	  assess	  associations	  that	  are	  independent	  of	  all	  factors	  shared	  by	  the	  twins	  in	  a	  twin	  pair.	  	  When	  a	  comparison	  is	  made	  between	  the	  twins	  in	  a	  twin	  pair	  all	  factors	  they	  have	  in	  common	  are	  held	  constant,	  thus	  any	  differences	  between	  them	  cannot	  be	  due	  to	  the	  factors	  that	  they	  share.	  All	  twins	  share	  early	  environment	  and	  a	  varying	  degree	  of	  genetic	  factors,	  which	  together	  are	  commonly	  referred	  to	  as	  familial	  factors.	  Birth	  weight	  differences	  within	  twin	  pairs	  will	  thus	  be	  independent	  of	  e.g.	  gestational	  age,	  maternal	  factors	  such	  as	  constitution	  and	  behaviors,	  early	  socioeconomic	  environment,	  etc.	  In	  monozygotic	  twin	  pairs	  a	  difference	  in	  birth	  weight	  can	  further	  (generally)	  not	  be	  attributed	  to	  any	  genetic	  influence.	  As	  previously	  described,	  growth	  discordance	  in	  twin	  pairs	  (which	  can	  be	  measured	  by	  the	  discordance	  in	  birth	  weights)	  is	  a	  result	  of	  the	  twins’	  unequal	  share	  of	  the	  supply	  line	  -­‐	  and	  in	  DZ	  twins	  also	  fetal	  genetic	  factors.	  The	  availability	  of	  the	  supply	  line,	  in	  turn,	  is	  a	  reflection	  of	  fetal	  nutrition.	  	  Thus,	  by	  targeting	  the	  influence	  of	  fetal	  growth	  that	  is	  independent	  of	  familial	  factors	  (and	  genetic	  factors	  in	  MZ),	  assessments	  of	  the	  association	  between	  birth	  weight	  and	  later	  health	  outcome	  within	  twin	  pairs	  may	  help	  provide	  some	  clues	  about	  the	  potential	  early	  life	  (fetal)	  influence	  on	  health	  and	  disease.	  	  	  	   ______________________________________________________	  	  	  	  Twins	  have	  been	  used	  to	  explore	  DOHaD	  associations	  previously,	  in	  several	  different	  ways.	  First,	  the	  adverse	  intrauterine	  experience	  of	  twins	  compared	  to	  singletons	  has	  been	  proposed	  as	  a	  test	  for	  the	  fetal	  origins	  hypothesis	  [22,	  23].	  Reports	  of	  no	  difference	  in	  CVD	  mortality	  between	  twins	  and	  the	  general	  population	  however	  sparked	  a	  debate	  about	  the	  role	  of	  fetal	  programming	  in	  twins.	  Some	  argue	  that	  growth	  in	  twins	  is	  inherently	  different	  from	  that	  in	  singletons.	  For	  example,	  twins	  would	  be	  under	  much	  stronger	  influence	  of	  determinants	  (such	  as	  maternal	  constraint)	  that	  may	  not	  be	  importantly	  linked	  to	  later	  disease	  development	  [183].	  The	  same	  authors	  also	  propose	  that	  twins	  may	  downregulate	  their	  growth	  early	  so	  as	  to	  avoid	  negative	  consequences	  of	  fetal	  growth	  restriction.	  Still,	  twin	  growth	  appears	  similar	  to	  that	  of	  singletons	  up	  until	  at	  least	  the	  third	  trimester	  (which	  is	  the	  originally	  proposed	  critical	  window	  for	  fetal	  programming)	  [180,	  181].	  No	  differences	  between	  twins	  and	  the	  general	  population	  have	  nevertheless	  been	  taken	  as	  an	  indication	  that	  the	  general	  adverse	  environment	  and	  growth	  constraint	  of	  twin	  pregnancies	  (compared	  to	  singletons)	  may	  not	  be	  pathological	  [25].	  It	  has	  also	  been	  pointed	  out	  that	  twin-­‐singleton	  comparisons	  may	  be	  confounded	  if	  twins	  as	  a	  group	  were	  to	  have	  a	  slightly	  different	  genetic	  or	  socioeconomic	  background	  than	  the	  general	  population	  [29].	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The	  contrast	  between	  DZ	  and	  MZ	  twins	  has	  also	  been	  used	  to	  indicate	  a	  varying	  degree	  of	  intrauterine	  exposure	  (using	  zygosity	  as	  a	  proxy	  for	  placentation).	  By	  this	  logic,	  differences	  in	  glucose	  metabolism	  between	  MZ	  and	  DZ	  have	  been	  proposed	  to	  be	  due	  to	  a	  more	  adverse	  fetal	  experience	  in	  MZ	  compared	  to	  DZ	  (due	  to	  a	  greater	  degree	  of	  placental	  sharing	  among	  MZMC)	  [191].	  Conversely,	  the	  presence	  of	  two	  hormone-­‐producing	  placentas	  has	  been	  proposed	  to	  put	  DZ	  at	  greater	  risk	  of	  breast	  cancer	  (compared	  to	  singletons	  or	  MZ)	  [17].	  	  Several	  studies	  have	  also	  used	  within-­‐twinpair	  comparisons	  in	  the	  DOHaD	  field	  to	  explore	  the	  role	  of	  shared	  environment	  and	  genetic	  factors.	  The	  reasoning	  is	  such	  that	  if	  an	  association	  remains	  holding	  shared	  factors	  constant	  (i.e.	  within-­‐twinpairs),	  such	  factors	  (e.g.	  maternal	  and	  socioeconomic	  factors)	  are	  not	  likely	  to	  be	  influential	  for	  the	  original	  association.	  Conversely,	  if	  an	  association	  changes	  within-­‐twinpairs	  compared	  to	  between	  unrelated	  twins,	  the	  shared	  factors	  may	  play	  a	  role	  in	  the	  appearance	  of	  the	  original	  association.	  Commonly,	  this	  role	  has	  been	  attributed	  that	  of	  a	  common	  cause,	  so	  that	  inference	  about	  the	  influence	  of	  shared	  factors	  has	  been	  expressed	  in	  terms	  of	  potential	  confounding	  of	  the	  studied	  association.	  These	  types	  of	  inferences	  are	  also	  commonly	  based	  on	  a	  two-­‐step	  approach,	  in	  which	  a	  “crude”	  association	  of	  birth	  weight	  and	  outcome	  (ignoring	  twin	  pair	  structure)	  is	  first	  contrasted	  to	  the	  within-­‐twinpair	  association	  in	  all	  twins,	  and	  then	  in	  DZ	  and	  MZ	  twins	  separately.	  If	  the	  within-­‐twinpair	  association	  is	  different	  from	  the	  “crude”	  (between	  unrelated	  twins),	  this	  is	  taken	  as	  an	  indication	  that	  the	  original	  association	  could	  be	  confounded	  by	  familial	  factors.	  Differing	  within-­‐twinpair	  associations	  between	  DZ	  and	  MZ	  is	  sometimes	  further	  attributed	  to	  a	  genetic	  influence	  (based	  on	  the	  assumption	  that	  the	  only	  factors	  shared	  within	  MZ	  twin	  pairs	  and	  not	  DZ	  twin	  pairs,	  are	  genetic).	  	  As	  with	  DOHaD	  studies	  in	  singletons,	  the	  majority	  of	  within-­‐twinpair	  comparisons	  have	  assessed	  the	  association	  between	  birth	  weight	  and	  blood	  pressure.	  A	  meta-­‐analysis	  of	  the	  first	  10	  studies	  reported	  of	  great	  heterogeneity	  between	  these,	  and	  also	  that	  all	  estimates	  had	  been	  adjusted	  for	  current	  BMI	  [192].	  More	  recently,	  a	  large	  study	  from	  the	  STR	  has	  found	  an	  association	  between	  birth	  weight	  and	  hypertension	  within	  both	  DZ	  and	  MZ	  pairs,	  with	  and	  without	  adjustment	  for	  adult	  factors	  [21].	  In	  the	  same	  cohort	  no	  association	  between	  birth	  weight	  and	  NIDDM	  within	  MZ	  has	  been	  interpreted	  as	  supporting	  a	  common	  genetic	  etiology	  for	  low	  birth	  weight	  and	  NIDDM	  (in	  contrast	  with	  findings	  in	  smaller	  twin	  samples	  of	  birth	  weight	  being	  associated	  with	  glucose	  metabolism	  within	  MZ	  [193,	  194])	  [20].	  Attenuation	  of	  the	  association	  between	  birth	  weight	  and	  acute	  myocardial	  infarction	  in	  a	  small	  co-­‐twin-­‐control	  study	  in	  twins	  of	  the	  STR	  has	  further	  been	  taken	  as	  an	  indication	  of	  familial	  confounding	  of	  the	  original	  DOHaD	  association	  [24].	  The	  only	  previous	  study	  of	  the	  association	  between	  birth	  weight	  and	  breast	  cancer	  in	  like-­‐sexed	  twins	  is	  also	  a	  small	  co-­‐twin-­‐control	  from	  the	  STR.	  In	  this	  study,	  indications	  were	  of	  increasing	  risk	  of	  breast	  cancer	  with	  increasing	  birth	  weight	  within	  twins,	  but	  estimates	  were	  not	  statistically	  significant	  [195].	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3 AIMS	  	  	  
o To	  study	  the	  potential	  influence	  of	  ethnicity	  and	  familial	  factors	  on	  the	  association	  between	  birth	  weight	  and	  blood	  pressure	  in	  adolescence	  (PAPER	  I)	  —	  Is	  there	  any	  support	  for	  the	  claim	  that	  ethnic	  differences	  in	  blood	  pressure	  originate	  in	  utero?	  	  	  	  
o To	  investigate	  whether	  the	  reported	  positive	  association	  between	  birth	  weight	  and	  risk	  of	  breast	  cancer	  is	  present	  also	  within	  twin	  pairs	  (PAPER	  II)	  —	  Does	  fetal	  growth	  that	  is	  independent	  of	  familial	  factors	  predict	  risk	  of	  breast	  cancer	  in	  like-­‐sexed	  twins?	  	  	  	  
o To	  study	  the	  potential	  influence	  of	  within-­‐twinpair	  fetal	  growth	  on	  the	  risk	  of	  cardiovascular	  disease	  in	  adulthood	  (PAPER	  III)	  —	  Is	  there	  an	  association	  between	  birth	  weight	  and	  cardiovascular	  disease	  independent	  of	  factors	  shared	  within	  twin	  pairs?	  	  	  	  
o To	  study	  the	  potential	  influence	  of	  twinning	  on	  adult	  mortality	  and	  morbidity	  from	  cardiovascular	  disease	  and	  cancer	  (PAPER	  IV)	  —	  Are	  twins	  different	  from	  singletons	  with	  respect	  to	  morbidity	  and	  mortality	  in	  adulthood?	  If	  so,	  is	  this	  a	  result	  of	  the	  unique	  experience	  of	  being	  a	  twin,	  or	  of	  belonging	  to	  a	  twin	  family	  (or	  both)?	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4 MATERIALS	  &	  METHODS	  	  4.1 SETTINGS	  Observational	  studies	  of	  twins	  are	  generally	  based	  on	  data	  collected	  in	  volunteer	  twin	  cohorts	  or	  population-­‐based	  twin	  registers.	  This	  thesis	  has	  predominantly	  been	  based	  on	  data	  from	  the	  Swedish	  Twin	  Register,	  but	  has	  also	  made	  use	  of	  data	  from	  a	  volunteer	  cohort	  of	  bi-­‐ethnic	  adolescent	  twins	  in	  the	  US.	  In	  addition,	  the	  Swedish	  Multi-­‐Generation	  Register	  has	  been	  used	  to	  identify	  twins	  and	  their	  singleton	  siblings,	  as	  well	  as	  random	  samples	  of	  singletons	  from	  the	  population.	  	  	  	  4.2 DATA	  SOURCES	  	  
4.2.1 TWIN	  COHORTS	  4.2.1.1 THE	  GEORGIA	  CARDIOVASCULAR	  TWIN	  STUDY	  	  The	  Georgia	  Cardiovascular	  Twin	  Study	  (GCTS)	  is	  a	  longitudinal	  study	  of	  >500	  African	  American	  (AA)	  and	  European	  American	  (EA)	  twin	  pairs.	  The	  cohort	  was	  established	  to	  study	  changes	  in	  influence	  of	  genetic	  and	  environmental	  factors	  on	  development	  of	  bio-­‐behavioral	  risk	  factors	  for	  cardiovascular	  disease	  in	  youth.	  	  Twins	  were	  recruited	  from	  schools	  in	  Augusta,	  Georgia	  and	  308	  EA	  and	  223	  AA	  pairs	  attended	  a	  baseline	  visit	  between	  1997	  and	  2000.	  During	  their	  scheduled	  follow-­‐up	  visit	  between	  2001	  and	  2004,	  an	  additional	  53	  EA	  and	  51	  AA	  pairs	  were	  recruited.	  All	  subjects	  were	  healthy	  (as	  assessed	  by	  parental	  reports	  about	  previous	  medical	  history,	  and	  not	  using	  any	  hypertensive	  drug)	  when	  entering	  the	  study.	  The	  Institutional	  Review	  Board	  of	  the	  Medical	  College	  of	  Georgia	  has	  approved	  the	  GCTS	  and	  written	  consent	  has	  been	  obtained	  from	  all	  subjects	  (or	  parents,	  if	  subject	  was	  aged	  <18	  years).	  [196]	  	  	  4.2.1.1.1 Data	  collection	  Ethnic	  designation	  was	  determined	  from	  self-­‐reports.	  Subjects	  were	  classified	  as	  either	  EA	  or	  AA	  if	  1)	  both	  parents	  reported	  being	  of	  European	  or	  African	  ancestry	  respectively;	  2)	  parents	  and	  child	  were	  born	  and	  raised	  in	  the	  United	  States;	  and	  3)	  parents	  considered	  themselves	  and	  their	  child	  to	  be	  EA	  or	  AA	  respectively	  (and	  not	  of	  Hispanic,	  Native	  American,	  or	  Asian	  descent).	  Self-­‐identification	  of	  ethnic	  designation	  has	  been	  strongly	  advocated	  when	  used	  for	  human	  categorization	  in	  biomedical	  and	  genetic	  research	  [197].	  	  Zygosity	  was	  determined	  using	  5	  standard	  microsatellite	  markers	  (TPOX,	  THO1,	  FGA,	  F13A01,	  FES/FPS)	  on	  DNA	  collected	  through	  mucosal	  swabs.	  	  The	  likelihood	  of	  MZ	  using	  Bayes	  Theorem	  (Q	  =	  1.8)	  for	  five	  concordant	  markers	  for	  EA	  and	  AA	  was	  99.0%	  and	  99.2%,	  respectively	  [198].	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All	  physical	  tests	  were	  performed	  in	  a	  laboratory	  setting,	  and	  the	  procedures	  used	  were	  the	  same	  during	  baseline	  recruitment	  and	  follow-­‐up.	  Blood	  pressures	  were	  examined	  using	  a	  Dinamap	  Vital	  Signs	  Monitor	  (Model	  1864	  SX,	  Criticon,	  Inc.,	  Tampa,	  FL)	  after	  11,	  13,	  and	  15	  min	  in	  supine	  position	  (subjects	  were	  instructed	  to	  relax	  on	  a	  hospital	  bed).	  An	  average	  of	  the	  three	  measurements	  was	  calculated	  and	  used	  as	  the	  resting	  value.	  	  	  4.2.1.1.2 Birth	  records	  Information	  on	  birth	  weight	  was	  self-­‐reported	  by	  the	  twins’	  mother	  (N	  =	  810;	  54%	  EA	  and	  46%	  AA).	  In	  a	  subset	  of	  twins,	  birth	  weight	  information	  was	  also	  available	  from	  birth	  register	  data	  of	  the	  state	  of	  Georgia	  (N	  =	  617;	  53%	  EA	  and	  47%	  AA).	  In	  the	  399	  subjects	  with	  both	  types	  of	  information	  available,	  self-­‐reports	  were	  found	  to	  be	  in	  good	  agreement	  with	  registers	  (r	  =	  0.92,	  P	  =	  0.001).	  	  	  Other	  self-­‐reported	  information	  included	  family	  social	  status,	  maternal	  age	  at	  birth	  and	  maternal	  smoking	  habits	  at	  the	  time	  of	  the	  interview	  (yes/no).	  	  	  4.2.1.2 THE	  SWEDISH	  TWIN	  REGISTER	  The	  Swedish	  Twin	  Register	  (STR)	  was	  established	  in	  the	  late	  1950s	  to	  study	  the	  health	  effects	  of	  smoking,	  with	  ability	  to	  adjust	  for	  genetic	  liability	  for	  disease.	  The	  register	  consists	  of	  four	  consecutive	  birth	  cohorts,	  spanning	  over	  more	  than	  a	  century	  (1886	  to	  2001)	  and	  including	  over	  170	  000	  twins	  [199].	  Since	  the	  cohorts	  were	  compiled	  at	  different	  time	  points,	  slightly	  different	  methods	  of	  ascertainment	  and	  data	  collection	  have	  been	  used	  (multiple	  births	  were	  for	  example	  identified	  in	  national	  parish	  records	  in	  the	  first	  cohort,	  and	  in	  national	  birth	  registrations	  in	  the	  following).	  In	  the	  two	  first	  cohorts,	  both	  twins	  of	  the	  twin	  pair	  had	  to	  be	  alive	  and	  traceable	  at	  the	  time	  of	  compilation.	  Although	  population-­‐based,	  it	  follows	  that	  the	  register	  does	  not	  include	  all	  twins	  born	  in	  Sweden	  between	  1886	  and	  2001.	  Moreover,	  most	  studies	  in	  twins	  rely	  on	  information	  that	  requires	  the	  twins	  to	  have	  participated	  in	  one	  or	  more	  rounds	  of	  data	  collection	  (e.g.	  mail-­‐,	  telephone-­‐	  or	  web-­‐questionnaires).	  The	  STR	  is	  hosted	  at	  the	  Department	  of	  Medical	  Epidemiology	  and	  Biostatistics	  at	  Karolinska	  Insitutet.	  	  The	  twins	  under	  study	  in	  this	  thesis	  were	  born	  between	  1926	  and	  1958.	  This	  2nd	  cohort	  of	  the	  STR	  was	  compiled	  in	  1970,	  and	  thus	  includes	  all	  identified	  as	  twin	  pairs,	  where	  both	  twins	  were	  alive	  and	  traceable	  in	  1971	  (N=58	  836).	  	  4.2.1.2.1 Data	  collection	  During	  1972-­‐1973	  a	  paper-­‐based	  questionnaire	  was	  mailed	  out	  to	  all	  alive	  and	  traceable	  like-­‐sexed	  twins	  born	  1926-­‐1958	  (N=	  38	  955).	  Over	  14,000	  pairs	  responded	  (overall	  response	  rate	  81%)	  to	  questions	  about	  twin	  similarity,	  anthropometric	  measures	  (height	  and	  weight),	  health	  related	  behaviors	  (smoking,	  drinking	  and	  dietary	  habits)	  and	  health	  symptoms	  (cardiovascular	  and	  respiratory	  symptoms	  including	  allergies)	  [200].	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During	  1998-­‐2002	  the	  Screening	  Across	  the	  Lifespan	  Twin	  Study	  was	  performed	  in	  all	  living	  twins	  born	  1958	  or	  earlier.	  Twins	  were	  contacted	  for	  an	  extensive	  telephone	  interview,	  including	  questions	  about	  twin	  similarity,	  birth	  order,	  health-­‐related	  behaviors	  and	  indicators	  of	  health	  status	  (incl.	  prescription	  drug	  use).	  In	  those	  of	  the	  1926-­‐1958	  cohort	  who	  were	  still	  alive	  and	  traceable	  the	  response	  rate	  was	  74%.	  [199]	  	  	  4.2.1.2.2 Zygosity	  determination	  Questions	  used	  to	  determine	  zygosity	  in	  the	  questionnaire	  (Q73)	  and	  telephone	  interview	  (SALT)	  are	  shown	  below.	  For	  Q73,	  pair	  response	  agreement	  classified	  twins	  as	  either	  monozygotic	  or	  dizygotic,	  whereas	  non-­‐agreement	  or	  missing	  response(s)	  resulted	  in	  undetermined	  zygosity.	  This	  method	  has	  been	  reported	  to	  correctly	  classify	  zygosity	  in	  over	  95%	  of	  Swedish	  twins	  (estimated	  from	  the	  twins	  that	  could	  be	  classified;	  excluding	  unclassified	  twins	  from	  the	  denominator)	  [201].	  In	  SALT,	  twins	  were	  asked	  an	  additional	  question	  about	  twin	  similarity,	  and	  DNA	  analysis	  of	  a	  subsample	  of	  199	  twins	  found	  this	  method	  for	  zygosity	  determination	  to	  be	  99%	  accurate	  [199].	  	  
Questions	  about	  twin	  similarity	   Q73	   SALT	  
1.	  During	  childhood,	  were	  you	  and	  your	  twin	  partner	  as	  like	  as	  	  
‘‘two	  peas	  in	  a	  pod’’	  or	  not	  more	  alike	  than	  siblings	  in	  general?	  	  






2.	  How	  often	  did	  strangers	  have	  difficulty	  in	  distinguishing	  	  
between	  you	  and	  your	  twin	  partner	  when	  you	  were	  children	  
	   *	  	  The	  STR	  presently	  uses	  the	  best	  available	  information	  of	  zygosity,	  based	  on	  the	  following	  algorithm:	  1.	  DNA	  analysis	  2.	  Agreement	  in	  pair	  response	  to	  Q73	  3.	  Agreement	  in	  pair	  response	  to	  SALT	  if	  undetermined	  in	  Q73	  4.	  Agreement	  in	  singleton	  response	  in	  SALT	  (2	  questions)	  	  	  4.2.1.2.3 Birth	  records	  In	  the	  beginning	  of	  the	  new	  millennium,	  a	  large	  effort	  was	  made	  to	  locate	  the	  birth	  records	  of	  all	  twins	  born	  1926-­‐1958.	  Records	  of	  births	  were	  collected	  from	  all	  over	  Sweden,	  including	  hospital	  records	  for	  hospital	  deliveries	  and	  midwives	  records	  for	  home	  deliveries.	  The	  records	  include	  maternal	  information	  such	  as	  age,	  marital	  status,	  occupation,	  parity,	  last	  menstrual	  period,	  and	  potential	  disease(s)	  during	  pregnancy.	  The	  time	  of	  birth	  and	  type	  of	  delivery	  have	  been	  registered,	  together	  with	  anthropometric	  measures	  of	  the	  offspring	  at	  birth	  and	  birth	  order	  of	  twins.	  If	  the	  twins	  were	  baptized	  at	  birth,	  their	  Christian	  names	  were	  attached	  to	  their	  birth	  order	  in	  the	  report	  to	  the	  official	  birth	  registration.	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Anthropometric	  measures	  at	  birth	  include	  birth	  weight	  (measured	  with	  scales	  in	  grams),	  birth	  length	  (measured	  with	  measuring	  tape	  with	  the	  baby	  lying	  on	  its	  back	  with	  legs	  stretched	  and	  the	  head	  against	  a	  vertical	  headboard)	  and	  head	  circumference	  (measured	  with	  measuring	  tape	  around	  the	  scull	  above	  the	  ears).	  	  	  The	  establishment	  and	  data	  collection	  of	  this	  cohort	  of	  the	  STR	  has	  been	  approved	  by	  the	  Swedish	  Data	  Inspection	  Board	  (DNR	  3083-­‐74;	  7254-­‐95).	  	  	  
4.2.2 NATIONAL	  REGISTERS	  AND	  LINKAGE	  Residents	  in	  Sweden	  are	  assigned	  a	  civic	  registration	  number,	  which	  includes	  the	  complete	  birthdate	  (yyyy-­‐mm-­‐dd)	  and	  four	  administrative	  numbers	  (-­‐xxxx)	  [202].	  Through	  this	  unique	  identifier,	  individuals	  can	  be	  tracked	  and	  linked	  to	  national	  registries	  of	  health	  and	  demographic	  information.	  National	  registers	  of	  health	  are	  kept	  by	  the	  National	  Board	  of	  Health	  and	  Welfare,	  whereas	  registers	  containing	  demographic	  information	  and	  censuses	  are	  kept	  by	  Statistics	  Sweden.	  	  	  	  4.2.2.1 THE	  INPATIENT	  REGISTER	  Data	  in	  the	  Inpatient	  Register	  exist	  from	  1964,	  when	  6	  counties	  in	  Sweden	  started	  recording	  their	  hospital	  admissions.	  Coverage	  was	  up	  to	  85%	  by	  1983,	  and	  the	  register	  includes	  all	  public	  admissions	  in	  Sweden	  from	  1987	  and	  onwards.	  Information	  includes	  dates	  of	  admission	  and	  discharge	  and	  up	  to	  eight	  discharge	  diagnoses,	  coded	  according	  to	  the	  International	  Classification	  of	  Disease	  (ICD).	  The	  register	  also	  includes	  information	  about	  potential	  procedures	  performed	  during	  the	  hospital	  stay.	  Validation	  of	  the	  recorded	  main	  diagnoses	  (combining	  translation	  error,	  coding	  error	  and	  diagnosing	  error)	  has	  shown	  an	  overall	  misclassification	  of	  12%	  at	  the	  three-­‐digit	  level	  of	  the	  ICD	  code,	  and	  4%	  at	  the	  ICD-­‐chapter	  level.	  [203]	  	  	  4.2.2.2 THE	  CANCER	  REGISTER	  The	  Cancer	  Register	  holds	  information	  on	  all	  primary	  incident	  cancers	  in	  Sweden	  since	  1958	  [204].	  Reporting	  is	  mandatory	  for	  physicians	  as	  well	  as	  pathologists	  and	  cytologists	  separately,	  ensuring	  all	  cancers	  found	  in	  autopsy,	  histologic,	  and/or	  cytological	  specimens	  are	  included	  and	  are	  classified	  according	  to	  the	  ICD.	  99	  %	  of	  the	  registered	  cancers	  have	  been	  morphologically	  verified.	  In	  2006	  the	  registry	  roughly	  covered	  95%	  of	  all	  cancers	  reported	  in	  the	  Cause	  of	  Death	  Register,	  the	  deficit	  mainly	  represented	  by	  lung,	  pancreatic,	  and	  prostate	  cancers	  in	  patients	  above	  the	  age	  of	  75	  [204].	  Validation	  studies	  restricted	  to	  females	  have	  found	  the	  completeness	  of	  the	  registry	  to	  be	  99%	  [205,	  206].	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4.2.2.3 THE	  CAUSE	  OF	  DEATH	  REGISTER	  National	  records	  of	  cause	  of	  death	  have	  been	  computerized	  since	  1952,	  and	  are	  considered	  reliable	  from	  1961	  and	  onwards.	  Reports	  of	  death	  and	  filing	  of	  cause	  of	  death	  certificates	  are	  mandatory,	  so	  that	  the	  record	  completely	  covers	  all	  deaths	  occurring	  in	  Sweden.	  Information	  includes	  date	  of	  death,	  underlying	  cause	  of	  death	  and	  up	  to	  10	  contributing	  diagnoses	  classified	  according	  to	  ICD.	  There	  is	  also	  information	  of	  potential	  autopsy.	  [207]	  	  	  4.2.2.4 THE	  MULTI-­‐GENERATION	  REGISTER	  The	  Multi-­‐Generation	  Register	  links	  all	  Swedish	  residents	  to	  their	  parents,	  thereby	  allowing	  for	  identification	  of	  full	  and	  half-­‐siblings,	  as	  well	  as	  more	  complex	  family	  structures.	  The	  register	  was	  created	  in	  the	  early	  1990s	  and	  includes	  all	  individuals	  who	  have	  been	  registered	  in	  Sweden	  since	  1961.	  Of	  these,	  all	  individuals	  aged	  15	  years	  or	  younger	  at	  the	  time	  the	  personal	  registration	  number	  was	  introduced	  (in	  1947)	  were	  included	  in	  the	  register	  together	  with	  information	  on	  their	  parents.	  Index	  individuals	  thus	  include	  those	  born	  from	  1932	  and	  onwards,	  who	  were	  alive	  and	  residing	  in	  Sweden	  sometime	  after	  1961.	  [208]	  	  Completeness	  of	  parental	  information	  depends	  on	  birth	  year,	  with	  a	  greater	  extent	  of	  missing	  data	  on	  one	  or	  both	  of	  the	  parents	  in	  the	  oldest	  cohorts	  (more	  commonly	  the	  father,	  as	  paternity	  is	  established	  either	  by	  marital	  connection	  at	  the	  time	  of	  birth,	  or	  “by	  acknowledgement”	  if	  not	  married).	  Non-­‐biological	  or	  adoptive	  relations	  are	  flagged.	  From	  the	  structure	  of	  the	  register	  it	  follows	  that	  an	  individual	  can	  only	  appear	  once	  as	  an	  index	  person,	  but	  may	  be	  recorded	  several	  times	  as	  parent	  (to	  new	  index	  individuals).	  	  	  	  4.2.2.5 THE	  POPULATION	  AND	  HOUSING	  CENSUSES	  Population	  censuses	  have	  been	  conducted	  in	  Sweden	  since	  1860,	  and	  housing	  censuses	  since	  1945.	  Censuses	  are	  performed	  every	  decade	  through	  postal	  enquiries,	  and	  for	  the	  twins	  under	  study	  in	  this	  thesis,	  data	  was	  available	  from	  the	  1970,	  1980	  and	  1990	  censuses.	  The	  censuses	  include	  socioeconomic	  indices	  such	  as	  income,	  occupation	  and	  education.	  There	  is	  also	  information	  on	  type,	  size	  and	  quality	  of	  housing,	  etc.	  Demographic	  information	  of	  migration	  (emigration	  -­‐1961	  and	  immigration	  -­‐1969)	  is	  further	  available	  in	  the	  register	  of	  the	  total	  population.	  [209]	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4.3 STATISTICAL	  METHODS	  FOR	  TWIN	  DATA	  In	  this	  thesis,	  we	  use	  the	  unique	  features	  of	  twins	  to	  gain	  more	  insight	  about	  the	  role	  of	  the	  fetal	  environment	  for	  health	  and	  disease	  development	  later	  in	  life.	  While	  the	  degree	  of	  similarity	  in	  twins	  tends	  to	  be	  the	  (direct	  or	  indirect)	  target	  in	  most	  studies	  of	  twins,	  it	  is	  also	  a	  feature	  that	  requires	  special	  care	  in	  the	  methods	  used	  for	  statistical	  inference.	  Twins	  in	  a	  twin	  pair	  are	  likely	  to	  be	  more	  correlated	  than	  any	  two	  random	  individuals,	  and	  twin	  data	  thus	  violates	  an	  assumption	  most	  commonly	  used	  in	  statistical	  inference,	  namely	  that	  of	  independent	  observations.	  	  	  	  
4.3.1 METHODS	  TO	  HANDLE	  NON-­‐INDEPENDENT	  OBSERVATIONS	  Assuming	  that	  observations	  are	  independent	  when	  they	  are	  in	  fact	  positively	  correlated	  can	  lead	  to	  an	  overestimation	  of	  the	  statistical	  information	  of	  the	  data.	  	  As	  a	  consequence,	  the	  precision	  of	  statistical	  predictions	  may	  become	  overstated;	  reflected	  by	  too	  narrow	  confidence	  intervals	  and	  too	  low	  P-­‐values	  [210].	  	  It	  is	  generally	  recognized	  that	  for	  most	  standard	  regression	  techniques,	  the	  estimation	  of	  the	  (fix)	  parameters	  will	  be	  consistent	  irrespective	  of	  potential	  dependencies	  in	  the	  data,	  provided	  that	  the	  model	  for	  the	  mean	  has	  been	  correctly	  specified	  [211].	  Some	  of	  the	  methods	  to	  account	  for	  non-­‐dependence	  in	  data	  are	  therefore	  solely	  aimed	  at	  improving	  the	  estimation	  of	  the	  variance	  (standard	  errors).	  The	  efficiency	  of	  the	  parameter	  estimation	  could	  however	  be	  improved	  by	  making	  full	  use	  of	  the	  information	  of	  the	  data	  (including	  the	  dependencies).	  Methods	  that	  improve	  both	  parameter	  and	  variance	  estimation	  at	  the	  same	  time	  either	  require	  the	  specification	  of	  a	  full	  probability	  model	  or	  use	  a	  quasi-­‐likelihood	  approach.	  In	  the	  methods	  used	  in	  this	  thesis	  (described	  below)	  the	  size	  of	  the	  correlations	  are	  not	  of	  interest	  by	  their	  own,	  but	  rather	  treated	  as	  nuisance	  factors	  that	  need	  to	  be	  accounted	  for.	  	  	  4.3.1.1 BOOTSTRAPPING	  In	  the	  bootstrap	  method,	  the	  sampling	  variability	  of	  the	  parameter	  of	  interest	  is	  estimated	  from	  an	  empirical	  distribution	  of	  parameter	  estimates	  obtained	  in	  subsamples	  of	  the	  data	  [212].	  These	  are	  created	  through	  a	  series	  of	  resamplings	  of	  the	  observed	  data,	  where	  study	  subjects	  are	  drawn	  with	  replacement	  to	  achieve	  samples	  with	  the	  same	  size	  each	  time.	  In	  paper	  IV	  of	  this	  thesis,	  the	  bootstrap	  method	  was	  used	  to	  estimate	  the	  confidence	  intervals	  of	  the	  standardized	  cumulative	  risk	  functions.	  This	  approach	  also	  accounts	  for	  the	  dependencies	  in	  the	  data	  brought	  on	  by	  the	  comparison	  of	  members	  from	  the	  same	  family.	  While	  implementation	  of	  the	  bootstrap	  method	  is	  simple	  in	  theory,	  it	  may	  become	  quite	  demanding	  computationally.	  	  	  	  4.3.1.2 ROBUST	  COVARIANCE	  ESTIMATOR	  Also	  known	  as	  the	  empirical	  covariance	  matrix	  estimator,	  the	  sandwich	  estimator,	  or	  the	  Huber/White	  estimator,	  the	  robust	  covariance	  estimator	  has	  been	  developed	  to	  provide	  consistent	  estimates	  of	  variance	  in	  the	  presence	  of	  model	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misspecification	  (particularly	  when	  the	  assumption	  of	  homoscedasticity	  or	  independence	  of	  the	  error	  terms	  is	  violated)	  [213,	  214].	  Essentially	  this	  is	  achieved	  by	  including	  an	  empirical	  estimate	  of	  the	  covariance	  of	  the	  error	  terms	  in	  the	  variance	  estimation	  of	  the	  parameter.	  The	  sandwich	  variance	  estimators	  tend	  to	  have	  larger	  variance	  than	  variance	  estimates	  obtained	  by	  methods	  that	  improve	  the	  estimation	  of	  parameters	  and	  variance	  simultaneously.	  In	  paper	  II	  of	  this	  thesis	  Cox	  proportional	  hazard	  regression	  is	  used	  to	  study	  the	  association	  between	  birth	  weight	  and	  the	  instantaneous	  rate	  (hazard)	  of	  breast	  cancer.	  To	  account	  for	  the	  dependence	  within	  twin	  pairs	  a	  robust	  estimator	  proposed	  for	  Cox	  regression	  [215,	  216]	  was	  used.	  	  	  	  4.3.1.3 GENERALIZED	  ESTIMATING	  EQUATIONS	  The	  generalized	  estimating	  equations	  (GEEs)	  are	  a	  quasi-­‐likelihood	  approach	  to	  estimation	  which	  does	  not	  require	  any	  specification	  of	  the	  distribution	  of	  the	  error	  terms	  [217].	  The	  specification	  of	  a	  working	  correlation	  matrix	  for	  the	  covariance	  increases	  the	  efficiency	  of	  the	  parameter	  estimation,	  leading	  to	  reduced	  variance	  compared	  to	  a	  method	  solely	  aimed	  at	  improving	  the	  variance	  estimation	  [211].	  Also,	  if	  the	  robust	  sandwich	  method	  is	  used	  for	  the	  estimation	  of	  variance,	  this	  will	  be	  consistently	  estimated	  even	  under	  misspecification	  of	  the	  working	  correlation	  matrix.	  GEEs	  can	  be	  implemented	  in	  all	  generalized	  linear	  models	  [218],	  and	  were	  used	  to	  assess	  the	  association	  between	  birth	  weight	  and	  blood	  pressure	  in	  paper	  I.	  	  	  	  	  
4.3.2 METHODS	  TO	  COMPARE	  TWINS	  IN	  A	  TWIN	  PAIR	  The	  objective	  of	  using	  twins	  in	  this	  thesis	  has	  been	  to	  enable	  within-­‐twinpair	  comparisons.	  To	  achieve	  this	  in	  turn,	  two	  different	  methods	  have	  been	  used.	  	  	  4.3.2.1 BETWEEN	  AND	  WITHIN	  DESIGN	  The	  clustering	  of	  correlated	  observations	  may	  not	  always	  be	  treated	  merely	  as	  a	  nuisance	  to	  statistical	  inference.	  Cluster	  information	  may	  provide	  an	  opportunity	  to	  investigate	  the	  relative	  contributions	  of	  between-­‐cluster	  and	  within-­‐cluster	  effects	  to	  that	  of	  the	  individual	  (which	  when	  estimated	  alone	  will	  be	  a	  weighted	  average	  of	  the	  between-­‐	  and	  within-­‐cluster	  effects)	  [219].	  	  	  While	  some	  use	  this	  type	  of	  separation	  to	  remove	  bias	  of	  the	  individual	  level	  exposure	  effect	  (from	  confounding	  by	  the	  cluster	  level	  mean	  exposure),	  others	  may	  be	  interested	  to	  evaluate	  the	  influence	  of	  the	  contextual	  effect	  (e.g.	  a	  neighborhood	  cluster)	  on	  individual	  response.	  	  In	  the	  between	  –	  within	  model,	  the	  individual	  exposure	  is	  partitioned	  into	  a	  between-­‐cluster	  and	  a	  within-­‐cluster	  component.	  	  Applied	  to	  twins,	  these	  will	  correspond	  to	  the	  twin	  pair	  mean	  and	  the	  individual	  deviance	  from	  that	  mean.	  Formally,	  the	  exposure	  !!" 	  of	  the	  ith	  twin	  of	  the	  jth	  twin	  pair	  is	  replaced	  by	  the	  twin	  pair	  mean	  !! 	  and	  the	  individual	  deviance	  from	  the	  twin	  pair	  mean	  !!" −   !! .	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A	  regression	  model	  of	  the	  independent	  outcome	  !!" 	  could	  thus	  look	  like:	  	  	   !"#$  (! !!" ) = !! +   !!  !!   +     !!  (!!" −   !!)	  	  Conceptually,	  the	  between	  regression	  coefficient	  measures	  the	  effect	  of	  exposure	  between	  twin	  pairs,	  whereas	  the	  within	  regression	  coefficient	  measures	  the	  effect	  within	  twin	  pairs.	  The	  between	  and	  within	  components	  are	  orthogonal	  i.e.	  statistically	  independent	  of	  each	  other.	  If	  estimation	  of	  either	  effect	  is	  not	  dependent	  on	  the	  simultaneous	  estimation	  of	  the	  other,	  it	  follows	  that	  centering	  the	  individual	  predictor	  around	  it’s	  cluster	  mean	  is	  what	  achieves	  the	  within-­‐cluster	  comparison.	  This	  is	  further	  equivalent	  to	  including	  the	  cluster	  mean	  (!!)	  in	  a	  model	  with	  the	  individual	  predictor	  (!!")	  [220].	  	  The	  formulation	  of	  the	  model	  above	  makes	  the	  assumption	  that	  the	  effect	  of	  the	  individual	  deviance	  from	  the	  mean	  is	  linearly	  related	  to	  the	  mean	  outcome	  modeled.	  The	  method	  can	  thus	  be	  used	  in	  the	  generalized	  linear	  regression	  setting	  as	  long	  as	  care	  is	  taken	  that	  the	  effect	  of	  the	  individual	  deviance	  from	  the	  twin	  pair	  mean	  exposure	  on	  the	  mean	  outcome	  modeled	  is	  linear	  (e.g.	  the	  log-­‐odds	  or	  log-­‐rate).	  The	  partitioning	  into	  between	  and	  within	  component	  for	  continuous	  predictors	  is	  less	  flexible	  for	  dichotomous	  exposures	  in	  twins	  (where	  the	  deviation	  from	  the	  mean	  is	  restricted	  to	  -­‐0.5	  or	  0.5	  in	  discordant	  pairs	  and	  0	  in	  concordant	  pairs).	  In	  such	  instances	  it	  has	  been	  recommended	  to	  instead	  perform	  within-­‐pair	  comparisons	  of	  discordant	  pairs	  [221].	  	  	  When	  the	  individual	  deviance	  from	  the	  twin	  pair	  mean	  (within-­‐component)	  is	  used	  to	  obtain	  within-­‐twinpair	  comparison,	  all	  twins	  with	  information	  about	  exposure	  for	  their	  co-­‐twin	  can	  be	  used	  for	  the	  effect	  estimation.	  The	  ability	  to	  study	  all	  twins	  in	  a	  cohort	  contrasts	  with	  the	  co-­‐twin-­‐control	  method	  used	  in	  study	  III	  (and	  described	  next),	  which	  only	  includes	  disease-­‐discordant	  twins.	  	  The	  individual	  deviance	  in	  birth	  weight	  from	  the	  twin	  pair	  mean	  birth	  weight	  can	  be	  seen	  as	  an	  estimate	  of	  fetal	  growth	  that	  is	  independent	  of	  all	  factors	  shared	  by	  the	  twins	  in	  a	  twin	  pair.	  In	  this	  thesis	  we	  evaluate	  its	  association	  with	  systolic	  blood	  pressure	  (paper	  I)	  and	  log-­‐hazard	  of	  breast	  cancer	  (paper	  II).	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4.3.2.2 CO-­‐TWIN-­‐CONTROL	  METHOD	  Another	  way	  of	  achieving	  within-­‐twinpair	  comparison	  is	  by	  matching	  twins	  to	  their	  co-­‐twins.	  Similar	  to	  a	  matched	  cohort	  design,	  twin	  pairs	  discordant	  for	  the	  exposure	  can	  be	  followed	  with	  respect	  to	  outcome	  [222].	  Alternatively,	  a	  matched	  case-­‐control	  design	  can	  be	  applied	  in	  which	  cases	  are	  matched	  to	  their	  disease-­‐free	  co-­‐twins.	  	  	  In	  the	  case-­‐control	  design,	  the	  study	  population	  is	  selected	  on	  the	  basis	  of	  disease-­‐status.	  Cases	  (diseased)	  and	  controls	  (non-­‐diseased)	  can	  be	  sampled	  from	  a	  theoretical	  study	  base,	  or	  from	  a	  well-­‐defined	  cohort.	  In	  both	  cases	  the	  purpose	  of	  the	  controls	  is	  to	  represent	  the	  exposure	  status	  of	  the	  underlying	  study	  base/cohort.	  In	  a	  matched	  case	  control	  study	  n	  number	  of	  disease-­‐free	  controls	  are	  matched	  to	  each	  case	  with	  respect	  to	  certain	  characteristics	  (matching	  factors).	  	  In	  the	  co-­‐twin-­‐control	  method,	  the	  disease-­‐free	  control	  is	  the	  co-­‐twin	  of	  the	  case,	  thus	  matched	  on	  all	  factors	  shared	  by	  the	  twins	  of	  the	  twin	  pair.	  Control-­‐selection	  (evaluation	  of	  disease-­‐status)	  could	  be	  made	  at	  the	  end	  of	  a	  fixed	  follow-­‐up	  time	  (as	  in	  a	  traditional	  case-­‐control	  study),	  or	  at	  the	  time	  of	  case	  ascertainment,	  when	  a	  co-­‐twin	  is	  matched	  if	  found	  to	  be	  disease-­‐free	  (incidence-­‐density	  sampling).	  The	  latter	  method	  is	  used	  in	  paper	  III	  to	  sample	  disease-­‐discordant	  twin	  pairs	  from	  the	  underlying	  cohort	  of	  twins	  in	  the	  STR.	  	  	  As	  previously	  mentioned,	  this	  co-­‐twin-­‐control	  method	  only	  includes	  disease	  discordant	  twins.	  In	  addition,	  only	  twin	  pairs	  that	  are	  also	  discordant	  with	  respect	  to	  the	  exposure	  will	  contribute	  to	  the	  estimation	  of	  effect.	  	  	  In	  any	  matched	  case-­‐control	  design,	  the	  parameter	  estimates	  will	  be	  independent	  of	  the	  matching	  factors	  if	  the	  analyses	  are	  made	  conditional	  on	  the	  matching	  factors.	  In	  the	  co-­‐twin	  control	  design,	  matching	  takes	  place	  at	  the	  twin-­‐pair	  level,	  and	  estimates	  of	  effect	  will	  thus	  be	  independent	  of	  all	  factors	  that	  are	  shared	  by	  the	  twins	  in	  a	  twin	  pair.	  In	  the	  1:1	  matched	  sample	  produced	  by	  twin	  pair	  matching,	  conditional	  logistic	  regression	  will	  estimate	  the	  effect	  (change	  in	  log-­‐odds	  of	  the	  outcome)	  of	  the	  difference	  between	  the	  two	  observations	  in	  the	  strata	  [223].	  Thus,	  a	  continuous	  measure	  of	  birth	  weight	  will	  estimate	  the	  linear	  effect	  of	  the	  within-­‐twinpair	  difference	  in	  birth	  weight.	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4.4 STUDY	  DESIGNS	  &	  METHODS	  	  
4.4.1 PAPER	  I	  	  	  To	  evaluate	  the	  influence	  of	  ethnicity	  and	  familial	  factors	  on	  the	  birth	  weight	  –	  blood	  pressure	  association,	  baseline	  measurements	  for	  all	  individuals	  in	  the	  Georgia	  Cardiovascular	  Twin	  Study	  (N=1270,	  635	  pairs)	  were	  considered.	  Due	  to	  missing	  birth	  weight	  information	  (N=243),	  the	  final	  study	  population	  consisted	  of	  1027	  individuals.	  Of	  these,	  562	  were	  EA	  (279	  pairs	  and	  4	  singletons),	  and	  465	  were	  AA	  (232	  pairs	  and	  one	  singleton).	  	  	  EAs	  were	  more	  frequent	  among	  those	  with	  missing	  information	  on	  birth	  weight	  (64%	  versus	  54%),	  as	  were	  MZs	  (56%	  compared	  with	  48%).	  After	  adjustment	  for	  sex	  and	  ethnicity,	  missing	  cases	  were	  not	  different	  from	  the	  study	  population	  in	  any	  of	  the	  characteristics	  investigated	  (age,	  height,	  weight,	  systolic	  and	  diastolic	  blood	  pressure,	  maternal	  smoking	  and	  parental	  education).	  	  	  The	  association	  between	  birth	  weight	  and	  blood	  pressure	  (systolic	  and	  diastolic)	  was	  evaluated	  through	  linear	  regression	  using	  GEEs	  to	  account	  for	  the	  dependence	  within	  twin	  pairs	  (SAS	  GENMOD	  procedure	  [224]).	  Birth	  weight	  and	  individual	  deviance	  from	  the	  twin	  pair	  mean	  birth	  weight	  were	  used	  to	  estimate	  separate	  cohort	  and	  within	  effects	  respectively.	  Potential	  differences	  in	  effect	  (on	  the	  absolute	  scale)	  between	  groups	  were	  tested	  by	  the	  introduction	  of	  interaction	  terms	  between	  the	  main	  effect	  and	  ethnicity,	  and	  both	  cohort	  and	  within	  associations	  were	  also	  evaluated	  in	  ethnic	  groups	  separately.	  	  	  In	  the	  cohort	  analyses,	  potential	  confounding	  factors	  under	  consideration	  included	  sex,	  age,	  maternal	  age	  at	  birth	  and	  maternal	  smoking,	  as	  well	  as	  the	  highest	  level	  of	  education	  of	  the	  parents.	  Unfortunately	  there	  was	  no	  information	  on	  gestational	  age.	  However,	  the	  individual	  deviance	  in	  birth	  weight	  from	  the	  twin	  pair	  mean	  is	  independent	  of	  all	  factors	  shared	  by	  the	  twins	  in	  a	  twin	  pair,	  including	  gestational	  age.	  In	  this	  study	  we	  also	  performed	  all	  analyses	  with	  and	  without	  adjustment	  for	  BMI	  at	  baseline.	  The	  problems	  with	  adjusting	  for	  potential	  colliders	  -­‐	  such	  as	  adult	  anthropometric	  measures	  in	  studies	  of	  fetal	  growth	  and	  later	  disease	  -­‐	  are	  further	  illustrated	  and	  discussed	  in	  the	  causal	  inference	  section	  (pages	  22	  &	  24).	  	  All	  statistical	  analyses	  were	  performed	  in	  SAS	  software	  version	  9.1.	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4.4.2 PAPER	  II	  	  In	  order	  to	  study	  the	  association	  between	  birth	  weight	  and	  breast	  cancer,	  all	  like-­‐sexed	  female	  twins	  of	  the	  1926-­‐1958	  birth	  cohort	  for	  which	  zygosity	  was	  known	  (N=16	  895)	  were	  selected.	  Of	  these,	  16	  604	  were	  alive	  and	  at-­‐risk	  (no	  previous	  breast	  cancer	  diagnosis)	  at	  the	  start	  of	  follow-­‐up	  in	  1973.	  Birth	  records	  were	  available	  in	  79%	  of	  these,	  and	  further	  restrictions	  due	  to	  missing	  birth	  weight	  data	  (n=39)	  and	  the	  requirement	  of	  correct	  birth	  identification	  of	  each	  twin	  within	  a	  twin	  pair	  (n=1185)	  resulted	  in	  a	  final	  study	  population	  of	  11	  923	  twins	  (of	  which	  5859	  were	  intact	  twin	  pairs).	  	  	  Gestational	  age	  was	  estimated	  from	  the	  first	  day	  of	  the	  last	  menstrual	  period	  (self-­‐reported	  by	  the	  mother)	  and	  the	  twins’	  birth	  date.	  Socioeconomic	  status	  at	  birth	  was	  derived	  from	  the	  highest	  self-­‐reported	  occupation	  of	  the	  parents.	  From	  the	  1972-­‐1973	  questionnaire	  self-­‐reported	  height	  (cm),	  weight	  (kg)	  and	  smoking	  status	  (yes/no)	  was	  also	  available.	  	  A	  diagnosis	  of	  breast	  cancer	  was	  defined	  as	  a	  registration	  of	  either	  ICD	  code	  171	  (7th	  revision)	  and/or	  C50	  (10th	  revision)	  in	  the	  Cancer	  Register.	  Time	  at-­‐risk	  was	  defined	  from	  the	  start	  of	  1973	  (when	  zygosity	  was	  first	  established)	  until	  incident	  disease,	  death	  or	  end	  of	  follow-­‐up	  in	  Dec	  31	  2006.	  	  The	  association	  between	  birth	  weight	  and	  breast	  cancer	  was	  evaluated	  through	  Cox	  proportional	  hazards	  regression	  in	  the	  SAS	  PHREG	  procedure,	  using	  robust	  standard	  errors	  to	  account	  for	  the	  dependence	  between	  twins	  in	  a	  twin	  pair	  [215].	  Attained	  age	  was	  used	  as	  underlying	  time	  scale	  and	  baseline	  hazards	  allowed	  to	  vary	  with	  year	  of	  birth.	  When	  Schoenfeld	  residuals	  from	  a	  model	  with	  birth	  weight	  predicting	  the	  log-­‐hazard	  of	  breast	  cancer	  were	  plotted	  against	  age,	  an	  indication	  of	  non-­‐proportional	  hazards	  was	  revealed.	  This	  was	  further	  confirmed	  by	  a	  statistically	  significant	  difference	  in	  effect	  between	  women	  over	  the	  age	  of	  50	  compared	  to	  women	  aged	  50	  or	  younger.	  As	  a	  consequence	  we	  performed	  all	  analyses	  in	  these	  two	  groups	  of	  women	  separately.	  	  	  Further	  evaluation	  of	  the	  nature	  of	  the	  relationship	  between	  birth	  weight	  and	  the	  log-­‐hazard	  of	  breast	  cancer	  was	  conducted	  by	  plotting	  Martingale	  residuals	  against	  birth	  weight.	  	  As	  shown	  in	  figure	  1	  on	  the	  next	  page,	  for	  women	  aged	  50	  or	  under,	  these	  indicated	  a	  positive	  linear	  relationship	  between	  birth	  weight	  and	  log-­‐hazard	  of	  breast	  cancer	  from	  2,500	  grams	  and	  upward.	  For	  women	  above	  the	  age	  of	  50	  there	  were	  weak	  indications	  of	  an	  opposite	  pattern	  (results	  not	  shown).	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Figure	  1.	  Martingale	  residuals	  from	  a	  model	  predicting	  the	  log-­‐hazard	  of	  breast	  cancer	  plotted	  against	  birth	  weight	  in	  grams.	  	  	  
	  	  	  For	  both	  cohort	  and	  within-­‐twinpair	  analyses	  other	  covariates	  considered	  included	  other	  anthropometric	  measures	  at	  birth	  (birth	  length	  and	  head	  circumference),	  individual	  socioeconomic	  status	  (highest	  level	  of	  attained	  education	  in	  1970)	  and	  smoking	  status	  in	  1973.	  For	  cohort	  analyses	  zygosity,	  gestational	  age	  and	  socioeconomic	  status	  at	  birth	  were	  also	  considered.	  	  	  All	  statistical	  analyses	  were	  performed	  in	  SAS	  software	  version	  9.2.	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4.4.3 PAPER	  III	  In	  the	  study	  of	  birth	  weight	  and	  cardiovascular	  disease,	  all	  like-­‐sexed	  twins	  born	  between	  1926	  and	  1958	  (N=37	  194)	  were	  considered.	  Birth	  records	  were	  available	  in	  N=26	  204	  (81%)	  of	  those	  with	  known	  zygosity	  (N=32	  539).	  Further	  requirements	  of	  birth	  order	  ascertainment	  (twins	  either	  having	  to	  have	  been	  baptized	  at	  birth	  or	  answered	  in	  agreement	  to	  questions	  about	  birth	  order	  in	  the	  telephone	  interview)	  limited	  the	  study	  population	  to	  N=23	  689	  twins.	  In	  this	  sample,	  the	  mean	  birth	  weight	  discordance	  between	  like-­‐sexed	  twin	  siblings	  was	  350	  grams	  (range	  0-­‐2250	  grams)	  in	  DZ	  and	  304	  grams	  (range	  0-­‐2420	  grams)	  in	  MZ	  twins.	  
	  Twins	  were	  followed	  in	  national	  registries	  of	  hospital	  admissions,	  causes	  of	  death	  and	  population	  statistics	  (concerning	  migration).	  Time	  at-­‐risk	  was	  defined	  from	  the	  beginning	  of	  1973	  (when	  zygosity	  was	  first	  established)	  until	  incident	  disease,	  migration,	  death	  or	  end	  of	  follow-­‐up	  in	  Dec	  31	  2006.	  Cerebrovascular	  and	  coronary	  heart	  diseases	  (CHD)	  were	  combined	  for	  a	  relatively	  strict	  definition	  of	  overall	  CVD.	  CHD	  and	  stroke	  were	  also	  considered	  separately,	  and	  the	  latter	  further	  categorized	  according	  to	  subtype	  (ischemic,	  hemorrhagic	  or	  not	  otherwise	  specified).	  Due	  to	  the	  potentially	  fatal	  outcome	  of	  these	  diseases,	  the	  few	  cases	  identified	  through	  the	  Cause	  of	  Death	  Register	  only	  were	  also	  included.	  The	  diagnose	  codes	  included	  from	  each	  revision	  of	  the	  ICD	  are	  presented	  below,	  along	  with	  the	  total	  number	  of	  cases	  identified	  (only	  in	  Cause	  of	  Death	  register).	  	  	  
	  Co-­‐twin-­‐control	  selection	  was	  performed	  for	  each	  of	  the	  three	  main	  outcomes.	  Eligible	  pairs	  were	  those	  where	  both	  twins	  were	  at	  risk	  of	  the	  disease	  until	  the	  date	  of	  case	  diagnosis.	  The	  final	  study	  samples	  amounted	  to	  1942	  pairs	  discordant	  for	  CVD	  (1194	  male	  and	  748	  female),	  1334	  pairs	  discordant	  for	  CHD	  (884	  male	  and	  450	  female),	  and	  686	  pairs	  discordant	  for	  stroke	  (388	  male	  and	  298	  female).	  	  	  Conditional	  logistic	  regression	  was	  used	  in	  the	  SAS	  LOGISTIC	  procedure	  [225]	  to	  evaluate	  the	  association	  between	  birth	  weight	  and	  CVD	  within	  (matched)	  twin	  pairs.	  Information	  on	  adult	  characteristics	  not	  shared	  by	  the	  twins	  of	  the	  pair	  (e.g.	  height,	  weight,	  smoking	  and	  socioeconomic	  status)	  were	  considered	  and	  discarded	  on	  the	  basis	  of	  their	  likely	  roles	  in	  causal	  diagrams.	  	  All	  statistical	  analyses	  were	  performed	  in	  SAS	  software	  version	  9.2.	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4.4.4 PAPER	  IV	  	  To	  investigate	  a	  potential	  influence	  of	  twinship	  on	  adult	  morbidity	  and	  mortality,	  three	  cohorts	  with	  varying	  degree	  of	  exposure	  to	  twinning	  were	  compared.	  	  	  
	  	  Overall	  morbidity	  and	  mortality	  of	  twins	  was	  compared	  to	  that	  of	  their	  singleton	  siblings.	  By	  accounting	  for	  factors	  shared	  by	  twin	  families,	  these	  comparisons	  aimed	  to	  capture	  the	  effect	  of	  the	  unique	  experience	  of	  being	  a	  twin	  on	  morbidity	  and	  mortality	  (independent	  of	  potential	  twin	  family	  influence	  on	  health).	  	  Further	  comparison	  of	  singleton	  from	  twin	  families	  and	  non-­‐twin	  families,	  was	  aimed	  at	  providing	  some	  insight	  into	  whether	  belonging	  to	  a	  twin	  family	  (rather	  than	  being	  a	  twin)	  influences	  health	  (the	  comparisons	  are	  illustrated	  in	  figure	  2).	  	  	  Families	  with	  and	  without	  twins	  were	  identified	  in	  the	  Multi-­‐Generation	  Register	  (MGR).	  To	  identify	  twins,	  any	  pair	  of	  individuals	  born	  to	  the	  same	  mother	  within	  3	  days	  of	  each	  other	  was	  considered	  eligible.	  This	  method	  identified	  N=24	  578	  twin	  pairs	  born	  between	  1932	  and	  1958,	  771	  of	  which	  were	  born	  within	  1	  to	  3	  days	  of	  each	  other.	  The	  twin	  pairs	  represented	  a	  total	  of	  24	  150	  families,	  some	  families	  containing	  two	  (n=408)	  or	  three	  (n=10)	  twin	  pairs.	  The	  twin	  cohort	  identified	  through	  the	  MGR	  is	  illustrated	  in	  Figure	  1	  (cohort	  1)	  and	  comprised	  of	  7631	  like-­‐sexed	  male,	  7757	  like-­‐sexed	  female	  and	  9190	  opposite-­‐sexed	  pairs.	  	  In	  18	  098	  of	  the	  twin	  families,	  one	  or	  more	  singleton	  full	  sibling	  was	  identified	  (Figure	  1,	  cohort	  2).	  The	  number	  of	  singleton	  full-­‐siblings	  in	  these	  families	  ranged	  from	  1-­‐13	  (averaging	  at	  1.6	  per	  twin	  family).	  Overall	  N=38	  364	  singletons	  were	  found	  in	  twin	  families,	  but	  to	  allow	  for	  comparison	  across	  birth	  cohorts	  only	  those	  born	  between	  1932	  and	  1958	  were	  considered	  (cohort	  2,	  N=35	  227).	  	  	  Lastly,	  two	  random	  samples	  from	  the	  general	  population	  were	  considered	  for	  the	  “unexposed”	  comparison	  group.	  First,	  the	  aim	  was	  to	  ensure	  that	  the	  comparison	  group	  was	  truly	  unexposed	  to	  twinning	  (no	  twins	  in	  the	  family).	  Therefore,	  for	  each	  individual	  in	  cohort	  2,	  up	  to	  10	  individuals	  were	  retrieved	  from	  the	  MGR	  with	  same	  birth	  year,	  sex	  and	  family	  constellation	  (cohort	  3a,	  figure	  2).	  For	  some	  unique	  or	  rare	  sibling	  constellations	  the	  number	  of	  eligible	  individuals	  in	  the	  MGR	  was	  not	  enough,	  and	  as	  a	  consequence	  the	  average	  number	  of	  matches	  in	  cohort	  3a	  was	  4.5	  (range	  0-­‐10).	  Second,	  to	  allow	  for	  a	  comparison	  group	  to	  represent	  the	  population,	  all	  individuals	  of	  the	  MGR	  who	  had	  not	  already	  been	  included	  in	  cohorts	  1	  or	  2	  were	  eligible	  for	  selection	  to	  the	  second	  sample.	  From	  this	  population	  up	  to	  10	  individuals	  from	  the	  MGR	  were	  selected,	  matched	  to	  the	  singletons	  in	  cohort	  2	  with	  respect	  to	  birth	  year	  and	  sex	  (cohort	  3b,	  figure	  2).	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  Figure	  2.	  Study	  populations	  and	  matching	  design	  for	  paper	  IV	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  The	  three	  main	  contrast	  samples	  under	  evaluation	  were;	  twins	  and	  singleton	  siblings	  of	  twins	  (cohort	  1	  vs.	  cohort	  2);	  singletons	  from	  twin	  families	  and	  non-­‐twin	  families	  (cohort	  2	  vs.	  cohort	  3a	  or	  b);	  and	  twins	  and	  singletons	  from	  the	  population	  (cohort	  1	  vs.	  cohort	  3b).	  	  	  Survival	  functions	  were	  estimated	  through	  Cox	  proportional	  hazards	  regression	  (SAS	  PHREG	  procedure	  [215]),	  with	  age	  as	  underlying	  time	  scale	  and	  allowing	  non-­‐proportional	  hazards	  for	  the	  two	  groups	  being	  contrasted.	  To	  account	  for	  the	  noted	  systematic	  differences	  in	  distribution	  of	  predictors	  of	  the	  outcome	  (e.g.	  birth	  year,	  sex	  and	  family	  size)	  between	  the	  groups,	  the	  survival	  functions	  were	  standardized	  to	  the	  distribution	  of	  the	  covariates	  in	  the	  contrast	  sample	  under	  study.	  In	  the	  traditional	  method	  of	  standardization,	  the	  predicted	  outcome	  under	  a	  set	  of	  covariates	  (the	  confounders)	  in	  the	  exposed	  versus	  the	  unexposed	  is	  weighted	  according	  to	  the	  joint	  distribution	  of	  those	  covariates	  in	  a	  reference	  sample	  (e.g.	  the	  combined	  sample	  of	  exposed	  and	  unexposed).	  The	  method	  thus	  relies	  on	  a	  correct	  model	  specification	  for	  the	  outcome	  given	  the	  covariates.	  In	  order	  to	  evaluate	  the	  influence	  of	  potential	  misspecification	  of	  this	  model,	  a	  standardization	  method	  that	  only	  requires	  model	  specifications	  for	  the	  exposure	  was	  also	  used	  (inverse	  probability	  weighting),	  and	  the	  results	  compared.	  	  All	  standardized	  survival	  estimates	  were	  converted	  into	  cumulative	  risks	  of	  failure	  	  (f	  =	  1	  -­‐	  s)	  and	  plotted	  against	  age.	  Bootstrapping	  methods	  were	  used	  to	  obtain	  estimates	  of	  statistical	  precision	  (95%	  confidence	  intervals)	  for	  the	  risk	  differences	  between	  groups.	  	  All	  statistical	  analyses	  were	  performed	  in	  SAS	  software	  version	  9.22.	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5 RESULTS	  	  5.1 BIRTH	  WEIGHT	  &	  BLOOD	  PRESSURE	  IN	  BIETHNIC	  TWINS	  (I)	  Baseline	  characteristics	  of	  the	  twins	  of	  the	  GCTS	  are	  shown	  in	  Table	  2	  below.	  	  
	  	  AAs	  had	  significantly	  higher	  blood	  pressure	  levels	  than	  EAs	  (both	  boys	  and	  girls).	  It	  was	  however	  only	  girls	  that	  differed	  in	  body	  size;	  AA	  girls	  being	  smaller	  at	  birth	  and	  bigger	  (higher	  BMI)	  at	  baseline	  compared	  to	  EA	  girls	  (Table	  2).	  	  	  Diastolic	  blood	  pressure	  was	  not	  associated	  to	  birth	  weight	  in	  either	  ethnic	  group.	  In	  the	  cohort	  combined	  a	  1	  kg	  increase	  in	  birth	  weight	  was	  associated	  with	  a	  mean	  drop	  in	  systolic	  blood	  pressure	  by	  1.4	  (-­‐2.6	  to	  -­‐0.20)	  mmHg.	  Stratified	  analysis	  showed	  a	  statistically	  significant	  inverse	  association	  in	  AAs	  and	  a	  weak	  non-­‐significant	  inverse	  association	  in	  EAs.	  Although	  the	  within-­‐twinpair	  comparisons	  were	  hampered	  by	  decreased	  precision,	  indications	  were	  of	  a	  remaining	  inverse	  association	  in	  AAs	  but	  not	  in	  EAs	  (in	  which	  it	  appeared	  reversed)	  (Table	  3).	  	  	  
	  	  Precision	  was	  further	  decreased	  with	  stratification	  according	  to	  zygosity,	  but	  indications	  were	  of	  an	  inverse	  association	  within	  AAs	  in	  both	  zygotic	  groups.	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5.2 BIRTH	  WEIGHT	  &	  BREAST	  CANCER	  IN	  FEMALE	  TWINS	  (II)	  In	  the	  cohort	  of	  11	  923	  women,	  590	  developed	  breast	  cancer	  during	  follow-­‐up.	  	  	  High	  birth	  weight	  (≥3000	  grams)	  was	  associated	  with	  an	  increased	  rate	  of	  early	  (≤50	  years)	  but	  not	  late	  (>50	  years)	  breast	  cancer.	  Birth	  length	  and	  head	  circumference	  were	  not	  statistically	  significant	  associated	  with	  rate	  of	  breast	  cancer,	  whereas	  adult	  height	  was	  positively	  associated	  with	  breast	  cancer	  diagnosed	  early.	  Maternal	  age,	  parity,	  individual	  BMI	  and	  smoking	  status	  were	  not	  statistically	  significantly	  associated	  with	  rate	  of	  breast	  cancer	  in	  either	  age	  group.	  	  Table	  4	  presents	  the	  hazard	  ratios	  of	  breast	  cancer	  diagnosed	  at	  50	  years	  or	  earlier,	  and	  after	  the	  age	  of	  50	  according	  to	  birth	  weight	  categories.	  Adjusting	  for	  other	  anthropometric	  measures	  at	  birth	  did	  not	  change	  the	  overall	  findings	  of	  an	  increased	  rate	  of	  early	  breast	  cancer	  in	  the	  highest	  birth	  weight	  category,	  and	  no	  association	  between	  birth	  weight	  and	  breast	  cancer	  diagnosed	  after	  the	  age	  of	  50.	  With	  indications	  of	  a	  slightly	  increased	  rate	  also	  in	  the	  lower	  birth	  weight	  category,	  linearity	  could	  not	  be	  assumed.	  	  	  
	  	  Plotting	  of	  Martingale	  residuals	  confirmed	  a	  positive	  linear	  association	  between	  birth	  weight	  and	  log-­‐hazard	  of	  early	  (≤50	  years)	  breast	  cancer	  from	  2,500g	  and	  upward.	  As	  a	  consequence,	  the	  effect	  of	  birth	  weight	  continuous	  and	  individual	  deviance	  from	  twin	  pair	  mean	  birth	  weight	  on	  the	  log-­‐hazard	  of	  early	  diagnosed	  breast	  cancer	  were	  evaluated	  in	  twins	  weighting	  2,500g	  or	  more	  (Table	  5).	  	  
	  	  The	  effect	  estimates	  were	  similar	  in	  the	  cohort	  and	  within	  twin	  pairs	  overall.	  While	  a	  slight	  attenuation	  could	  be	  noted	  in	  MZ,	  the	  sample	  was	  less	  than	  half	  of	  the	  DZs	  and	  the	  confidence	  intervals	  in	  fact	  completely	  overlapped/included	  those	  of	  the	  DZ	  estimates.	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5.3 BIRTH	  WEIGHT	  &	  CARDIOVASCULAR	  DISEASE	  IN	  TWINS	  (III)	  Table	  6	  shows	  the	  within-­‐twinpair	  estimates	  of	  birth	  weight	  and	  CVD,	  CHD,	  and	  stroke	  in	  like-­‐sexed	  dizygotic	  twins	  and	  monozygotic	  twins	  respectively.	  	  	  Overall,	  there	  was	  an	  inverse	  association	  between	  birth	  weight	  and	  CVD	  within	  DZ	  [P	  for	  linear	  trend=0.005]	  but	  not	  MZ	  [P	  for	  linear	  trend=0.82]	  twin	  pairs	  (Table	  5).	  The	  pattern	  was	  consistent	  for	  both	  coronary	  heart	  disease	  and	  stroke.	  With	  further	  stratification	  according	  to	  subtypes	  of	  stroke,	  interpretation	  was	  slightly	  hampered	  by	  reduced	  statistical	  power.	  Nevertheless,	  for	  ischemic	  stroke	  the	  same	  pattern	  of	  an	  inverse	  linear	  association	  was	  obvious	  within	  DZ	  but	  not	  within	  MZ	  twin	  pairs.	  For	  hemorrhagic	  stroke,	  estimates	  were	  imprecise	  for	  both	  DZ	  and	  MZ,	  precluding	  interpretation	  of	  potential	  effects	  in	  either	  group.	  	  	  	  
	  	  	  The	  difference	  in	  the	  within-­‐twinpair	  associations	  between	  DZ	  and	  MZ	  pairs	  was	  further	  tested	  by	  the	  introduction	  of	  an	  interaction	  term	  between	  birth	  weight	  and	  zygosity	  in	  a	  model	  including	  all	  twin	  pairs.	  Global	  Wald	  test	  of	  overall	  significance	  of	  this	  interaction	  term	  (with	  birth	  weight	  categorized	  to	  allow	  for	  potential	  non-­‐linearity	  of	  the	  within	  pair	  effect	  in	  MZ)	  yielded	  P-­‐values	  of	  0.27	  for	  CVD;	  0.18	  for	  CHD;	  and	  0.06	  for	  ischemic	  stroke.	  	  	  The	  differences	  between	  DZ	  and	  MZ	  in	  the	  estimate	  for	  the	  lowest	  birth	  weight	  category	  compared	  to	  the	  reference	  were	  1.47	  (0.96	  to	  2.24)	  for	  CVD;	  1.61	  (0.97	  to	  2.66)	  for	  CHD;	  and	  4.13	  (1.45	  to	  11.8)	  for	  ischemic	  stroke.	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5.4 MORBIDITY	  &	  MORTALITY	  IN	  TWINS	  AND	  SINGLETONS	  (IV)	  Figure	  3	  below	  shows	  cumulative	  risks	  of	  cardiovascular	  disease,	  overall	  cancer	  and	  all-­‐cause	  death	  respectively,	  contrasting	  twins	  and	  singletons	  of	  twin	  families	  in	  the	  left	  column,	  and	  singletons	  of	  twin	  and	  non-­‐twin	  families	  in	  the	  right	  column.	  In	  both,	  the	  underlying	  survival	  functions	  have	  been	  standardized	  to	  the	  sex,	  birth	  cohort	  and	  family	  size	  distributions	  of	  the	  contrasted	  cohorts	  combined.	  	  
Figure	  3.	  	  Cumulative	  risks	  of	  CVD,	  cancer	  and	  all-­‐cause	  death	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6 DISCUSSION	  	  The	  interest	  for	  the	  importance	  of	  early	  life	  exposures	  with	  respect	  to	  health	  and	  disease	  development	  has	  grown	  exponentially	  during	  the	  last	  decades.	  Spurred	  by	  the	  early	  reports	  of	  associations	  between	  birth	  weight	  and	  cardiovascular	  disease	  mortality,	  extensive	  studies	  have	  found	  birth	  weight	  a	  predictor	  of	  a	  wide	  variety	  of	  disorders	  including	  asthma,	  psychiatric	  disorders,	  hypertension,	  non-­‐insulin	  dependent	  diabetes,	  some	  types	  of	  cancer,	  and	  cardiovascular	  disease.	  From	  the	  early	  theories	  of	  maternal	  nutrition	  and	  the	  “paradigm	  shift”	  to	  an	  evolutionary	  perspective	  and	  developmental	  plasticity	  [69],	  the	  true	  underlying	  mechanisms	  to	  the	  associations	  have	  proved	  difficult	  to	  unravel.	  In	  humans,	  several	  attempts	  have	  been	  made	  to	  link	  birth	  weight	  to	  indicators	  of	  potential	  pathways	  of	  pathogenesis,	  such	  as	  hormonal	  exposures	  [110],	  endothelial	  function	  [125],	  sympathetic	  nerve	  activity	  [126],	  beta-­‐cell	  function	  [127],	  and	  low-­‐grade	  inflammation	  [128].	  Exploring	  the	  effects	  of	  causes	  or	  components	  of	  birth	  weight	  in	  turn	  has	  turned	  out	  to	  be	  more	  complicated,	  at	  least	  in	  humans.	  Instead,	  animal	  experiments	  have	  provided	  important	  insights,	  however	  most	  such	  studies	  involve	  manipulation	  of	  the	  maternal	  diet,	  which	  may	  or	  may	  not	  influence	  fetal	  growth	  and/or	  birth	  weight	  [70].	  As	  a	  consequence,	  it	  has	  even	  been	  argued	  that	  programming	  mechanisms	  may	  be	  independent	  of	  birth	  weight	  (and	  fetal	  growth),	  suggesting	  the	  study	  of	  birth	  weight	  inappropriate	  in	  the	  first	  place	  [70].	  However,	  apart	  from	  natural	  experiments,	  like	  the	  Leningrad	  siege	  [71]	  and	  the	  Dutch	  famine	  [72],	  findings	  to	  support	  fetal	  programming	  of	  adult	  disease	  in	  humans	  rest	  mainly	  on	  associations	  with	  birth	  weight	  or	  other	  proxies	  of	  fetal	  growth,	  and	  the	  underlying	  reasons	  for	  their	  association	  with	  later	  health	  outcomes	  remain	  unresolved.	  	  	  In	  this	  thesis	  twins	  are	  used	  in	  an	  attempt	  to	  increase	  our	  understanding	  of	  the	  potential	  health	  consequences	  of	  adverse	  fetal	  growth.	  By	  comparing	  fetal	  growth	  within	  twin	  pairs,	  a	  specific	  measure	  of	  fetal	  growth	  is	  targeted.	  Since	  all	  factors	  shared	  by	  the	  twins	  in	  a	  twin	  pair	  are	  held	  constant	  (e.g.	  early	  socioeconomic	  environment	  and	  common	  genetic	  factors),	  these	  cannot	  influence	  the	  within-­‐twinpair	  associations.	  Twins	  as	  a	  group	  are	  further	  exposed	  to	  a	  more	  adverse	  fetal	  environment	  than	  singletons.	  By	  comparing	  adult	  morbidity	  and	  mortality	  in	  twins	  to	  singletons	  from	  twin	  families,	  the	  influence	  of	  twinning	  on	  later	  health	  will	  be	  independent	  of	  factors	  shared	  by	  twin	  families.	  The	  comparison	  serves	  as	  an	  instrument	  to	  evaluate	  whether	  twins	  are	  different	  from	  singletons	  with	  respect	  to	  large	  common	  disease	  outcomes.	  Potential	  differences	  throughout	  the	  life	  course	  may	  have	  implications	  for	  the	  extent	  to	  which	  findings	  in	  twins	  can	  be	  generalized	  to	  singletons	  or	  the	  population	  at	  large.	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6.1 TWINS	  AND	  DOHAD	  The	  validity	  of	  using	  twins	  to	  evaluate	  DOHaD	  related	  hypotheses	  has	  been	  questioned.	  The	  predominant	  reservations	  appear	  to	  concern	  whether	  findings	  in	  twins	  can	  be	  considered	  representative	  of	  singleton	  populations.	  	  	  
6.1.1 EXTERNAL	  VALIDITY	  OF	  TWIN	  STUDIES	  Generalizability	  of	  twin	  studies	  to	  the	  general	  population	  is	  commonly	  questioned.	  A	  potential	  threat	  to	  representativeness	  could	  be	  if	  twins	  were	  to	  be	  different	  from	  the	  general	  (predominantly	  singleton)	  population	  with	  respect	  to	  the	  phenotypes	  under	  study.	  With	  the	  advent	  of	  fetal	  programming	  theory,	  it	  was	  suggested	  that	  the	  growth	  constraint	  that	  twins	  experience	  compared	  to	  singletons,	  would	  put	  twins	  at	  a	  different	  risk	  of	  some	  adult	  diseases.	  When	  twins	  were	  compared	  to	  the	  general	  population	  with	  respect	  to	  cardiovascular	  mortality	  in	  adulthood,	  however,	  no	  differences	  were	  found	  [22,	  23].	  The	  findings	  have	  further	  been	  confirmed	  by	  our	  comparison	  of	  twins	  and	  singletons	  from	  twin	  families	  concerning	  all-­‐cause	  mortality	  and	  adult	  morbidity	  in	  cardiovascular	  disease	  and	  cancer	  (paper	  IV).	  	  In	  response	  to	  these	  findings,	  it	  has	  been	  argued	  that	  twins	  may	  not	  be	  useful	  in	  exploring	  fetal	  origins	  of	  adult	  disease,	  because	  the	  regulation	  of	  growth	  in	  twins	  may	  be	  inherently	  different	  from	  that	  in	  singletons	  [183].	  Twins	  have	  also	  been	  suggested	  to	  physiologically	  downregulate	  their	  growth	  early	  in	  gestation,	  and	  as	  a	  consequence	  become	  less	  sensitive	  to	  environmental	  insults	  throughout	  gestation	  [183].	  Others	  have	  speculated	  that	  the	  splitting	  into	  two	  embryos	  from	  one	  zygote	  may	  lead	  to	  a	  delay	  of	  the	  embryonic	  development	  in	  MZ,	  which	  in	  turn	  could	  result	  in	  less	  sensitivity	  to	  insults	  compared	  to	  a	  more	  rapidly	  developing	  fetus	  [165].	  With	  respect	  to	  developmental	  plasticity,	  it	  has	  also	  been	  suggested	  that	  epigenetic	  change	  (in	  response	  to	  maternal	  nutrition)	  may	  occur	  already	  in	  the	  preimplantation	  embryo,	  and	  that	  the	  environmental	  influence	  that	  causes	  discordant	  growth	  in	  twins	  would	  then	  occur	  too	  late	  to	  induce	  any	  systemic	  epigenetic	  change	  [130].	  	  In	  contrast	  to	  these	  suggestions	  of	  a	  greater	  resilience	  in	  twins	  against	  fetal	  programming	  effects,	  the	  associations	  seen	  between	  birth	  weight	  and	  adult	  diseases	  in	  singletons	  appear	  to	  be	  present	  also	  in	  twin	  samples	  [20,	  21,	  24].	  To	  reconcile	  these	  findings	  with	  those	  of	  no	  differences	  between	  singletons	  and	  twins	  with	  respect	  to	  adult	  outcomes,	  it	  has	  been	  suggested	  that	  the	  general	  growth	  constraint	  of	  twinning	  (due	  to	  sharing	  of	  space	  and	  supply	  line)	  does	  not	  influence	  adult	  disease	  risks,	  whereas	  factors	  that	  make	  twins	  experience	  different	  growth	  (from	  other	  twins	  and	  potentially	  also	  from	  their	  co-­‐twin)	  could	  [25].	  Several	  of	  these	  factors	  would	  be	  fetal	  growth	  determinants	  common	  also	  for	  singletons,	  such	  as	  gestational	  length,	  maternal,	  socioeconomic,	  and	  genetic	  factors.	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6.1.2 INTERNAL	  VALIDITY	  OF	  TWIN	  STUDIES	  The	  main	  challenge	  of	  studying	  fetal	  exposures	  in	  humans	  concerns	  the	  procurement	  of	  valid	  measures	  for	  the	  exposures	  of	  interest.	  Indicators	  of	  the	  fetal	  experience	  are	  commonly	  evaluated	  at	  birth,	  with	  measures	  of	  size	  for	  example	  taken	  to	  indicate	  growth	  in	  utero.	  The	  foundation	  of	  DOHaD	  theories	  relies	  on	  such	  proxy	  measures	  of	  fetal	  growth,	  which	  in	  turn	  appears	  to	  have	  been	  taken	  to	  indicate	  fetal	  nutrition.	  As	  discussed	  in	  the	  background,	  both	  proxy	  measures	  (such	  as	  birth	  weight)	  and	  fetal	  growth	  are	  determined	  by	  many	  other	  factors	  than	  fetal	  nutrition.	  Unrelated	  individuals	  may	  differ	  in	  these	  measures	  due	  to	  differences	  in	  gestational	  age,	  maternal	  constitution,	  environment	  and	  behavior,	  genetic	  differences,	  etc.	  Other	  than	  the	  potential	  for	  misclassification	  when	  using	  proxies,	  there	  is	  concern	  that	  some	  of	  the	  factors	  influencing	  these	  may	  also	  be	  involved	  in	  disease	  development,	  introducing	  a	  spurious	  association.	  	  	  	  In	  twins,	  growth	  discordance	  is	  mainly	  a	  result	  of	  unequal	  share	  of	  the	  supply	  line	  (in	  DZ	  twins	  also	  a	  difference	  in	  fetal	  genetic	  factors).	  The	  availability	  of	  the	  supply	  line	  in	  turn,	  is	  a	  reflection	  of	  individual	  fetal	  nutrition.	  In	  addition,	  the	  birth	  weight	  discordance	  within	  twin	  pairs	  is	  commonly	  relatively	  large	  and	  develops	  predominantly	  in	  the	  third	  trimester,	  which	  by	  the	  original	  fetal	  origins	  hypothesis	  was	  stipulated	  to	  be	  the	  most	  critical	  period	  for	  insults.	  	  	  	  Moreover,	  when	  comparisons	  are	  made	  within	  twin	  pairs,	  all	  factors	  shared	  by	  the	  pair	  are	  held	  constant.	  Birth	  weight	  differences	  within	  twin	  pairs	  will	  thus	  be	  independent	  of	  factors	  such	  as	  gestational	  age,	  maternal	  factors	  (e.g.	  constitution	  and	  behaviors),	  the	  early	  socioeconomic	  environment,	  etc.	  In	  monozygotic	  twin	  pairs,	  a	  difference	  in	  birth	  weight	  can	  further	  not	  be	  attributed	  to	  genetic	  influence.	  	  	  The	  unique	  features	  of	  twins	  have	  also	  been	  used	  to	  evaluate	  the	  role	  of	  shared	  environment	  and	  common	  genes	  on	  associations	  between	  birth	  weight	  and	  later	  outcome,	  by	  comparing	  within-­‐twinpair	  associations	  to	  the	  crude	  (i.e.	  between	  twins).	  The	  validity	  of	  such	  practice	  relies	  on	  assumptions	  that	  are	  not	  often	  made	  explicit.	  The	  perhaps	  most	  important	  pertains	  to	  the	  influence	  of	  other	  sources	  of	  bias.	  While	  going	  from	  crude	  to	  within	  comparison	  serves	  to	  remove	  the	  (potential	  confounding)	  influence	  of	  familial	  factors,	  this	  action	  could	  potentially	  also	  change	  the	  influence	  of	  other	  biases.	  Such	  a	  concern	  may	  arise,	  when,	  for	  instance,	  the	  sample	  used	  to	  obtain	  the	  within-­‐twinpair	  estimate	  is	  much	  reduced	  (selected)	  compared	  to	  the	  between-­‐twins	  comparison.	  Potential	  unmeasured	  individual	  confounding	  could	  also	  influence	  the	  between	  and	  within-­‐pair	  association	  differently	  [226].	  	  	   	  Additional	  speculation	  about	  the	  specific	  role	  of	  genetic	  factors	  has	  further	  come	  from	  contrasting	  DZ	  and	  MZ.	  The	  assumption	  that	  MZ	  are	  more	  alike	  than	  DZ	  purely	  as	  a	  result	  of	  their	  genetic	  resemblance	  may	  however	  be	  put	  into	  question.	  While	  the	  common	  reservation	  that	  MZ	  pairs	  may	  be	  treated	  differently	  (and	  therefore	  become	  more	  similar)	  does	  not	  quite	  apply	  to	  the	  intrauterine	  environment,	  the	  plausibility	  of	  an	  equal	  environment	  in	  utero	  may	  still	  need	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scrutiny.	  A	  difference	  in	  the	  shared	  intrauterine	  environment	  for	  DZ	  and	  MZ	  would	  mainly	  be	  attributed	  to	  the	  fraction	  of	  monochorionic	  MZ	  twins,	  which	  have	  a	  greater	  potential	  for	  inter-­‐fetal	  exchange	  (through	  vascular	  anastomoses	  in	  the	  placenta	  they	  share).	  With	  respect	  to	  twin	  growth	  discordance,	  however,	  other	  than	  the	  difference	  in	  genetic	  resemblance,	  the	  main	  determinants	  appear	  to	  be	  the	  same	  in	  monochorionic	  and	  dichorionic	  twins,	  namely	  unequal	  sharing	  of	  the	  supply	  line	  due	  to	  placental	  and	  chord	  function.	  	  By	  allowing	  for	  a	  measure	  of	  fetal	  growth	  that	  is	  independent	  of	  gestational	  age,	  maternal	  factors	  and	  (to	  a	  varying	  degree)	  genetic	  factors,	  within-­‐twin	  pair	  comparisons	  of	  birth	  weight	  can	  address	  several	  of	  the	  shortcomings	  of	  previous	  studies.	  Like	  all	  observational	  studies,	  however,	  internal	  validity	  will	  also	  depend	  on	  the	  potential	  influence	  of	  other	  sources	  of	  bias.	  	  Below	  follows	  a	  discussion	  of	  the	  methodological	  considerations	  specific	  to	  the	  papers	  in	  this	  thesis.	  	  	  6.2 SPECIFIC	  METHODOLOGICAL	  CONSIDERATIONS	  	  The	  study	  subjects	  in	  this	  thesis	  are	  all	  members	  of	  cohorts	  sampled	  from	  some	  theoretical	  source	  population.	  Individuals	  that	  meet	  a	  set	  of	  inclusion	  criteria	  (e.g.	  birth	  year,	  inclusion	  in	  a	  register,	  participation	  in	  data	  collection,	  etc.)	  are	  selected	  and	  followed	  prospectively,	  usually	  for	  a	  fixed	  period	  of	  time.	  When	  follow-­‐up	  extends	  for	  a	  long	  time,	  as	  when	  subjects	  are	  followed	  in	  registers	  of	  health	  (studies	  II-­‐IV),	  another	  type	  of	  selection	  occurs	  as	  subjects	  may	  be	  censored	  due	  to	  migration	  or	  death	  from	  other	  causes.	  Both	  types	  of	  selection	  (to	  and	  from)	  may	  have	  consequences	  for	  validity.	  	  Other	  than	  fulfilling	  the	  features	  that	  define	  the	  source	  population	  (such	  as	  being	  twins	  of	  AA	  or	  EA	  descent	  and	  attending	  public	  schools	  in	  Georgia)	  the	  twins	  of	  the	  GCTS	  were	  characterized	  by	  their	  willingness	  to	  participate	  in	  a	  study.	  Volunteerism	  can	  be	  associated	  with	  health	  consciousness.	  In	  twin	  volunteer	  cohorts	  females	  and	  monozygotic	  twin	  pairs	  are	  often	  overrepresented,	  and	  this	  was	  noted	  also	  in	  the	  GCTS.	  Any	  greater	  influence	  from	  potential	  unmeasured	  common	  causes	  of	  volunteering	  and	  blood	  pressure	  (e.g.	  health	  consciousness),	  and	  birth	  weight	  (e.g.	  socioeconomic	  status,	  as	  illustrated	  in	  the	  DAG	  on	  page	  22),	  is	  considered	  unlikely,	  and	  not	  least	  with	  respect	  to	  within-­‐twinpair	  birth	  weight.	  We	  see	  no	  reason	  why	  the	  within-­‐twinpair	  comparison	  of	  the	  GCTS	  twins	  would	  further	  not	  be	  representative	  for	  the	  source	  population.	  	   	  For	  the	  STR	  cohort	  used	  in	  this	  thesis,	  and	  the	  matched	  cohorts	  of	  twins	  and	  singletons	  from	  the	  MGR,	  selection	  depends	  on	  inclusion	  criteria	  of	  the	  registers.	  Because	  the	  registers	  were	  established	  several	  years	  after	  the	  study	  subjects	  were	  born,	  the	  members	  of	  the	  cohorts	  will	  be	  survivors	  up	  to	  a	  certain	  age.	  In	  the	  cohorts	  sampled	  from	  the	  MGR,	  individuals	  had	  to	  be	  alive	  from	  3	  up	  to	  29	  years.	  In	  the	  STR	  both	  twins	  of	  the	  pair	  had	  to	  be	  alive	  in	  1971,	  and	  in	  addition,	  zygosity	  status	  had	  to	  be	  determined	  through	  data	  collection	  participation.	  Over	  80%	  response	  rate	  in	  the	  1972-­‐1973	  questionnaire	  should	  however	  mitigate	  concerns	  about	  strong	  volunteer	  selection.	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  The	  potential	  influence	  of	  survival	  selection	  bias	  was	  of	  particular	  interest	  in	  the	  contrasting	  of	  twins	  and	  singleton	  morbidity	  and	  mortality	  “across	  the	  lifespan”.	  Twins	  are	  at	  increased	  risk	  of	  perinatal	  and	  infant	  mortality	  [227],	  and	  early	  selection	  could	  potentially	  make	  twins	  a	  more	  resilient	  group	  (on	  average)	  compared	  to	  singleton	  survivors.	  In	  the	  comparison	  of	  survivors	  one	  would	  then	  expect	  a	  lower	  risk	  of	  mortality	  (and	  potentially	  also	  lower	  risk	  of	  other	  negative	  health	  outcomes)	  in	  the	  resilient	  group	  (twins)	  compared	  to	  singletons.	  The	  fact	  that	  we	  did	  not	  see	  any	  such	  tendencies	  could	  either	  indicate	  that	  such	  survival	  bias	  does	  not	  exist,	  that	  it	  has	  little	  influence,	  or	  that	  its	  expected	  effect	  has	  been	  outweighed	  by	  the	  presence	  of	  another	  negative	  health	  influence	  unique	  to	  twins.	  	  In	  cohort	  studies,	  exposure	  status	  is	  established	  before	  the	  outcome	  occurs.	  This	  prospective	  design	  ensures	  that	  the	  exposure	  assessment	  is	  not	  influenced	  by	  the	  outcome.	  If	  the	  exposure	  is	  assessed	  in	  retrospect	  once	  the	  outcome	  has	  occurred,	  the	  accuracy	  with	  which	  exposure	  is	  reported	  may	  differ	  between	  the	  diseased	  and	  the	  non-­‐diseased	  (a	  differential	  misclassification	  referred	  to	  as	  recall	  bias).	  In	  the	  Georgia	  cohort,	  birth	  weight	  information	  was	  self-­‐reported	  by	  the	  mothers	  at	  the	  twins’	  first	  visit.	  Since	  our	  outcome	  blood	  pressure	  was	  also	  measured	  at	  baseline,	  this	  self-­‐reported	  exposure	  assessment	  was	  not	  prospective.	  At	  the	  time	  of	  recall,	  it	  was	  nevertheless	  unlikely	  that	  mothers	  were	  aware	  of	  their	  healthy	  children’s	  blood	  pressure.	  	  	   	   	  Moreover,	  birth	  weight	  information	  was	  also	  retrieved	  from	  official	  birth	  records	  and	  used	  when	  available,	  so	  that	  self-­‐reports	  were	  used	  in	  40%	  of	  the	  sample.	  In	  the	  twins	  that	  had	  both	  types	  of	  data,	  the	  self-­‐reports	  were	  found	  to	  be	  in	  good	  agreement	  with	  birth	  records	  (r=0.92,	  P<0.01).	  A	  difference	  in	  the	  degree	  of	  misclassification	  (as	  a	  result	  of	  using	  self-­‐reports)	  could	  potentially	  contribute	  to	  the	  difference	  seen	  between	  AAs	  and	  EAs.	  Still,	  there	  was	  no	  greater	  difference	  in	  the	  distribution	  of	  self-­‐reports,	  or	  their	  agreement	  with	  birth	  records,	  between	  ethnic	  groups.	  	  In	  within-­‐twinpair	  comparison	  of	  exposures	  at	  birth	  in	  particular,	  the	  potential	  influence	  from	  cross-­‐misclassification	  also	  needs	  to	  be	  considered.	  Assigning	  a	  twin	  the	  characteristics	  of	  its	  co-­‐twin	  (and	  vice	  versa)	  will	  distort	  any	  true	  influence	  of	  that	  characteristic,	  and	  conclusions	  from	  within-­‐twinpair	  comparisons	  may	  be	  biased	  as	  a	  result.	  In	  the	  GCTS	  we	  had	  little	  ability	  to	  evaluate	  potential	  existence	  and	  influence	  of	  cross-­‐misclassification,	  other	  than	  indirect	  indications	  from	  the	  high	  correlation	  between	  self-­‐reports	  and	  birth	  records.	  In	  the	  STR	  cohort,	  however,	  efforts	  were	  made	  to	  minimize	  cross-­‐misclassification,	  by	  requiring	  twins	  to	  either	  have	  been	  baptized	  at	  birth	  or	  to	  have	  accurately	  reported	  their	  birth	  order	  (in	  agreement	  with	  the	  recorded	  birth	  order).	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Outcome	  classification	  was,	  in	  the	  three	  Swedish	  studies,	  based	  on	  diagnose	  identification	  in	  national	  registers	  of	  health.	  This	  practice	  assumes	  that	  incident	  events	  occur	  in	  Sweden,	  and	  are	  correctly	  diagnosed	  and	  recorded	  to	  the	  register(s).	  In	  this	  thesis	  the	  cardiovascular	  disease	  definition	  was	  restricted	  to	  acute	  events,	  in	  part	  to	  target	  the	  main	  adult	  CVDs,	  but	  also	  because	  these	  outcomes	  are	  likely	  to	  be	  caught	  in	  either	  hospital	  or	  cause	  of	  death	  records	  (high	  sensitivity).	  For	  breast	  cancer,	  there	  was	  a	  concern	  that	  cancer	  cases	  may	  be	  missed	  due	  to	  the	  limited	  ability	  to	  account	  for	  migration.	  In	  the	  study	  population	  considered	  at	  risk,	  individuals	  could	  have	  migrated	  (from	  Sweden	  and	  back)	  during	  the	  follow-­‐up.	  If	  a	  woman	  was	  diagnosed	  (and	  treated)	  abroad,	  her	  cancer	  status	  could	  be	  delayed	  or	  missed	  in	  the	  Swedish	  Cancer	  Register.	  The	  likelihood	  of	  this	  happening	  in	  the	  estimated	  small	  number	  of	  migrators	  was,	  however,	  judged	  to	  be	  low.	  Later	  linkage	  with	  migration	  data	  has	  also	  allowed	  verification	  of	  no	  discernible	  outcome	  misclassification	  bias.	  	  	  	   	  The	  presence	  of	  collider-­‐stratification	  bias	  may,	  as	  previously	  discussed,	  be	  of	  concern	  for	  the	  topics	  under	  study	  here.	  In	  the	  field	  of	  early	  origins	  of	  later	  disease	  there	  are	  a	  number	  of	  things	  happening	  from	  the	  time	  of	  exposure	  until	  the	  onset	  of	  disease	  that	  may	  or	  may	  not	  be	  appropriate	  to	  account	  for.	  The	  careful	  reader	  may	  notice	  that	  the	  present	  work	  is	  not	  exempt	  from	  potentially	  inappropriate	  practice.	  In	  the	  first	  study,	  our	  aim	  was	  to	  explore	  whether	  there	  was	  any	  support	  for	  the	  claim	  that	  ethnic	  differences	  originate	  in	  utero.	  For	  this	  to	  hold,	  it	  was	  argued	  that	  fetal	  growth	  would	  have	  to	  be	  associated	  with	  blood	  pressure	  independent	  of	  familial	  factors	  in	  African	  Americans.	  Before	  exploring	  this	  through	  within-­‐twinpair	  comparison,	  we	  assessed	  whether	  the	  effect	  of	  ethnicity	  on	  blood	  pressure	  remained	  after	  adjustment	  for	  birth	  weight.	  Ethnicity	  is	  a	  strong	  predictor	  of	  birth	  weight,	  and	  we	  do	  suspect	  that	  there	  can	  be	  unmeasured	  common	  causes	  of	  birth	  weight	  and	  blood	  pressure	  	  (e.g.	  socioeconomic	  and	  genetic	  factors).	  Since	  conditioning	  on	  birth	  weight	  thus	  may	  have	  introduced	  a	  spurious	  association	  between	  ethnicity	  and	  blood	  pressure,	  the	  claim	  that	  birth	  weight	  cannot	  “explain”	  ethnic	  differences	  in	  blood	  pressure	  may	  not	  be	  valid.	  	  In	  studies	  of	  associations	  between	  birth	  weight	  and	  later	  health	  outcomes,	  the	  influence	  from	  potential	  confounding	  is	  of	  particular	  concern.	  The	  cohort	  analyses	  in	  this	  thesis	  share,	  and	  illustrate,	  several	  of	  the	  limitations	  of	  previous	  studies	  in	  unrelated	  individuals.	  In	  the	  GCTS	  there	  was,	  for	  example,	  no	  ability	  to	  account	  for	  gestational	  age,	  which	  may	  be	  an	  independent	  determinant	  of	  blood	  pressure.	  In	  addition,	  information	  on	  maternal	  morbidities	  and	  parental	  socioeconomic	  status	  was	  incomplete	  both	  in	  the	  GCTS	  and	  the	  STR.	  The	  purpose	  of	  the	  within-­‐twinpair	  comparisons,	  however,	  has	  been	  to	  address	  several	  of	  these	  shortcomings.	  	  While	  the	  associations	  obtained	  from	  within-­‐twinpair	  comparison	  cannot	  be	  confounded	  by	  the	  factors	  shared	  by	  the	  twin	  pair,	  they	  are	  still	  susceptible	  to	  potential	  confounding	  from	  factors	  that	  are	  not	  shared	  by	  the	  twins	  of	  a	  twin	  pair.	  In	  these	  studies	  of	  prenatal	  growth,	  influence	  from	  individual	  common	  causes	  of	  the	  exposure	  and	  later	  outcome	  may	  be	  of	  a	  less	  concern.	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6.3 FINDINGS	  &	  IMPLICATIONS	  	  In	  paper	  I,	  the	  aim	  was	  to	  investigate	  the	  grounds	  for	  the	  claim	  that	  ethnic	  differences	  in	  blood	  pressure	  originate	  in	  utero.	  For	  this	  to	  hold,	  we	  would	  expect	  there	  to	  be	  an	  association	  between	  birth	  weight	  and	  blood	  pressure,	  independent	  of	  familial	  factors,	  in	  African	  Americans.	  While	  abundant	  evidence	  exist	  to	  support	  such	  an	  association	  predominantly	  in	  white	  populations	  of	  all	  ages	  [85],	  investigations	  in	  AAs	  are	  still	  scarce.	  	  Only	  one	  of	  the	  few	  studies	  assessing	  the	  association	  in	  AA	  children	  or	  young	  adults	  has	  reported	  of	  an	  inverse	  association	  in	  AAs	  similar	  to	  that	  seen	  in	  EAs,	  amplifying	  with	  age	  [97].	  Another	  study	  tracking	  children	  into	  adolescence	  found	  an	  inverse	  association	  only	  in	  EAs	  [88].	  In	  these	  and	  most	  other	  studies,	  the	  ability	  to	  evaluate	  confounding	  by	  common	  causes	  of	  birth	  weight	  and	  blood	  pressure	  was	  limited.	  	  	  As	  expected,	  mean	  blood	  pressure	  levels	  were	  found	  higher	  in	  AAs	  than	  in	  EAs	  in	  our	  sample	  of	  adolescent	  twins.	  However,	  only	  the	  girls	  were	  also	  significantly	  different	  with	  respect	  to	  mean	  birth	  weight	  (AA	  girls	  weighted	  less	  than	  EA	  girls).	  More	  importantly,	  an	  inverse	  association	  between	  birth	  weight	  and	  systolic	  blood	  pressure	  was	  present,	  and	  found	  to	  be	  independent	  of	  familial	  factors	  in	  AA,	  but	  not	  in	  EA	  twins.	  	  The	  inconsistency	  of	  results	  from	  previous	  bi-­‐ethnic	  samples	  could	  be	  due	  to	  small	  sample	  sizes,	  different	  age	  distributions	  when	  measuring	  blood	  pressure,	  and	  inadequate	  control	  for	  confounding	  factors.	  Particularly	  the	  variation	  with	  age	  may	  be	  of	  importance	  in	  this	  case,	  as	  a	  general	  attenuation	  of	  the	  association	  of	  birth	  weight	  and	  blood	  pressure	  during	  adolescence	  has	  been	  noted	  and	  attributed	  to	  changes	  during	  puberty	  [89].	  Potential	  ethnic	  differences,	  in	  for	  instance	  sexual	  maturation,	  could	  thus	  in	  part	  account	  for	  disparities	  in	  the	  birth	  weight	  –	  blood	  pressure	  association.	  Catch-­‐up	  growth,	  and	  especially	  centile	  crossing	  catch-­‐up	  in	  childhood	  by	  babies	  small	  at	  birth,	  is	  often	  discussed	  as	  an	  important	  component	  in	  the	  pathway	  towards	  future	  morbidity	  [228].	  Without	  knowledge	  of	  the	  early	  postnatal	  growth	  trajectories	  in	  this	  cohort,	  we	  cannot	  exclude	  that	  ethnic	  differences	  also	  with	  respect	  to	  catch-­‐up	  growth	  could	  explain	  some	  of	  our	  findings.	  	  	  Ethnic	  differences	  in	  mean	  blood	  pressure	  levels	  found	  in	  this	  sample	  were	  not	  consistently	  matched	  by	  corresponding	  differences	  in	  birth	  weight.	  However,	  the	  finding	  of	  an	  inverse	  association	  between	  birth	  weight	  and	  systolic	  blood	  pressure	  in	  AAs	  (independent	  of	  familial	  factors)	  suggests	  that	  the	  generally	  less	  favorable	  birth	  weight	  outcome	  in	  AAs	  may	  be	  of	  consequence	  for	  future	  blood	  pressure.	  The	  findings	  support	  further	  tracking	  of	  the	  birth	  weight	  association	  to	  blood	  pressure	  into	  adulthood	  in	  this	  ethnic	  group.	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In	  like-­‐sexed	  Swedish	  twins	  of	  known	  zygosity,	  high	  birth	  weight	  was	  found	  to	  confer	  an	  increased	  risk	  of	  breast	  cancer	  diagnosed	  before	  or	  at	  the	  age	  of	  50.	  The	  positive	  linear	  association	  seen	  in	  twins	  above	  2,500	  g	  also	  appeared	  to	  be	  independent	  of	  familial	  factors	  (shared	  early	  environment	  and	  common	  genes).	  	  The	  findings	  are	  in	  agreement	  with	  the	  results	  from	  recent	  reviews	  and	  meta-­‐analyses	  [16-­‐19]	  which	  all	  confirm	  a	  modest	  increased	  risk	  of	  breast	  cancer	  with	  increasing	  birth	  weight,	  particularly	  in	  women	  diagnosed	  before	  or	  at	  menopause.	  In	  a	  large	  re-­‐analysis	  of	  individual-­‐level	  data,	  birth	  length	  was	  found	  to	  be	  a	  stronger	  predictor	  of	  breast	  cancer	  risk	  than	  birth	  weight	  [19].	  Birth	  length	  had	  no	  effect	  on	  the	  risk	  of	  breast	  cancer	  in	  our	  study,	  which	  could	  potentially	  be	  a	  result	  of	  imprecise	  measurement	  	  (birth	  length	  generally	  being	  more	  prone	  to	  measurement	  error).	  	  Finding	  a	  positive	  association	  between	  birth	  weight	  and	  risk	  of	  early	  onset	  breast	  cancer	  also	  within	  twin	  pairs	  indicates	  a	  role	  for	  the	  individual	  prenatal	  experience	  with	  respect	  to	  fetal	  nutrition	  and	  growth.	  The	  association	  between	  birth	  weight	  and	  breast	  cancer	  has	  been	  proposed	  to	  reflect	  uterine	  hormonal	  exposure,	  which	  could	  both	  stimulate	  fetal	  growth	  and	  have	  carcinogenic	  effects	  on	  the	  breast	  [12].	  Our	  findings	  have	  no	  straightforward	  translation	  to	  inference	  concerning	  potential	  hormone	  exposure	  pathways.	  Little	  is	  known	  of	  fetal	  hormonal	  exposure	  in	  twins,	  both	  in	  relation	  to	  the	  mother	  and	  the	  co-­‐twin.	  While	  pregnancy	  is	  associated	  with	  high	  estrogen	  levels	  in	  the	  mother	  [229],	  the	  correlations	  to	  the	  levels	  in	  the	  fetal	  cord	  blood	  seem	  moderate	  [230].	  Furthermore,	  the	  levels	  of	  estrogen	  in	  the	  fetal	  circulation	  throughout	  pregnancy	  are	  still	  largely	  unknown.	  Maternal	  estrogen	  levels	  are	  higher	  in	  twin	  compared	  with	  singleton	  pregnancies	  [109],	  but	  to	  which	  extent	  prenatal	  hormonal	  exposures	  are	  shared	  within	  twin	  siblings	  is	  also	  unknown.	  	  	  There	  is	  increasing	  interest	  for	  the	  potential	  role	  of	  epigenetics	  in	  DOHaD	  [130].	  Epigenetic	  modulation	  may	  (due	  to	  differing	  gene	  expression)	  lead	  to	  phenotypic	  differences	  within	  monozygotic	  twin	  pairs	  [175].	  	  Fetal	  growth	  may	  in	  part	  be	  epigenetically	  determined	  through	  imprinting,	  with	  most	  imprinted	  genes	  also	  being	  expressed	  in	  the	  placenta	  [231].	  The	  imprinted	  IGF2	  gene	  has	  been	  proposed	  to	  control	  both	  placental	  supply	  and	  fetal	  demand	  for	  nutrients	  [115],	  and	  loss	  of	  imprinting	  and	  bi-­‐allelic	  expression	  of	  the	  IGF2	  allele	  has	  been	  linked	  to	  both	  fetal	  growth	  [115,	  116]	  and	  breast	  cancer	  development	  [113,	  114].	  With	  respect	  to	  our	  findings,	  any	  individually	  acquired	  epigenetic	  changes	  during	  prenatal	  life	  (possibly	  in	  response	  to	  individual	  environmental	  stimuli)	  would	  appear	  independent	  of	  familial	  factors.	  	  These	  findings	  indicate	  that	  the	  intrauterine	  experience	  may	  be	  of	  importance	  for	  the	  development	  of	  early	  onset	  breast	  cancer.	  In	  the	  continued	  efforts	  to	  understand	  how	  fetal	  factors	  influence	  breast	  cancer	  etiology,	  these	  findings	  support	  further	  investigation	  of	  prenatal	  exposures	  or	  events	  that	  are	  independent	  of	  familial	  factors.	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Including	  also	  the	  like-­‐sexed	  men	  of	  the	  1926-­‐1958	  STR	  cohort,	  we	  could	  further	  show	  that	  birth	  weight	  was	  inversely	  associated	  with	  risk	  of	  CVD	  within	  dizygotic,	  but	  not	  within	  monozygotic	  twin	  pairs.	  Similar	  to	  previous	  findings	  in	  singletons,	  associations	  were	  seen	  for	  both	  coronary	  heart	  disease	  and	  ischemic	  stroke,	  but	  only	  within	  dizygotic	  twin	  pairs.	  The	  findings	  indicate	  that	  understanding	  what	  factors	  are	  shared	  within	  monozygotic	  but	  not	  within	  dizygotic	  twin	  pairs	  could	  provide	  insights	  to	  the	  mechanisms	  behind	  birth	  weight	  –	  CVD	  association.	  	  Factors	  that	  are	  shared	  within	  MZ	  twin	  pairs	  but	  not	  DZ	  pairs	  are	  discussed	  in	  detail	  in	  the	  background	  (twins;	  pages	  24-­‐27).	  Vascular	  anastomoses	  in	  the	  placentas	  of	  MZMC	  twins	  allow	  for	  a	  unique	  sharing	  between	  these	  twins	  compared	  to	  MZDC	  and	  DZ.	  Within-­‐twinpair	  estimates	  of	  growth	  will	  be	  independent	  of	  such	  factors,	  so	  that	  if	  these	  were	  to	  be	  the	  causal	  antecedents	  of	  fetal	  programming,	  we	  would	  not	  expect	  to	  see	  a	  within-­‐twinpair	  association	  in	  MZMC.	  It	  is	  however	  unclear	  what	  these	  factors	  would	  be.	  The	  other	  fundamental	  difference	  between	  MZ	  and	  DZ	  with	  respect	  to	  within-­‐twinpair	  sharing	  concerns	  the	  degree	  of	  shared	  genetic	  factors.	  Since	  the	  within-­‐twinpair	  association	  is	  independent	  of	  genetic	  factors	  within	  MZ	  but	  not	  DZ	  twin	  pairs,	  our	  findings	  are	  compatible	  with	  there	  being	  a	  common	  genetic	  background	  for	  fetal	  growth	  and	  cardiovascular	  disease.	  In	  such	  a	  case	  an	  intergenerational	  association	  between	  the	  two	  phenotypes	  could	  be	  expected,	  and	  has	  been	  confirmed	  in	  some	  studies	  (offspring	  birth	  weight	  and	  parental/grandparental	  CVD	  mortality)	  [232,	  233].	  	  	  Another	  potential	  and	  speculative	  explanation	  to	  the	  lack	  of	  association	  within	  MZ	  twins	  would	  be	  if	  epigenetic	  changes	  in	  response	  to	  maternal	  nutrition	  only	  occur	  in	  the	  preimplantation	  embryo	  [130].	  Epigenetic	  changes	  occurring	  at	  this	  early	  stage	  would	  be	  independent	  of	  the	  processes	  that	  later	  produce	  within-­‐twinpair	  growth	  discordance.	  However,	  under	  this	  scenario	  we	  see	  no	  principal	  reason	  why	  this	  would	  not	  also	  apply	  to	  DZ	  twins	  who	  also	  share	  early	  environment,	  and	  we	  would	  thus	  not	  expect	  to	  find	  an	  association	  within	  any	  type	  of	  twin	  pairs.	  	  	  It	  has	  further	  been	  proposed	  that	  the	  underlying	  genotype	  may	  modify	  the	  programming	  effects	  of	  early	  life	  exposures	  [234].	  If	  susceptibility	  to	  early	  life	  exposures	  depends	  on	  underlying	  genotype,	  only	  susceptible	  individuals	  would	  contribute	  to	  the	  observed	  associations.	  This	  would	  also	  be	  the	  case	  in	  twins,	  where	  only	  pairs	  in	  which	  the	  exposed	  twin	  was	  also	  genetically	  susceptible	  would	  contribute	  to	  a	  within	  pair	  association.	  It	  follows	  that	  for	  this	  scenario	  to	  be	  compatible	  with	  the	  present	  findings,	  there	  would	  have	  to	  be	  a	  systematic	  difference	  in	  distribution	  of	  genetic	  susceptibility	  between	  DZ	  and	  MZ	  twins;	  notably	  MZ	  twins	  would	  have	  to	  be	  significantly	  less	  genetically	  susceptible	  to	  programming	  in	  utero	  compared	  to	  DZ	  twins.	  	  	  Our	  findings	  indicate	  that	  understanding	  which	  factors	  are	  shared	  within	  MZ	  but	  not	  DZ	  twin	  pairs,	  may	  help	  identify	  the	  underlying	  mechanisms	  to	  the	  association	  between	  birth	  weight	  and	  cardiovascular	  disease.	  	  	   	  
	  	  60	  
Past	  the	  first	  years	  of	  life,	  we	  found	  no	  indication	  that	  twins	  would	  have	  any	  survival	  disadvantage	  (or	  advantage)	  compared	  to	  singletons.	  Overall,	  twins	  did	  not	  appear	  to	  fare	  worse	  than	  singletons	  from	  twin	  families	  with	  respect	  to	  risk	  of	  common	  diseases	  such	  as	  cancer	  and	  CVD,	  or	  with	  respect	  to	  all-­‐cause	  mortality.	  Nor	  did	  individuals	  from	  twin	  families	  appear	  to	  be	  at	  any	  different	  risk	  of	  morbidity	  and	  mortality	  compared	  to	  individuals	  from	  non-­‐twin	  families.	  	  	  	  These	  findings	  confirm	  those	  of	  previous	  studies	  of	  CVD	  and	  all-­‐cause	  mortality	  in	  Swedish	  and	  Danish	  twins	  [22,	  23,	  235].	  The	  lack	  of	  difference	  in	  risk	  between	  twins	  and	  the	  general	  population	  has	  been	  taken	  as	  an	  indication	  that	  the	  general	  growth	  constraint	  due	  to	  twinning	  (sharing	  space	  and	  supply	  line)	  is	  different	  from	  the	  type	  of	  growth	  impairment	  (experienced	  by	  both	  twins	  and	  singletons)	  that	  appears	  to	  be	  associated	  with	  diseases	  later	  in	  life	  [25].	  If	  the	  apparent	  association	  between	  birth	  weight	  and	  CVD	  were	  to	  be	  the	  result	  of	  common	  genetic	  factors	  (which	  would	  be	  in	  line	  with	  the	  results	  of	  our	  assessment	  of	  the	  association	  in	  disease-­‐discordant	  twins)	  there	  would	  be	  no	  reason	  to	  suspect	  any	  difference	  in	  CVD	  risk	  between	  twins	  and	  singletons.	  The	  present	  method	  to	  compare	  twins	  to	  singletons	  of	  twin	  families	  should	  further	  mitigate	  any	  concern	  for	  potential	  confounding	  from	  twin	  family	  factors	  (e.g.	  socioeconomic	  or	  genetic	  factors	  shared	  by	  twin	  families	  at	  large).	  Still,	  the	  unique	  twinning	  experience	  in	  this	  setting	  does	  not	  discriminate	  between	  the	  pre-­‐	  and	  postnatal	  environment.	  	  	  	  	  With	  respect	  to	  overall	  cancer	  risk	  the	  situation	  may	  be	  less	  straightforward.	  Overall,	  our	  findings	  do	  not	  support	  any	  effect	  of	  twinning	  on	  overall	  cancer	  risk.	  This	  is	  in	  line	  with	  previous	  findings	  from	  comparisons	  of	  twins	  and	  the	  population	  in	  Sweden	  [26,	  28],	  whereas	  in	  Norway	  twins	  have	  been	  found	  at	  decreased	  risk	  of	  cancer	  overall	  compared	  to	  the	  general	  population	  [27].	  Cancer	  is	  a	  heterogeneous	  group	  of	  diseases,	  and	  it	  is	  possible	  that	  increased	  risks	  for	  some	  type(s)	  are	  washed	  out	  by	  decreased	  risks	  for	  other(s),	  when	  considered	  all	  together.	  Decreased	  risks	  of	  skin	  and	  colorectal	  cancer	  have	  been	  noted	  in	  both	  Norwegian	  and	  Swedish	  twins	  [26,	  27],	  whereas	  the	  Swedish	  studies	  also	  found	  young	  twins	  at	  increased	  risk	  of	  testicular	  cancer	  [26,	  28]	  and	  breast	  cancer	  [28].	  Since	  these	  studies	  compared	  the	  experience	  of	  twins	  to	  rates	  in	  the	  general	  population,	  it	  should	  be	  interesting	  to	  evaluate	  risks	  of	  subtypes	  of	  cancer	  using	  the	  present	  study	  design	  –	  with	  ability	  to	  make	  comparisons	  independent	  of	  twin	  family	  factors.	  Hence,	  even	  though	  the	  present	  findings	  of	  no	  effect	  of	  twinning	  on	  overall	  risk	  of	  cancer	  may	  present	  some	  comfort	  with	  respect	  to	  representativeness,	  we	  believe	  that	  further	  research	  is	  required,	  as	  twinning	  (and	  potentially	  also	  zygosity)	  may	  influence	  certain	  specific	  cancer	  diseases.	  	  Finding	  that	  the	  unique	  experience	  of	  twinning	  does	  not	  appear	  to	  put	  twins	  at	  any	  different	  risk	  of	  common	  complex	  diseases	  compared	  to	  singletons	  should	  be	  reassuring	  for	  the	  use	  of	  twins	  in	  epidemiological	  research.	  The	  ability	  to	  generalize	  findings	  in	  twins	  is	  of	  great	  importance	  for	  all	  types	  of	  twin	  studies.	  Particularly	  with	  respect	  to	  cardiovascular	  disease	  and	  overall	  mortality	  –	  which	  have	  been	  associated	  with	  an	  adverse	  intrauterine	  experience	  –	  the	  present	  findings	  are	  in	  line	  with	  previous	  claims	  that	  the	  twinning	  experience	  per	  se	  may	  not	  put	  twins	  at	  greater	  risk	  of	  common	  adverse	  health	  outcomes.	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The	  time	  we	  spend	  in	  utero	  is	  undoubtedly	  the	  most	  important	  developmental	  period	  of	  our	  lives.	  Experiences	  in	  this	  critical	  time	  may	  influence	  the	  future	  functioning,	  and	  thereby	  health,	  of	  the	  developing	  individual.	  The	  emergence	  and	  explosion	  of	  the	  DOHaD	  research	  field	  has	  been	  instrumental	  in	  increasing	  the	  awareness	  and	  interest	  for	  the	  importance	  of	  early	  life	  and	  development.	  Although	  extensive	  research	  has	  produced	  sophisticated	  theories	  and	  plausible	  potential	  mechanisms,	  the	  complete	  pathways	  through	  which	  the	  fetal	  environment	  may	  influence	  future	  disease	  development	  in	  humans	  remain	  to	  be	  unraveled,	  and	  even	  more	  so	  the	  specific	  (and	  potentially	  modifiable)	  insults	  or	  triggers.	  	  In	  this	  thesis	  the	  aim	  has	  been	  to	  target	  a	  more	  specific	  measure	  of	  intrauterine	  exposure,	  obtained	  by	  the	  difference	  in	  growth	  between	  twins	  in	  a	  twin	  pair.	  While	  providing	  some	  clues	  about	  the	  role	  of	  fetal	  growth	  in	  DOHaD,	  the	  findings	  also	  illustrate	  the	  complexity	  of	  the	  field,	  and	  of	  attributing	  various	  health	  outcomes	  to	  one	  unifying	  hypothesis.	  Similarly,	  the	  associations	  seen	  between	  birth	  weight	  and	  later	  disease	  are	  not	  likely	  to	  share	  one	  comprehensive	  explanation,	  but	  rather	  reflect	  a	  varying	  degree	  of	  interplay	  between	  influence	  from	  genetic	  factors,	  the	  fetal	  environment	  and	  possibly	  also	  the	  postnatal	  period.	  	  	  The	  major	  challenge	  in	  this	  field	  of	  research	  clearly	  concerns	  the	  ability	  to	  study	  specific	  intrauterine	  exposures.	  While	  animal	  models	  can	  contribute	  with	  information	  about	  the	  consequences	  of	  specific	  prenatal	  insults	  by	  allowing	  experimental	  manipulation,	  the	  extent	  to	  which	  such	  findings	  apply	  to	  the	  generally	  much	  slower	  fetal	  development	  in	  humans	  is	  inconspicuous.	  	  	  While	  we	  believe	  within-­‐twinpair	  comparisons	  can	  provide	  valuable	  clues	  about	  the	  role	  of	  fetal	  growth	  in	  “fetal	  programming”,	  they	  come	  with	  their	  own	  challenges	  and	  potential	  limitations.	  Among	  the	  things	  that	  will	  require	  further	  study	  is	  the	  evaluation	  of	  potential	  threats	  to	  generalizability	  from	  twin	  studies	  concerning	  the	  role	  of	  the	  fetal	  environment	  for	  adult	  disease.	  This	  includes	  a	  better	  understanding	  of	  the	  nature	  of	  twin	  sharing	  of	  e.g.	  hormonal	  factors	  in	  utero	  and	  the	  influence	  of	  inter-­‐fetal	  sharing	  via	  vascular	  anastomoses	  (in	  MZMC).	  Potential	  systematic	  differences	  in	  genetic	  factors	  and/or	  patterns	  of	  epigenetic	  modulation	  in	  twins	  (DZ	  vs.	  MZ)	  also	  need	  further	  investigation.	  Naturally,	  understanding	  if	  and	  to	  what	  extent	  environmentally	  induced	  epigenetic	  changes	  could	  also	  be	  inherited	  should	  be	  of	  great	  consequence.	  The	  potential	  presence	  of,	  and	  influence	  from,	  individual	  common	  causes	  of	  exposure	  and	  outcome	  in	  within-­‐twinpair	  comparisons	  will	  also	  require	  further	  study.	  Lastly,	  many	  previous	  within-­‐twinpair	  comparisons	  have	  been	  hampered	  by	  limited	  power	  (so	  also	  papers	  I	  &	  II	  of	  this	  thesis).	  Stratification	  beyond	  that	  into	  zygotic	  groups	  reduces	  the	  precision	  with	  which	  associations	  are	  estimated.	  Thus,	  even	  with	  high	  validity	  large	  samples	  will	  be	  required	  for	  inference	  from	  within-­‐twinpair	  comparisons.	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6.4 OVERALL	  CONCLUSIONS	  	  	  
o The	  previously	  well-­‐established	  inverse	  association	  between	  birth	  weight	  and	  blood	  pressure	  appears	  to	  be	  present	  also	  in	  African	  American	  adolescent	  twins,	  independent	  of	  familial	  factors.	  	  	  
o Increasing	  birth	  weight	  (from	  2,500g	  and	  upward)	  in	  female	  twins	  is	  associated	  with	  an	  increased	  risk	  of	  breast	  cancer	  diagnosed	  at	  50	  years	  or	  earlier,	  and	  the	  association	  appears	  independent	  of	  familial	  factors.	  	  	  
o Birth	  weight	  is	  inversely	  associated	  with	  risk	  of	  cardiovascular	  disease	  within	  dizygotic	  but	  not	  monozygotic	  twin	  pairs.	  In	  twins,	  there	  is	  no	  support	  for	  an	  association	  between	  birth	  weight	  and	  cardiovascular	  disease	  in	  the	  absence	  of	  genetic	  variation.	  	  	  	  
o Twins	  do	  not	  fare	  worse	  than	  their	  singleton	  siblings	  with	  respect	  to	  cumulative	  risks	  of	  cardiovascular	  disease,	  overall	  cancer	  or	  mortality.	  Furthermore,	  twin	  family	  membership	  does	  not	  appear	  to	  influence	  the	  risk	  of	  either	  of	  these	  outcomes.	  Overall,	  twins	  do	  not	  appear	  different	  from	  the	  general	  population	  with	  respect	  to	  adult	  morbidity	  and	  mortality.	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